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Selective gas-phase dissociation strategies have been developed for the 
characterization of cross-linked peptides and proteins in quadrupole ion trap mass 
spectrometers.  An infrared chromogenic cross-linker (IRCX) containing a 
phosphotriester afforded rapid differentiation of cross-linked peptides from unmodified 
ones in proteolytic digests of cross-linked proteins by selective infrared multiphoton 
dissociation (IRMPD).  Only the cross-linked peptides containing the chromogenic 
phosphate underwent IRMPD and unmodified peptides were not affected by IR 
irradiation.  IRMPD of IRCX-cross-linked peptides yielded uncross-linked y-ion 
sequence tags of the constituent peptides due to secondary dissociation of all primary 
product ions which contained the chromophore, thus allowing successful de novo 
sequencing of the cross-linked peptides. 
Peptides cross-linked via a two-step conjugation strategy through the formation of 
a bis-arylhydrazone (BAH) bond were selectively dissociated by ultraviolet radiation at 
 vii
355 nm.  The BAH-cross-linked peptides could be distinguished from not only 
unmodified peptides but also dead-end modified peptides based on the selectivity of 
ultraviolet photodissociation.  In a complementary approach, electron transfer 
dissociation of BAH-cross-linked peptides resulted in preferential cleavage of the 
hydrazone bond which produced two modified peptides.  These modified peptides were 
subsequently interrogated by CID which allowed for the original site of cross-linking to 
be pinpointed. 
IRMPD was implemented in a dual pressure linear ion trap to demonstrate 
successful photodissociation of peptides having modest absorptivities.  Peptides were 
observed to efficiently dissociation by IR irradiation exclusively in the low pressure cell 
whereas no dissociation was observed in the high pressure cell due to extensive 
collisional cooling.  IRMPD provided greater sequence coverage of the peptides than 
CID and yielded product ion mass spectra which were predominantly composed of singly 
charged product ions which simplified spectral interpretation.  IRMPD was further 
applied for the sequencing of small-interfering RNA.  Complete sequence coverage was 
obtained and the results were compared to CID. 
 viii
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The field of proteomics has greatly expanded in the past decade, in part due to 
advances in the mass spectrometric analyses of such biological species.1, 2  Of particular 
interest is protein structure determination and identification of protein-protein 
interactions to better understand the roles and functions of proteins.3  One method that 
has shown considerable promise in these fields is chemical cross-linking with mass 
spectrometric analysis.  This dissertation focuses on the development and implementation 
of chemical cross-linking protocols utilizing selective gas-phase dissociation methods 
including infrared multiphoton dissociation (IRMPD), ultraviolet photodissociation 




The chemical cross-linking of proteins along with mass spectrometric analysis has 
become a more widely used method for the determination of low-resolution protein 
structure and identification of protein-protein interactions and their interfaces.4, 5  
Chemical cross-linking involves reacting proteins or protein-protein complexes with 
small, organic cross-linking reagents which binds two amino acids residues of the protein 
(or proteins) that are spatially constrained.  By identifying which amino acid residues 
were cross-linked, one can determine an approximate distance between the two residues 
or identify the interface of interaction of a protein-protein complex.  Chemical cross-
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linkers generally consist of two functional groups which are reactive towards a specific 
amino acid side chain (e.g., N-hydroxysuccinimide esters which react with primary 
amines of Lys; maleimides which react with free sulfhydryl groups of Cys) and are often 
separated by a carbon spacer chain.  
Mass spectrometry (MS) is an ideal method for the analysis of cross-linked 
proteins.  Unlike traditional protein structural determination techniques such as NMR and 
X-ray crystallography which require on the order of milligrams of pure protein, the MS 
analysis requires sub-microgram (picomole level) quantities of proteins that can exist as 
several different species (e.g., protein variants, or proteins with post-translational 
modifications).  The chemical cross-linking experiments and subsequent MS analysis can 
typically be performed in a few weeks compared to months or years to elucidate protein 
structures by NMR or X-ray crystallography.  Mass spectrometry is also well-suited for 
the analysis of chemically cross-linked protein-protein complexes which are often not 
amenable for traditional biological structural analyses.  The wide-range of cross-linking 
reagents available allows one to fine-tune the chemical cross-linking reaction by targeting 
specific amino acid side chains or functionalities based on the protein or protein-protein 
complex of interest.6  By varying the spanner arm length (i.e., the approximate distance 
the cross-linker can bridge) of the cross-linking reagents one can also obtain more precise 
spatial distance constraints between the cross-linked residues.7, 8  The distance constraints 
obtained from these results in general showed good agreement with measured distances 
in NMR and X-ray crystallography structures.7, 9  Chemical cross-linking with mass 
spectrometric analysis has not only been used to obtain low-resolution three-dimensional 
structures of proteins8, 9 and protein complexes10-13 but has been successfully been 
applied to determine the fold of a protein,14 determine sites of interaction of RNA-protein 
complexes15, 16  and identify DNA-binding proteins.17, 18 Kim et al. have probed 
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conformational changes of proteins upon ligand binding19 protein activation and 
inhibition.20, 21   
While the chemical cross-linking experimental procedure is well-established, 
several analytical hurdles in the identification of cross-link locations remain.  Cross-
linked proteins (or protein-protein complexes) are subjected to proteolytic digestion 
which produces a complex, heterogeneous mixture of unmodified, dead-end modified, 
intramolecularly cross-linked, and intermolecularly cross-linked peptides (Scheme 1.1).  
The low stoichiometry of the cross-linked peptides of interest further complicates the 
analysis and detection of these species.  After enzymatic digestion, the peptide mixture is 
typically analyzed by LC-MS/MS (i.e., tandem mass spectrometry) and the separated 
peptides are individually interrogated by gas-phase dissociation methods (e.g., collision-
induced dissociation) as shown in Scheme 1.2.  Interpretation of the product ion mass 
spectra (i.e., fragmentation spectra) of cross-linked peptides, particularly for 
intermolecularly cross-linked peptides, is complicated by the fact that dissociation can 
occur along the backbone of either constituent peptide or the cross-linker.  While several 
software tools are available to aid in interpreting product ion mass spectra of cross-linked 
peptides,22-25 few are capable of utilizing database search algorithms and none has found 
widespread use amongst the research community. 
Scheme 1.1 Cross-linked peptide product types. (A) Dead-end modification; (B) 
intramolecular cross-link; and (C) intermolecular cross-link. 
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The first challenge in determining the sites of cross-linking is identification of the 
cross-linked peptides of interest.  Enzymatic digestion of the cross-linked protein yields a 
heterogeneous mixture that predominantly contains unmodified peptides in addition to 
products of the cross-linking reaction which include dead-end modification peptides, 
intramolecularly cross-linked peptides, and intermolecularly cross-linked peptides.  These 
three types of products are shown in Scheme 1.1; dead-end modified peptides result from 
one end of the bifunctional cross-linking reagent reacting with an amino acid side chain 
of the protein and the other functional group is hydrolyzed.  These dead-end 
modifications generally only provide information as to the surface accessibility of the 
residue which was modified but no structural information as it relates to distance 
constraints or protein-protein interfaces.  The low abundance of cross-linked peptides in 
Scheme 1.2 Chemical cross-linking and mass spectrometry experimental and analytical
approach. 
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the enzymatic digest necessitates up-front separation methods or affinity chromatography 
methods to enrich cross-linked peptides. 
The Sinz group has utilized sulfhydryl reactive fluorogenic cross-linkers to 
distinguish between unmodified and cross-linked peptides during LC separations with 
online fluorescence detection and MS analysis.26, 27  While the fluorogenic cross-linkers 
allow for differentiation, several other groups have developed trifunctional cross-linkers 
with affinity tags for enrichment of cross-linked peptides.28-33  The most common 
approach has been using biotinylated cross-linkers for enrichment on avidin beads.29, 30  
Recently, Yan et al. designed a cross-linker with an acetyl-protected thiol group that upon 
deprotection selectively reacts with an iodo group on functionalized beads as a non-
protein based enrichment strategy.28 
Isotopically labeled cross-linkers have also been developed to aid in 
distinguishing cross-linked peptides from unmodified ones in the mass spectra acquired 
during LC separations.  By reacting the protein with the deuterium-labeled (i.e., heavy) 
and the unlabeled (i.e., light) cross-linkers at a 1:1 ratio, one can readily distinguish 
cross-linked peptides by mass spectrometric detection by searching for peaks with similar 
intensities but mass shifts that correspond to the mass difference between the heavy and 
light labels.34, 35  Back et al. performed the proteolytic digestion of cross-linked protein 
complexes in 18O labeled water which results in the incorporation of a two 18O atoms at 
each C-terminus; linear (i.e., unmodified), dead-end modified, and intramolecularly 
cross-linked peptides experience a 4 Da mass shift while intermolecularly cross-linked 
peptides shift 8 Da compared to the unlabeled analogs.36  Other groups have developed 
chemical cross-linkers which have incorporated a gas-phase labile bond, such that upon 
low-energy collisional activation this bond is preferentially cleaved yielding a “reporter” 
ion to aid in tracking cross-linked peptides.33, 37, 38   
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While these strategies aid in identification of cross-linked peptides from 
unmodified ones, other research has focused on simplifying the interpretation of the 
tandem mass spectra of the cross-linked peptides to locate the sites of the cross-link (i.e., 
the amino acid residues cross-linked).  Collision-induced dissociation of chemically 
cross-linked peptides, specifically those with Lys-Lys cross-linked, yields more complex 
product ion mass spectra than that of unmodified or linear peptides.  Schilling et al. first 
reported on the gas-phase dissociation trends of cross-linked peptides and noted that 
single bond cleavage is predominantly observed, originating from one or the other 
constituent peptides of intermolecularly species.39  They also observed double cleavage 
products originating from dissociation of both peptide backbones in lower abundances.  
While these double cleavage product ions are informative and aid in locating the site of 
the cross-link, they complicate spectral interpretation and necessitate manual 
identification and verification of these product ions.  Gaucher et al. reported product ions 
specific to cross-linked species including lysine immonium ions linked to a peptide as 
well as enhanced cleavage C-terminal to the cross-linked lysine for intramolecularly 
cross-linked peptides.40  Work in the Brodbelt group showed that cross-linked peptides 
which contain Asp or Pro, amino acid residues known to promote site-specific backbone 
dissociation,41-44 also greatly influenced the dissociation of cross-linked peptides.45  In 
addition, a high abundance of double-cleavage product ions were observed for cross-
linked peptides which did not possess a mobile proton.45 
Given the complexity of the product ion mass spectra of cross-linked peptides, 
much effort has been devoted to the design of chemical cross-linkers to simplify the 
fragmentation patterns.  The Bruce lab has developed a set of “protein interaction 
reporters” (PIRs) which possess an affinity tag for enrichment as well as gas-phase labile 
bonds within the cross-linker.33, 46  Upon low-energy ion activation, these bonds are 
 7
dissociated producing the two constituent peptides each with a unique mass tag.  
Soderblom et al. incorporated an aspartyl-prolyl bond into the center of their cross-linker 
which was preferentially dissociated upon CID yielding two modified peptides.47, 48  
These modified peptides were then individually isolated and subjected to another stage of 
CID for independent sequencing.  Their method was also shown to be compatible with 
database search algorithms for identifying the peptide and site of modification.  Recently 
the Reid group designed an ionic cross-linking reagent with a fixed charge sulfonium ion 
which directed cleavage of the adjacent C–S bond upon CID to similarly produce the two 
constituent peptides for subsequent isolation and dissociation by MS3 experiments.49  All 
of these techniques allow for independent sequencing of the constituent peptides for 
intermolecularly cross-linked peptides, eliminating the influence of the cross-link or the 
other peptide on the dissociation patterns.  All of these methods only addressed one of the 
two primary challenges in chemical cross-linking experiments with MS analysis – either 
simplifying interpretation of the product ion mass spectra of cross-linked peptides or 
aiding in the differentiation and identification of cross-linked peptides of interest from 
unmodified ones.  In this dissertation, the development of chromogenic cross-linkers 
along with selective photodissociation methods (e.g., IRMPD and UVPD) employed to 
afford rapid identification of cross-linked peptides and to simplify spectral interpretation 
are discussed, as well as fundamental studies into the dissociation trends of the biological 
species of interest. 
 
1.3 TANDEM MASS SPECTROMETRY
Tandem mass spectrometry refers to mass spectrometric experiments in which a 
specific ion of interest is selected (i.e., isolated) and is then subsequently manipulated.  
Tandem mass spectrometry is performed in order to gain more information about the 
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selected precursor ion including structure, energy, and reactivity.  Such experiments 
generally refer to ion activation and dissociation but also include ion-molecule reactions 
and ion-ion reactions.  For structural analysis of analyte ions, dissociation methods are 
employed and these techniques are widely used for the characterization and sequencing 
of biological species including peptides, proteins, and oligonucleotides.50-53   
 
1.3.1 Collision-Induced Dissociation 
The most common and well-established method for dissociating ions in the gas-
phase is collision-induced dissociation (CID).  Collision-induced dissociation, as 
employed in the majority of quadrupole ion trap mass spectrometers,54 involves the 
application of a supplemental ac waveform with a frequency that matches the secular 
frequency of the precursor ion.54, 55  The precursor ion gains kinetic energy through 
resonance with the applied ac waveform which results in energetic collisions with inert 
bath gas molecules in the trap and the kinetic energy is converted into internal energy.56  
Once the ion has accumulated enough internal energy through collisional activation, bond 
dissociation is observed.  While CID is the most mature dissociation method in 
quadrupole ion traps, it is not without its limitations.  To effectively perform CID, the rf 
trapping level (i.e., the amplitude of the rf potential) must be raised to increase the ion 
kinetic energy.  This increase in the rf amplitude results prevents the storage of low mass-
to-charge (m/z) ions.  For most commercial quadrupole ion trap instruments, the lower 
28% of the mass range, relative to the precursor ion m/z, is lost and this lower limit is 
referred to as the low-mass cut-off (LMCO).  Another disadvantage of CID is that as 
resonant dissociation method, only the precursor ion gains internal energy and is 
fragmented and the lowest energy dissociation pathway may be uninformative, such as 
dehydration or loss of other small neutral species.  These dead-end pathways often 
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necessitate the use of multiple stages of ion isolation and dissociation (i.e., MSn 
experiments) which are time consuming and result in losses in sensitivity.  As a collision 
based method, ion losses due to scattering events can also occur.  For these reasons, much 
effort has been devoted to developing and investigating alternative means to activate and 




Photon-based dissociation methods have found widespread use on a variety of 
mass analyzers including quadrupole ion traps,57-66 time-of-flight mass spectrometers,67, 68 
and Fourier transform ion cyclotron resonance (FT-ICR) instruments.69-71  
Photodissociation is performed by irradiating the ion population with photons at a 
wavelength at which the ions absorb.  Depending on the photon energy, the ion must 
absorb one or multiple photons to gain enough energy to undergo dissociation.  
Commonly used infrared (IR) lasers have photon energies on the order of ~0.1 eV (~10 
m) and absorption of IR photons results in vibrational excitation.  Tens to hundreds of 
IR photons must be absorbed to raise the ions internal energy above the critical energy 
for dissociation.  For ultraviolet and visible lasers with photon energies between 3 and 8 
eV (~400 to 150 nm), one or two photons provide enough energy to induce dissociation 
through electronic excitation transitions. 
There are several benefits of performing photodissociation as opposed to 
traditional collisional activation methods.  Photodissociation is largely independent of the 
rf trapping level which allows one to perform photodissociation at a low rf amplitude and 
thus trap ions of a broader m/z range and detect diagnostic low-mass fragment ions.59, 72, 
73  As a non-resonant process, all ions are simultaneously irradiated which results in the 
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activation and dissociation of not only the precursor ion but also any product ions.  Dead-
end pathways are circumvented as these primary product ions undergo secondary 
dissociation and can yield more informative fragment ions.  The ion kinetic energy (i.e., 
translation motion) is not affected by the photon absorption process so ion scattering 
losses are largely eliminated as well.  However, one of the primary advantages of 
photodissociation is that it allows one to finely tune the energy deposition by varying the 
irradiation time or number of laser pulses, the photon flux or laser power, and perhaps, 
most importantly the wavelength of the laser. 
 Infrared multiphoton dissociation (IRMPD) is typically performed using a CO2 
continuous wave laser at 10.6 m (~0.12 eV/photon).  While IRMPD has shown 
significant promise as an alternative and complementary dissociation method to CID, it 
has not found widespread implementation on quadrupole ion traps.  Quadrupole ion traps 
are generally operated at a pressure of ~1 – 5 mTorr of He to collisionally cool the ions to 
the center of the trap which improves sensitivity and mass resolution;74 these high 
pressures are also advantageous for performing CID.  However, at these pressures, the 
rate of collisional cooling (i.e., deactivation) is nearly equivalent to the rate of photon 
absorption (i.e., activation) for most analyte ions which do not possess a strong 
chromophore at the laser wavelength (e.g., peptides, proteins).52, 75  Due to the low 
probability of photon absorption, the dissociation efficiencies for these analyte ions are 
low. In recent years, several approaches have been devised to improve IRMPD 
efficiencies in quadrupole ion traps.  The Glish group investigated thermally-assisted 
IRMPD by heating the bath gas surrounding the ions and Hashimoto et al. collisionally 
activated the precursor ions during IR irradiation.76  These methods were aimed at raising 
the internal energy of the ions to reduce the amount of energy required for dissociation by 
IR activation at standard trap pressures; however, other groups have focused on reducing 
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the rate of collisional deactivation by adjusting the pressure of the trap such that gas is 
introduced during ion accumulation but reduced prior to IR irradiation.77, 78  Newsome 
and Glish reported on using a focused CO2 laser to increase the photon flux and thus 
reduce the irradiation time necessary to produce high dissociation efficiencies.65  The 
Brodbelt group has devoted efforts to developing chemical derivatization schemes to 
covalently attach chromogenic labels to increase the IR absorption cross-section of ions 
at 10.6 m.38, 73, 79-81 
 While a majority of biologically relevant molecules do not exhibit high IRMPD 
efficiencies, species containing phosphate groups have shown to readily photodissociate 
upon IR irradiation due to the high IR absorption cross-section of the P–O stretch.82   
Flora and Muddiman initially exploited this feature of phosphate groups to selectively 
dissociate phosphorylated peptides by IR irradiation in an FT-ICR.71, 83  Crowe and 
Brodbelt further utilized this characteristic and were able to rapidly differentiate between 
unmodified and phosphorylated peptides by IRMPD in a quadrupole ion trap, both by 
direct infusion electrospray ionization mass spectrometry84 and in an online LC-IRMPD-
MS experiment.85   
 Ultraviolet photodissociation has also been exploited as a screening tool to 
selectively dissociate species containing specific chromophores.  As most biological 
species, in particular proteins and peptides, do not possess naturally occurring 
chromophores at commonly used UV laser wavelengths above 200 nm, low UVPD 
efficiencies are typically observed.67  These low photodissociation efficiencies have 
promoted research into utilizing UVPD as a means to selectively dissociate chromogenic 
species.  Tyrosyl-containing peptides have been observed to undergo efficient UVPD at 
220 and 262 nm,63, 86 and peptides with tyrosine or tryptophan residues have dissociated 
readily by UV irradiation at 266 nm as well.87  The specific detection of a 107 Da neutral 
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loss from peptide precursor ions by UVPD at 262 nm indicated that the peptide contained 
at least a single tyrosyl residue, allowing for screening of these species in database 
searching.86  In an effort to improve UVPD efficiencies of biological species without 
naturally occurring chromophores, the covalent62, 88, 89 and non-covalent attachment66, 90 
of chromophores through derivatization methods, which have high absorptivities at the 
appropriate wavelengths, to peptides and proteins has been investigated.  Wilson and 
Brodbelt were able to not only successfully sequence peptides derivatized with 
chromophores by UVPD at 355 nm, but all primary product ions which retained the 
chromophore underwent secondary dissociation and were eliminated from the product ion 
mass spectrum.62  In this dissertation, the design and application of chromogenic cross-
linkers is discussed for rapid screening of cross-linked peptides in complex mixtures. 
 
1.3.3 Electron Transfer Dissociation 
 Electron-based dissociation methods, such as electron capture dissociation 
(ECD)91, 92 and electron transfer dissociation (ETD),93, 94 have gained widespread use in 
the past decade.  ECD is performed by irradiation of peptide or protein cations with low-
energy electrons produced from a conventional heated filament.  The electrons are 
captured at the sites of protonation which induces peptide backbone fragmentation in a 
non-ergodic manner.92, 95, 96  However, ECD is not easily implemented on quadrupole ion 
trap instruments as the thermal electrons are not stabilized and trapped by the rf field due 
to their low mass.  Syka et al. developed ETD, an analogous dissociation method to ECD 
utilizing radical reagent anions with low electron affinities as the electron source.93  By 
simultaneously trapping protonated peptide or protein cations and reacting them with the 
radical reagent anions, an electron is transferred to the protonated peptide in an 
exothermic reaction which triggers the migration of a hydrogen radical and initiates 
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dissociation.93  One of the primary advantages of ECD and ETD is that as non-ergodic 
dissociation methods, labile post-translational modifications (PTMs), such as 
phosphorylation, are retained upon dissociation.93, 97, 98  In contrast, thermal-based 
dissociation methods such as CID and IRMPD often result in dominant loss of 
phosphoric acid from the modified residues in phosphopeptides, negating the ability to 
unambiguously pinpoint the site of the PTMs.99  ECD and ETD of peptides and proteins 
results in nonselective backbone cleavage, however, it was observed early on that 
disulfide bonds were preferentially dissociated.100  While this preferential cleavage of 
disulfide bonds has been further investigated,101-105 selective dissociation of other 
chemical functionalities by ECD or ETD has not been reported.  In this dissertation 
preferential cleavage of bis-arylhydrazone cross-linked peptides by ETD is described. 
 
1.3.4 Biomolecular Fragmentation Nomenclature 
Ion activation and dissociation of peptides and proteins typically results in 
cleavage along the peptide backbone.  The fragmentation nomenclature of peptides, 
originally suggested by Roepstorff et al.,106 is shown graphically in Scheme 1.3. For a 
majority of low-energy, ergodic dissociation methods such as CID and IRMPD, cleavage 
of the thermally labile amide C–N bond is observed which yields b- and the 
complementary y-type product ions.  Subsequent loss of CO from b-type ions produces a-
type fragment ions.  Electron-based dissociation methods such as ECD and ETD 
generally result in cleavage of the N–C bond producing c- and the complementary z-
type ions.  Similarly, dissociation of the C–C bond produces a- and x-type ions.  If a 
charge is retained on the N-terminal fragment, a-, b-, and c-ions are produced; similarly, 
if a charge is retained on the C-terminal fragment, x-, y-, and z-type ions are observed.  
The numerical subscript refers to the number of N-terminal or C-terminal amino acids 
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contained in the product ion (e.g., dissociation of the amide bond C-terminal to the 
second amino acid residue with the charge retained on the N-terminus yields the b2 ion). 
The nomenclature for the dissociation of cross-linked peptides is similar to that 
for linear peptides.  For intramolecularly cross-linked peptides, the nomenclature is 
identical to that of linear peptides.  The nomenclature of the dissociation of 
intermolecularly cross-linked peptides is based on that proposed by Schilling et al.39 and 
Gaucher et al.40 and is shown in Scheme 1.4.  The two constituent peptides are termed  
and ; dissociation along the backbone of the -peptide yield e.g., bn and yn product 
ions and dissociation along the backbone of the -peptide yield e.g., bn and yn ions, 
where n refers to the number of amino acids contained in the product ion from the N-
terminus or C-terminus.  Bond dissociation along the cross-linker are labeled as Ln or 
Ln where n is the number of atoms from the C atom of the cross-linked amino acid 
(e.g., lysine residues for the cross-linked peptides discussed in this dissertation) of either 
the - or -peptide.  In addition, lysine immonium ions cross-linked to one of the 
constituent peptides are also observed often in conjunction with a loss of NH3 (17 Da 
loss) and these product ions are labeled KL and KL–17 or KL and KL–17. 
Scheme 1.3 Fragmentation nomenclature of peptides and proteins. 
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Scheme 1.4 Fragmentation nomenclature for cross-linked peptides. 
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The dissociation nomenclature for oligonucleotides (e.g., DNA and RNA) used 
was first proposed by McLuckey et al.51 as shown in Scheme 1.5.  Dissociation of DNA 
generally results in loss of nucleobases which initiates cleavage along the phosphate 
backbone at the 3’ C–O bond yielding [a–Base] and complementary w-type ions.  In 
contrast, dissociation of RNA predominantly results in cleavage of the 5’ P–O bond 
producing c- and the complementary y-type fragment ions. 
  
1.4 OVERVIEW OF CHAPTERS
The research presented in this dissertation aims at the development of selective 
gas-phase dissociation techniques for the characterization of cross-linked or conjugated 
biological molecules.  To understand the typical dissociation pathways of cross-linked 
peptides, a series of model peptides cross-linked by commercial cross-linkers were 
investigated by CID (Chapter 3).  Aspartic acid and proline residues positioned on either 
Scheme 1.5 Fragmentation nomenclature of oligoribonucleotides (RNA). 
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side of the cross-linked lysine affected the dissociation pathways in a similar manner 
observed for linear peptides.  For cross-linked peptide precursor ions with a mobile 
proton, cleavage C-terminal to Asp was enhanced, whereas dissociation of the backbone 
amide bond N-terminal to Pro was enhanced for all charge states of the cross-linked 
peptides.  A high abundance of double cleavage products and internal ion formation was 
observed for the cross-linked peptides in the low charge states, as well. 
An IR chromogenic cross-linker was synthesized to allow for rapid screening of 
cross-linked peptides in complex mixtures by selective IRMPD (Chapter 4).  Only cross-
linked peptides which contained the phosphate IR chromophore were observed to 
undergo efficient IRMPD; un-cross-linked peptides were unaffected by IR irradiation 
presumably due to a lower rate of photon absorption and thus near equivalent rates of IR 
photoactivation and collisional cooling.  By isolating a wide range of ions and comparing 
mass spectra acquired with the laser on (IRMPD mass spectra) and with the laser off, the 
cross-linked peptides were rapidly identified based on the fact that they were the only 
ones whose abundances decreased.  IRMPD of the cross-linked peptides also yielded a 
series of un-cross-linked y-type ions of both constituent peptides C-terminal to the cross-
linked lysines that allowed de novo sequencing of the cross-linked peptides due to rapid 
secondary dissociation of any primary product ion which still retained the chromogenic 
cross-link.  The protein ubiquitin was cross-linked and analyzed by this selective IRMPD 
strategy in an online LC-MS experiment and a total of four cross-links and two dead-end 
modifications were identified. 
The selective photodissociation based on IRMPD was further developed for 
peptides conjugated with a UV chromogenic bis-arylhydrazone (BAH) group for UVPD 
at 355 nm (Chapter 5).  Peptides were cross-linked via a two-step conjugation procedure 
and only upon cross-linking was the chromogenic BAH group formed.  This method was 
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applied to a mock mixture of peptides which was analyzed by online LC-UVPD-MS.  
Since the unmodified peptides did not contain the UV chromophore, they were not 
observed to dissociate allowing differentiation between conjugated peptides and both 
unmodified peptides and uninformative dead-end modified peptides. 
The bis-arylhydrazone cross-linked peptides were further investigated by ETD as 
discussed in Chapter 6.  ETD of these cross-linked peptides resulted in preferential 
dissociation of the hydrazone bond yielding the two constituent peptides – one an odd-
electron product, the other an even-electron species – each retaining a unique mass tag at 
the site of cross-linking.  These two tagged peptide product ions were observed at higher 
abundances than the electron transfer non-dissociative precursor ion and the abundance 
of all c- and z-type ions.  Subsequent CID of the tagged peptide product ions yielded 
informative sequence ions to identify the constituent peptides independently.  The 
proposed mechanism for this preferential cleavage of the hydrazone bond involved 
transfer of the electron directly to the protonated hydrazone and subsequent 
rearrangement and bond dissociation. 
To further extend the capabilities of IRMPD for the sequencing of peptides, an IR 
laser was interfaced to a dual pressure linear ion trap mass spectrometer (Chapter 7).  
IRMPD of peptides in the high pressure cell did not result in any dissociation, attributed 
to the high rate of collisional cooling and the low IR absorption cross-section rate of 
peptides.  However, rapid and efficient dissociation of peptides was observed in the low 
pressure cell; IRMPD of peptide cations conducted in the low pressure cell afforded 
slightly greater sequence coverage as compared to CID.  IRMPD predominantly yielded 
product ions in the 1+ charge state which simplified spectral interpretation. 
In the IRMPD studies conducted on the IR chromogenic cross-linked peptides and 
in the dual cell LIT, an interesting phenomenon was observed in which the abundances of 
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unmodified peptide ions actually increased upon IR irradiation.  It was hypothesized that 
this effect was due to IR activation of noise in the mass spectrum consisting of solvated 
analyte ions of unresolved m/z.  To investigate this phenomenon, regions of noise in the 
mass spectra of peptide and protein samples were subjected to supplemental IR activation 
which resulted in a decrease in the chemical noise and an increase in analyte ion signal 
(Chapter 8).  In fact, when chemical noise regions were isolated and subsequently 
irradiated, protonated analyte ions were observed in the mass spectrum.  The chemical 
noise was attributed to incomplete desolvation of the electrospray. 
Finally, IRMPD of small-interfering RNA (siRNA) single strands and duplexes 
was explored (Chapter 9).  SiRNA was observed to undergo rapid dissociation upon IR 
irradiation predominantly producing c- and y-type ions as opposed to [a – Base] and w-
type ions which are observed for DNA.  Full sequence coverage of the siRNAs was 
obtained by both IRMPD and CID; however, the IRMPD mass spectrum could be tuned 
to contain predominantly short product ions in the 1+ and 2+ charge states by adjusting 
the IR irradiation time to simplify spectra interpretation.  For future studies, these results 
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The mass spectrometric methods and procedures used for the experiments 
described in this dissertation are discussed within this chapter.  All mass spectrometry 
experiments were conducted on quadrupole ion trap mass spectrometers (3D and 2D) 
using an electrospray ionization (ESI) source.  Tandem mass spectrometry techniques 
such as collisional-induced dissociation (CID), infrared multiphoton dissociation 
(IRMPD), ultraviolet photodissociation (UVPD), and electron transfer dissociation (ETD) 
were also employed for structural characterization of the analyte ions.  The chemical 
cross-linking procedures for peptides and proteins, cross-linker syntheses, and sample 
preparations are included as well. 
 
2.2 MASS SPECTROMETRY
All mass spectrometry experiments were conducted on three-dimensional 
quadrupole ion trap (QITs) or linear quadrupole ion trap (LITs) mass spectrometers.  The 
instruments used included a ThermoFinnigan LCQ Duo three-dimensional quadrupole 
ion trap (San Jose, CA), an LCQ Deca XP modified for photodissociation experiments, a 
ThermoFisher Scientific LTQ XL linear ion trap (San Jose, CA) modified for 
photodissociation and with electron transfer dissociation capabilities, and a ThermoFisher 
Scientific LTQ Velos dual pressure linear ion trap mass spectrometer.  Each QIT consists 
of a ring electrode that has a hyperbolic profile to which an rf potential (8500 Vpp,max, 760 
KHz) is applied and two end-cap electrodes, also with hyperbolic profiles, to which 
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auxiliary ac or broadband waveforms are applied.  The rf potential creates a quadrupole 
electric field which traps the ions.  Mass spectra are acquired by ramping the rf amplitude 
applied to the ring electrode to sequentially destabilize ions and eject them from trap, a 
mode of operation termed mass selective instability scan.1  The auxiliary waveforms on 
the end-cap electrodes provide a means to perform ion isolation and resonant collisional 
ion activation by matching the applied ac frequency to the secular frequency of the ions.  
Helium buffer gas is introduced into the ion trap at ~1 mTorr which collisionally cools 
and focuses the ions to the center of trap, improving mass resolution.1 
A description of the LTQ linear quadrupole ion trap has been provided elsewhere2 
and is shown schematically in Figure 2.1a. Briefly, the linear ion trap consists of a 
quadrupole with hyperbolic rod profiles physically split into three section and front and 
back aperture lenses positioned on either side of the trap.  An rf potential is applied to the 
the three-segmented quadrupole of the LTQ linear ion trap (5000 Vpp,max, 1.2 MHz) in a 
dipolar fashion (i.e., one phase is applied to the x-rods and the 180° out-of-phase 
waveform is applied to the y-rods) to radially trap the ions.  Independent dc offset 
potentials can be applied to each section in order to trap the ions in the axial direction.  
Auxiliary ac and broadband waveforms are applied on top of the rf to one pair of rods of 
the center section of the LIT in a dipolar fashion (e.g., top y-rod = rf + ac; bottom y-rod = 
rf – ac) to perform ion isolation and resonant collisional ion activation (Figure 2.2b).  
Front and back aperture lenses are positioned on both sides of the LIT to which dc 
potentials are applied to gate ions into the trap or to which an auxiliary ac waveform is 
applied to create a pseudo-quadrupole electric field to allow simultaneous trapping of 
ions of both polarities in the axial direction.  Ions are sequentially ejected from the trap 
through slits machined into the quadrupole rods by a mass selective instability scan.  The 
LIT is held at approximately 2.5 mTorr with He buffer gas.  The dual pressure linear ion 
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trap mass spectrometer consists of two linear ion traps which are separated by a 
conductance limiting aperture.3  The first LIT is held at ~5 × 10-3 Torr and the second 
LIT is held at ~3 × 10-4 Torr of He.  The two LITs are operated in a similar manner to the 
LIT described above.  Ion isolation and activation can be performed in either cell of the 
dual pressure LIT; mass analysis was performed in the low pressure cell. 
Figure 2.1 (A) Schematic of ThermoFisher Scientific LTQ XL linear quadrupole ion
trap and (B) types of waveforms applied for ion trapping and resonant
excitation. 
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Ions are produced by electrospray ionization (ESI) and the standard ESI sources 
were used on all instruments.  ESI is a soft ionization method which allows for a wide 
variety of biological species, including peptides, proteins, oligonucleotides, and 
macromolecular complexes, to be analyzed by mass spectrometry.4  ESI is performed by 
applying a high potential (~ 4 kV) to a conductive needle or capillary through which the 
analyte solution is infused.  A nebulizing sheath gas flow of nitrogen (~0.3 – 1.0 L/min) 
is applied co-axial to the spray which aids in desolvation of the charged droplets.  
Multiply-charged analyte ions are often produced by protonation or deprotonation.  To 
afford efficient ion desolvation, the inlet to the mass spectrometry, a stainless steel 
capillary, is heated and the temperature was maintained at 180 °C for peptide and protein 
samples and at 90 °C for siRNA samples.  Samples were generally prepared at ~10 M in 
49.5: 49.5: 1 H2O/MeOH/acetic acid (v/v/v) and infused at 2.5 – 5.0 L/min using 
Harvard Apparatus PHD 2000 syringe pump (Holliston, MA).  The ESI potential was set 
to 4.0 – 4.5 kV for positive ion mode analysis and -3.5 to -4.0 kV for negative ion mode.  
Potentials to the ion optics were tuned for maximum signal.  All direct infusion ESI mass 
spectra are the average of 20 – 100 scans. 
 Tandem mass spectrometry (MS/MS) experiments are methods in which selected 
ions of interest are subjected to another or sequential stages of mass spectrometry.  Ion 
activation and dissociation are a subset of MS/MS experiments which involve ion 
isolation, accomplished by the appropriate application of auxiliary waveforms and 
ramping of the trapping rf amplitude to eject ions other than the precursor ion, and then 
ion activation through resonant collisional excitation (CID) or photon absorption 
(photodissociation).  Ion-ion reactions such as ETD are another type of MS/MS 
experiment in which a precursor ion is first isolated in the trap and then a chemical 
reagent ion of the opposite polarity is introduced. 
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2.2.1 Collision-Induced Dissociation (CID) 
 CID is a resonant excitation technique which is accomplished by applying an 
auxiliary ac waveform to the end-cap electrodes of a QIT or on top of the rf applied to the 
LIT with a frequency that matches the secular frequency of the precursor ion.  The 
precursor ion gains kinetic energy and its amplitude of motion increases.  As the ion 
collides with the inert bath gas (He) molecules, the precursor ion gains internal energy 
which is distributed amongst all degrees of freedom through intramolecular vibrational 
redistribution.  Once the precursor ion has gained enough internal energy through 
collisional activation (typically hundreds of low-energy collisions), bond dissociation is 
observed yielding product ions. 
CID experiments were performed on all mass spectrometers at an activation q-
value of 0.25 for 30 ms.  The normalized collision energy (NCE), a ThermoFinnigan 
parameter which is proportional to the excitation amplitude of the auxiliary ac waveform 
and normalized for precursor m/z, was varied to reduce the precursor ion to less than ~5% 
relative intensity.  Normalized collision energies were converted to excitation voltages 
using the following formula: 
 
    TickAmpIntpeTickAmpSlozmNCEV 	
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%     Equation 2.1 
where V is the excitation voltage, NCE is the normalized collision energy in percent, m/z 
is the precursor ion m/z value, and TickAmpSlope and TickAmpInt are instrument 
calibration factors.  In order to compare excitation voltages from one precursor ion to 








,        Equation 2.2 
where i refers to the control precursor ion, j the precursor ion for which the excitation 
voltage is being corrected, and the degrees of freedom N = 3n – 6 and n is the number of 
atoms in the precursor ion.5  Energy-resolved CID experiments were performed by 
sequentially increasing the NCE and plotting product ion abundances with respect to 
NCE.
 
2.2.2 Infrared Multiphoton Dissociation (IRMPD) 
 Photodissociation is another tandem mass spectrometric method in which ions 
gain internal energy through photon absorption.  IRMPD is an ergodic dissociation 
method similar to CID in which the more labile bonds are more readily dissociated.  
Typically, hundreds of IR photons of ~0.12 eV (10.6 m radiation) must be absorbed by 
the precursor ion to observe bond dissociation. 
IRMPD experiments were performed on the LTQ and the LTQ Velos linear ion 
trap mass spectrometers.  The instrument was modified to permit IRMPD as described in 
earlier reports.6  The back flange of the vacuum manifold of the instrument was modified 
with a CF viewport flange containing a ZnSe window to allow the transmission of 10.6 
m radiation.  The unfocused laser beam was aligned on axis with the linear ion trap such 
that the beam passed through a 1.8 mm aperture mounted to the back flange and then the 
2-mm aperture of the exit lens to irradiate the ion cloud.  IRMPD was performed using a 
model 48-5 Synrad 50-W CO2 continuous wave laser (Mukilteo, WA).  The laser was 
triggered during the activation step in the scan function by a TTL signal from pin 14 of 
the J1 connector on the digital printed circuit board.  All IRMPD experiments were 
performed at full power (50 W) with irradiation times varying between 0.03 and 250 ms 
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unless otherwise indicated.  The activation q-value was varied between 0.05 and 0.25 to 
reduce the low-mass cut-off.  Wide-range ion isolation and IRMPD mass spectra were 
acquired by turning off the isolation waveform in the diagnostics panel of the LTQTune 
instrument software.  Isolation mass spectra were acquired by turning off the laser and 
not performing any form of ion activation.  Time-resolved IRMPD experiments were 
performed by varying the irradiation time and plotting product ion abundances as a 
function of irradiation time. 
 
2.2.3 Ultraviolet Photodissociation (UVPD) 
 UVPD experiments were performed on a modified LCQ Deca XP quadrupole ion 
trap mass spectrometer as previously described.7  A Spectra-Physics Quanta-Ray GCR-
11 Nd:YAG laser with a HG-2 harmonics generator (Mountain View, CA) was used to 
produce the frequency-tripled harmonic photons at 355 nm (~3.5 eV/photon) for UVPD.  
Briefly, a CF viewport flange was welded to the vacuum manifold of the mass 
spectrometer and fitted with a quartz window to allow the transmission of UV radiation.  
The unfocused laser beam was aligned on-axis with a 5-mm hole drilled through the ring 
electrode to irradiate the ion cloud.  The laser was operated at full power (~65 mJ/pulse), 
unless otherwise noted, at a repetition rate of 10 Hz in the Q-switched mode which 
produced ~10 ns pulse widths.  The LCQ instrument TTL signal output from pin TP 15-3 
Sync_TP was used to trigger a Model 505-2C low-voltage pulse generator (Berkeley 
Nucleonics Corp., San Rafael, CA) which in turn was used to pulse the laser.  Typically, 
the activation time was set to 1000 ms to produce ten laser pulses unless indicated 
otherwise.  The instrument control files were modified to allow triggering of the laser 
during LC-MS/MS analyses.  Precursor ions were activated at a qz-value of 0.10.  Wide-
range ion isolation and UVPD mass spectra were acquired by turning off the second 
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waveform in the diagnostics panel of the LCQTune instrument software.  Isolation mass 
spectra were acquired by turning off the laser and not performing any form of ion 
activation.  Online liquid chromatography-UVPD-MS was performed by either isolating 
ions of m/z 450 – 1200 without any form of activation or by subjecting all ions of m/z 450 
– 1200 to ten pulses of UV irradiation at 355 nm.   
 
2.2.4 Electron Transfer Dissociation (ETD) 
 ETD experiments were performed on the LTQ linear ion trap mass spectrometer.  
Fluoranthene radical anions were produced by negative chemical ionization and 
introduced through a mass-resolving quadrupole into the linear ion trap from the opposite 
side as the electrospray ionization source.  The built-in ETD scan function of the 
LTQTune software was used and is described elsewhere.8  Briefly, the precursor ion 
(cation) is first isolated in the ion trap and then transferred to the front section of the LIT 
by application of appropriate dc potentials to the three sections of the LIT.  Fluoranthene 
radical anions are the introduced to the trap and sequestered in the back section of the 
LIT in a similar manner.  The axial dc trapping potentials are then removed to allow the 
ion-ion reaction to proceed and mutual storage of cations and anions in the LIT is 
accomplished by the application of an auxiliary ac waveform to the front and back lenses 
of the LIT.  The fluoranthene radical ions transfer an electron to the peptide or protein 
cations in an exothermic process which results in non-ergodic dissociation of the 
precursor ion.9  The ion-ion reactions varied between 0.03 and 200 ms.  The target 
reagent anion population was set to 1 × 105 ions and the precursor ion population was set 
to 3 × 104.  The activation q-value was such that the low-mass cut-off was reduced to m/z 
50.  Time-resolved ETD experiments were performed by plotting the relative abundances 
of the observed product ions as a function of the ETD reaction time. 
 35
 
2.3 CHEMICALS AND REAGENTS
 The following five peptides were synthesized at the Protein Microanalysis Facility 
at the University of Texas at Austin and purified by reversed-phase liquid 
chromatography: Ac-AAAKAAAAR, Ac-AADKAAAAR, Ac-AAAKDAAAR, Ac-
AAPKAAAAR, and Ac-AAAKPAAAR.  All other peptides were used without further 
purification.  The peptides -MSH (Ac-SYSMEHFRWGKPV-NH2), Ac-RFMWMK-
NH2, substance P (RPKPQQFFGLM-NH2), neurotensin (Pyr-LYENKPRRPYIL), 
neurotensin 1-6 (Pyr-LYENK), FSWGAEGQR, YGGFLK, ASHLGLAR, and 
AGCKNFFWKTFTSC (somatostatin-14)  were purchased from Bachem (Torrance, CA 
or King of Prussia, PA).  The peptide angiotensin II (DRVYIHPF) was purchased from 
AnaSpec (San Jose, CA).  The peptides fibrinopeptide A (ADSGEGDFLAEGGGVR) 
and bradykinin (RPPGFSPFR) were purchased from American Peptide Co. (Sunnyvale, 
CA).  The peptides methionine-enkephalin (YGGFM), angiotensin I (DRVYIHPFHL), 
and melittin (honey bee venom) were purchased from Sigma (St. Louis, MO).  Ubiquitin 
(bovine red blood cells), cytochrome c (horse heart), proteomics grade trypsin, resperine, 
and the cross-linker disuccinimidyl suberate (DSS) were also obtained from Sigma (St. 
Louis, MO).  N-hydroxysuccinimide (NHS), 4-hydroxybenzoic acid, ethyl 
dichlorophosphate, benzaldehyde, and 2-hydrazinopyridine were from Aldrich 
(Milwaukee, WI).  Imidazole, piperidine, and Amberlite IRN77 were purchased from 
Sigma-Aldrich (St. Louis, MO).  Water (HPLC grade) and acetonitrile (HPLC grade) 
were from Riedel-de Haën (Seelze, Germany).  1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC), succinimidyl 4-formylbenzoate (SFB), succinimidyl 
4-hydrazinonicotinate acetone hydrazone (SANH), and the cross-linker dithiobis 
(succinimidyl propionate) (DSP) were obtained from Pierce Biotechnology (Rockford, 
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IL).  The cross-linker disuccinimidyl L-tartrate (DST) was purchased from Toronto 
Research Chemicals (North York, Ontario, Canada).  The siRNAs targeting the 
glyceraldehydes 3-phosphate dehydrogenase (GAPDH) gene and the Lamin A/C gene 
were purchased from Integrated DNA Technologies (Coralville, IA). The sequences for 
anti-GAPDH were 5’OH-GUGGAUAUUGUUGCCAUCAdTdT-3’OH (sense strand, 
6633.9 Da) and 5’OH-UGAUGGCAACAAUAUCCACdTdT-3’OH (antisense strand, 
6644.9 Da). The sequences for anti-Lamin A/C were 5’-biotin-
GGAACUGGACUUCCAGAAGAACAUCAU-3’OH (sense strand, 9053.6 Da) and 5’-
UAGAUGUUCUUCUGGAAGUCCAGUUCC (antisense strand, 8544.1 Da).  All other 
chemicals and solvents were purchased from Fisher Scientific (Fairlawn, NJ) except for 
formic acid (EM Science, Gibbstown, NJ). 
 
2.4 CHEMICAL SYNTHESIS
2.4.1 Synthesis of Dibenzoyloxysuccinimidyl Ethyl Phosphate 
The synthetic procedure for the IR chromogenic cross-linker, 
dibenzoyloxysuccinimidyl ethyl phosphate is outlined in Scheme 2.1 and was prepared 
by first synthesizing the intermediate N-(4-hydroxybenzoyloxy)succinimide.  Under an 
argon atmosphere, dry tetrahydrofuran (THF; 45 mL) and dry dichloromethane (DCM; 
45 mL) were added to 5 mmol of 4-hydroxybenzoic acid, 8 mmol of NHS, and 6.5 mmol 
of EDC.  The reaction was stirred under argon at room temperature for 24 hours and then 
extracted with H2O (1 
 60 mL), saturated NaHCO3 (1 
 60 mL), and then a saturated 
brine solution (1 
 60 mL).  The final liquid extract was dried over Na2SO4, filtered, and 
dried under vacuum.  The intermediate was recrystallized in DCM at 20 °C overnight and 
filtered.   
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Dibenzoyloxysuccinimidyl ethyl phosphate was prepared by dissolving 0.5 mmol 
of N-(4-hydroxybenzoyloxy)succinimide in dry THF at 0 °C, and then adding 0.25 mmol 
of ethyldichlorophosphate dropwise to the solution, followed by 10 mmol of dry 
triethylamine.  The reaction was allowed to warm to room temperature while stirring over 
2 hours, then heated to 60 °C and stirred for additional 4 hours.  The final solution was 
dried and concentrated under reduced pressure.  The product was washed with cold H2O, 
filtered, recrystallized in DCM, and filtered.  The cross-linker structure was confirmed by 
1H NMR using a 400 MHz Varian instrument and ESI-IRMPD-MS. 
 
2.4.2  Synthesis of Benzaldehyde-2-pyridinylhydrazone and UV-Vis Measurements 
The ultra-violet chromophore benzaldehyde-2-pyridinylhydrazone (B2PH) was 
synthesized by dissolving 1.0 mmol of 2-hydrazinopyridine in 2.0 mL of MeOH and then 
102 L (1.0 mmol) of benzaldehyde was added (Scheme 2.2).  The solution was heated 
Scheme 2.1 Synthesis of dibenzoyloxysuccinimidyl ethyl phosphate. 
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to 55 °C and stirred for 16 hours.  The reaction mixture was then cooled to room 
temperature, and the yellow-orange precipitate of B2PH was vacuum filtered.  The final 
product was redissolved in MeOH and then diluted to 50 M for downstream analysis 
and characterization by UV-Vis spectroscopy and UVPD-MS.  All UV-Vis 
measurements were obtained on an Agilent 8453 spectrophotometer (Santa Clara, CA). 
 
2.5 CHEMICAL CROSS-LINKING AND CONJUGATION
2.5.1 Peptide Cross-Linking 
 Stock solutions of the model peptides were prepared at 5.0 mM in H2O.  Cross-
linkers were freshly prepared at 20.0 mM in DMSO prior to cross-linking.  For 
intermolecular cross-linking, the two peptides (termed  and ) were cross-linked with at 
a 4:4:5 molar ratio of -peptide: -peptide: cross-linker in 20 mM HEPES, pH 8.0 at a 
final concentration of ~200 – 500 M of peptide in ~10 – 50 L.  Intramolecular peptide 
cross-linking was similarly performed at a 4:5 molar ratio of peptide to cross-linker in the 
same buffer.  All peptide cross-linking reactions were allowed to incubate at room 
temperature overnight to increase the yield of cross-linked peptides.  The reactions were 
desalted by solid phase extraction using 50 mg tC18 Waters (Milford, MA) Sep-Pak 
cartridges. 
 
Scheme 2.2 Synthesis of benzaldehyde-2-pyridinylhydrazone. 
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2.5.2 Protein Cross-Linking 
 The cross-linker solution was prepared as described above; stock protein solutions 
at 200 M were prepared.  The proteins were intramolecularly cross-linked at 1:5, 1:10, 
1:25 and 1:50 molar ratios of protein: cross-linker in a 20 mM HEPES buffer, pH 8.0 at a 
final protein concentration of 10 M.  The reactions were allowed to proceed at room 
temperature for 30 minutes. The cross-linking was quenched by the addition of 
NH4HCO3 to a final concentration of 10 mM for 15 minutes.  The reaction mixtures were 
desalted against a 5 kDa molecular weight cut-off Ultrafree Biomax membrane 
(Millipore, Billerica, MA).  Aliquots were removed for direct-ESI-MS analysis and the 
remaining cross-linked protein sample was diluted to 180 M in 100 mM NH4HCO3, pH 
8.0 for enzymatic digestion. 
 
2.5.3 Peptide Conjugation 
 Model peptides were cross-linked together via a two-step conjugation method.  
All peptides were dissolved to 5.0 mM in H2O, and the modifying reagents SANH and 
SFB were each freshly prepared at 20.0 mM in DMSO.  Each peptide was individually 
modified at its primary amines (e.g. free N-termini or lysine residues) by either SANH or 
SFB in 20 mM HEPES, pH 8.0 buffer at a 1:10 molar ratio of peptide to modifier (200 
M: 2.0 mM).  The reactions were allowed to proceed at room temperature overnight to 
ensure complete modification of the peptides; the product mixture was then desalted 
using Waters tC18 SepPak cartridges (Milford, MA) and peptides were eluted with 100% 
MeOH.  The two modified peptides were then conjugated together at an equimolar ratio 
(~100 M) in 99/1 MeOH/HOAc acid at 55 °C overnight forming a bis-aryl hydrazone 
cross-link.  The conjugated peptides were subsequently diluted to ~10 M in 49.5:49.5:1 




 Proteins were enzymatically digested in solution with proteomics grade trypsin 
(Sigma-Aldrich, St. Louis, MO) at a 1:15 enzyme to protein (w/w) ratio.  Trypsin (20 g) 
was dissolved in 20 L of 1.0 mM HCl and then added to the protein solution in 100 mM 
NH4HCO3, pH 8.0.  Proteins were digested overnight while heating at 37 °C.  The 
digested sample was then desalted by solid-phase extraction using Waters tC18 Sep-Pak 




 All high performance liquid chromatography (HPLC) experiments were 
accomplished using reversed-phase separations using C18 columns.  A Waters 2695 
Separations Module and 486 Tunable Absorbance Detector (Milford, MA), which were 
both controlled by the Millennium version 3.00 software package, were interfaced to the 
LCQ Deca XP modified for UVPD experiments.  Reversed-phase HPLC was 
accomplished using a Symmetry300 C18 column (2.1 
 50 mm, 3.5 m packing) using a 
gradient elution consisting of (A) H2O with 0.1% formic acid and (B) acetonitrile with 
0.1% formic acid at a flow rate of 0.300 mL/min.  The mobile phase was held at 95% A 
for two minutes after sample injection (typically 10 L of ~10 M solutions) and then 
linearly reduced to 60% over 60 minutes.  Analytes were detected by UV-Vis absorption 
spectroscopy at 355 nm as well as by mass spectrometry 
A Hitachi L-7000 (Hitachi Ltd.) system including an L-7100 HPLC pump and L-
7000 autosampler was interfaced to the LTQ mass spectrometer; the LC system was 
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controlled using the Hitachi 3DQ software.  Reversed-phase HPLC was also 
accomplished using a Symmetry300 (Waters, Milford, MA) C18 column (2.1 
 50 mm, 
3.5 m packing) with a Symmetry300 C18 guard column (2.1 
 10 mm, 3.5 m packing).  
For analytical separations, a gradient elution of mobile phases consisting of (A) H2O with 
0.1% formic acid and (B) acetonitrile with 0.1% formic acid was used at a flow rate of 
0.300 mL/min.  After loading the sample (10 – 25 L injections of 10 M solutions), the 
mobile phase was held at 95% A for 2 minutes and then the peptides were eluted using a 
linear gradient from 95% A to 50% A over 58 minutes. 
 
2.8 SIRNA SAMPLE PREPARATION
 Single-strand siRNA samples were desalted by cation exchange using the 
Amberlite IRN77 resin as described by McLuckey et al.10  Duplex siRNA was annealed 
by combining the sense and antisense siRNA strands (30 M each) in 150 mM NH4OAc, 
pH 7.0.  The samples were heated at 90 °C for three minutes and then cooled to room 
temperature overnight.  Duplex siRNA solutions were diluted to 10 M in 25:75 (v/v) 
methanol/50 mM NH4OAc in nano-pure H2O.  Solutions of GAPDH single-strand 
siRNAs were prepared at 10 M in either 25:75 (v/v) methanol/25 mM NH4OAc for 
negative and positive electrospray mass spectrometry (ESI-MS) or 20:80 (v/v) 
isopropanol/H2O with 25 mM imidazole and 25 mM piperidine for negative ESI-MS.  
The Lamin A/C single strand siRNAs were prepared at 10 M in 25:75 (v/v) methanol/25 




Product ion spectra of cross-linked peptide ions were manually identified aided in 
part with the software program ProteinXXX, the protein cross-linking function of 
GPMAW (General Protein Mass Analysis for Windows) version 7.10 (Lighthouse Data, 
Odense, Denmark) (available at http://www.gpmaw.com) and an in-house program 
written in National Instruments LabView 8.5.  Product ions of siRNA single strands and 
duplex siRNA were identified using Mongo Oligo Mass Calculator 
(http://library.med.utah.edu/masspec/mongo.htm) in addition to an oligonucleotide 
product ion calculator program written in-house using National Instruments LabView 8.5.   















    Equation 2.3 
where P is the abundance of the surviving precursor ion after ion activation, and Fi is the 
abundance of each product ion.  The efficiency of the tandem MS experiment (i.e., 












     Equation 2.4 
where P0 is the abundance of the precursor ion prior to any IR irradiation, collisional 
activation, or ion-ion reaction, and Fi is the abundance of each product ion.  The sum of 
the product ion abundance (i.e., Fi) was determined by subtracting the abundance of any 
remaining precursor ion from the total ion abundance for the efficiency calculations.  Ion 
abundances were determined by calculating the peak areas using Origin 7.0.   
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For the dissociation of cross-linked peptides, the directionality of cleavage bias to 
the lysine residue was calculated for both the cross-linked peptides and the unmodified 
species using a method previously suggested by Tabb et al.11  The C-terminal cleavage 
bias was determined by taking the ratio of the difference in C-terminal and N-terminal 
fragment ions, relative to the lysine residue, to the sum of these fragment ion peak areas.  
For example, the y-ion C-terminal bias was calculated as follows:   
 
   













C                                               Equation 2.5 
 
where Ai is the peak area of the respective y-ions; the yn+1 ions are products of cleavage 
N-terminal to the cross-linked lysine, and the yn ions are a result of C-terminal cleavage 
to the cross-linked lysine.  The  and  subscripts refer to the  and  peptide of the 
cross-linked peptide.  A positive value indicates a fragmentation bias C-terminally to the 
lysine residue, whereas a negative value signifies an N-terminal bias.  Similarly, for the 
b-ions, the cleavage bias was calculated using the following formula: 
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,1,,1,                                               Equation 2.6 
 
where the bn+1 ions are the C-terminal cleavage products and the bn ions are the N-
terminal fragments to the cross-linked lysine. 
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Impact of Proline and Aspartic Acid Residues on the Dissociation of 
Intermolecularly Cross-linked Peptides 
3.1 OVERVIEW
The dissociation of intermolecularly cross-linked peptides was evaluated for a 
series of peptides with proline or aspartic acid residues positioned adjacent to the cross-
linking sites (lysine residues).  The peptides were cross-linked with either disuccinimidyl 
suberate (DSS) or disuccinimidyl L-tartrate (DST), and the influence of proline and 
aspartic acid residues on the fragmentation patterns were investigated for precursor ions 
with and without a mobile proton.  Collision-induced dissociation (CID) spectra of 
aspartic acid-containing cross-linked peptide ions, doubly-charged with both protons 
sequestered, were dominated by cleavage C-terminal to the Asp residue, similar to that of 
unmodified peptides.  The proline-containing cross-linked peptides exhibited a high 
degree of internal ion formation, with the resulting product ions having an N-terminal 
proline residue.  Upon dissociation of the doubly-charged cross-linked peptides, twenty 
to fifty percent of the fragment ion abundance was accounted for by multiple cleavage 
products.  Cross-linked peptides possessing a mobile proton yielded almost a full series 
of b- and y-type fragment ions, with only proline-directed fragments still observed at high 
abundances.  Interestingly, the cross-linked peptides exhibited a tendency to dissociate at 
the amide bond C-terminal to the cross-linked lysine residue, relative to the N-terminal 
side.  One could envision updating computer algorithms to include these cross-linker 
specific product ions – particularly for precursor ions with localized protons – that 
provide complementary and confirmatory information, to offer more confident 
identification of both the cross-linked peptides and the location of the cross-link, as well 
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With tremendous advances in proteomics in the past decade, the interest in 
understanding protein-protein interactions at a molecular level has expanded as new 
methods for exploring macromolecules have emerged.1-3  Chemical cross-linking of 
proteins coupled with mass spectrometric analysis has become a more widely used 
method for determining protein-protein interactions in recent years.4-6  Protein cross-
linking is a low resolution, structural analysis technique that allows one to determine 
distance constraints within single proteins,7, 8 or protein-ligand complexes.9-13  Cross-
linked proteins are typically subjected to enzymatic digestion to create more easily 
interpreted peptide segments upon subsequent tandem mass spectrometric analysis.  
Cross-linking has also been utilized to identify protein folds,6 conformational changes of 
proteins upon activation,14, 15 and RNA-protein interactions.16  While the chemical cross-
linking experiment is often rather straightforward, the technique is restricted by several 
limitations which must be overcome in order to obtain the desired structural information.  
First, the cross-linked peptides must be identified from unmodified ones, typically in 
complex mixtures such as enzymatic digests of the protein or protein-complexes, in 
which there may only be a few cross-links per protein among an abundance of 
unmodified peptide fragments.  Once distinguished and identified, collision-induced 
dissociation (CID) experiments on these species are performed in order to sequence the 
peptide or peptides.  Structural assignment of the cross-linked peptides is still not routine 
despite the emergence of several sequencing algorithms.17-22  In fact, one of the main 
pitfalls of mass spectrometric strategies for examination of cross-linked peptides is the 
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lack of comprehensive rules for interpretation of the product ion spectra.  Finally, with 
the known sequence tags, the site and residue of chemical modification must be 
pinpointed to estimate distance constraints.   
Despite the enormous number of investigations that have elucidated the 
fragmentation pathways of conventional tryptic peptides, to date only a few studies have 
focused on mapping the dissociation trends of cross-linked peptides in a systematic 
fashion.20, 23, 24  Initial work by Schilling et al. demonstrated that dissociation of 
intermolecularly cross-linked peptides typically resulted in amide bond cleavage of one 
peptide, with the cross-link and second peptide acting as a modification.20  In addition, 
they observed product ions unique to cross-linked peptides, including two-cleavage 
fragment ions such as b/b ions, in which two b-type fragment ions were linked together.  
A more recent study investigating the effects of lysine specific cross-linkers and 
precursor ion charge observed that without a mobile proton, many of the product ions 
formed were not of the a-, b-, or y-type.23  Gaucher et al. also noticed that 
intramolecularly cross-linked peptides exhibited enhanced dissociation at the peptide 
amide bonds adjacent to the cross-linked lysine residues.23 
While many fundamental studies and statistical analyses have examined the 
influence of amino acid content on the gas-phase dissociation of unmodified peptides,25-29 
no similar work to date has been performed for cross-linked peptides.  It has been shown 
that certain amino acids, including aspartic acid and proline, enhance or promote specific 
backbone cleavage of peptides.30-38  The mobile proton model, which proposes that 
peptide fragmentation is driven by charge-directed cleavages, has shown that higher 
energies are required to dissociate peptide ions in which the protons are sequestered at 
basic sites, particularly arginine residues.26, 30, 38-40  For such peptides which do not 
possess a mobile proton and have aspartic acid residues, enhanced cleavage at the Asp-
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Xxx bond has been observed.31, 41, 42  Work by the Wysocki group has demonstrated that 
the acidic side chain of aspartic acid directs fragmentation, site-specifically, at the C-
terminal amide bond.33, 43  Similar dissociation trends were also observed for glutamic 
acid containing peptides.33  Proline residues enhance dissociation N-terminally, at the 
Xxx-Pro amide bond, often yielding intense y-type ions, and has been observed for the 
dissociation of small, singly-charged peptides as well as multiply-charged proteins.32, 44  
This site-specific cleavage was first attributed to the high gas-phase basicity of the 
proline residue,45 but has also been theorized to be due to unfavorable ring strain of a 
proposed bicyclic structure of the b-type ion that would be formed upon cleavage C-
terminal to the proline.46 
The effects of amino acid content on the gas-phase fragmentation of cross-linked 
peptides, in particular residues which are known to promote site-specific dissociation 
along the peptide backbone, have not been analyzed.  Knowledge of the dissociation 
trends of cross-linked peptides, especially with regards to specific amino acids, would be 
useful for improving computer algorithms to aid in the interpretation of product ion 
spectra of these ions.  In this work, we investigate the influence of aspartic acid and 
proline on the dissociation of intermolecularly cross-linked peptides.  As unmodified 
peptides tend to exhibit enhanced fragmentation C-terminally to aspartic acid residues for 
precursor ions with sequestered protons, and N-terminally to prolines, these residues 
were positioned adjacent to the lysines modified by commonly used primary amine-
specific cross-linkers.  The impact of these residues on the directionality of cleavage 




The following five peptides were synthesized at the Protein Microanalysis Facility 
at the University of Texas at Austin and purified by reversed-phase liquid 
chromatography: Ac-AAAKAAAAR (AKA), Ac-AADKAAAAR (DKA), Ac-
AAAKDAAAR (AKD), Ac-AAPKAAAAR (PKA), and Ac-AAAKPAAAR (AKP).  
The peptides neurotensin (Pyr-LYENKPRRPYIL) and -MSH (Ac-
SYSMEHFRWGKPV-NH2) were purchased from Bachem (Torrance, CA).  The cross-
linker disuccinimidyl suberate (DSS) was purchased from Sigma-Aldrich (St. Louis, MO) 
and disuccinimidyl L-tartrate (DST) from Toronto Research Chemicals (North York, 
Ontario, Canada).  All other chemicals and solvents were obtained from Fisher Scientific 
(Fairlawn, NJ) except for extra dry dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. 
Louis, MO). 
 
3.3.2 Chemical Cross-linking 
Stock solutions of each peptide were prepared at 5.0 mM in 20.0 mM sodium 
phosphate buffer, pH 7.5, and the cross-linkers were freshly prepared at 20.0 mM in 
DMSO directly before use.  The cross-linking reaction was performed by adding 8.0 L 
of each peptide to 2.5 L of cross-linker, for a molar ratio of 4: 4: 5 ( peptide:  peptide: 
cross-linker).  The reaction was allowed to proceed at room temperature for one hour, 
after which the reaction mixture was desalted by solid-phase extraction using 50 mg tC18 
Waters (Milford, MA) Sep-Pak cartridges.   
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3.3.3 Methods and Instrumentation 
Samples were diluted to a concentration of 20 M in 70/30/1 MeOH/H2O/HOAc 
(v/v/v) for ESI-MS analysis.  Experiments were performed on a ThermoFinnigan LCQ 
Duo (San Jose, CA) quadrupole ion trap with the standard electrospray source.  Solutions 
were infused into the mass spectrometer at 3 L/min using a Harvard Apparatus PHD 
2000 syringe pump (Holliston, MA).  Ionization and ion optic conditions were optimized 
once for each precursor charge state and were not re-tuned for each individual cross-
linked peptide pair.  Precursor ions were activated for 30 ms at the typical qz value of 
0.25 for CID and the collision energy was adjusted such that precursor ion abundance 
was less than 10% of the total ion abundance.  Typical CID energies for doubly-charged 
cross-linked peptide ions ranged from 1.08 to 1.24 V (~30% normalized collision 
energy), and 0.57 to 0.62 V (~20% normalized collision energy) for the triply-charged 
species.  The precursor ion isolation window was set to 4 m/z units in order to retain 
isotopic profile to aid in determining the charge state of the product ions.  For some of the 
doubly-charged cross-linked peptides, the activation qz-value was decreased to 0.22 from 
0.25 in order to effectively trap the low-mass b3 fragment ion; the dissociation efficiency 
and fragment ion abundances were not significantly affected by this change.  All 
collision-induced dissociation experiments were collected in triplicate. 
 
3.3.4 Data Analysis 
Relative product ion abundances were calculated by dividing each product ion 
peak area by the total fragment ion abundance.  Fragment ions were grouped into 
different product ion types: y-ions, b and a-ions, cross-link amide bond cleavage 
products, lysine immonium ions, internal ions, other double cleavage products (b/b, b/y, 
and y/y), and specific cross-linker cleavage products (e.g., dissociation of the C7–C8 
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bond of DST).  Peaks were defined as having a minimum relative intensity of 1% and a 
minimum area of 0.1% of the total area in the spectrum.  Water and ammonia losses from 
each product ion type were included in the corresponding base group (e.g., peak area of a 
yn – NH3 ion were included in the y-ion group).  Neutral losses including water, 
ammonia, and CO2 from the precursor ion were excluded from the total fragment ion 
abundance for simplicity.  To determine the effect of Asp and Pro residues in regards to 
cleavage at the site of cross-linking, K4, the directionality of cleavage bias to the lysine 
residue was calculated for both the cross-linked peptides and the unmodified species 
using a method previously suggested by Tabb et al.28  The C-terminal cleavage bias was 
determined by taking the ratio of the difference in C-terminal and N-terminal fragment 
ions, relative to the lysine residue, to the sum of these fragment ion peak areas.  For 
example, the y-ion C-terminal bias was calculated as follows:   
 
   












                                              Equation 3.1 
where Ai is the peak area of the respective y-ions; the y6 ions are products of cleavage N-
terminal to the cross-linked lysine, and the y5 ions are a result of C-terminal cleavage for 
the nine-residue peptides analyzed in this study.  The  and  subscripts refer to cleavage 
of the  and  peptides, respectively, and are explained in more detail in the results and 
discussion.  A positive value indicates a fragmentation bias C-terminally to the lysine 
residue, whereas a negative value signifies an N-terminal bias.  Similarly, for the b-ions, 
the cleavage bias was calculated using the following formula: 
 
   












                                              Equation 3.2 
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where the b4 ions are the C-terminal cleavage products and the b3 ions are the N-terminal 
fragments. 
3.4 RESULTS AND DISCUSSION
The dissociation of cross-linked peptides containing either a proline or an aspartic 
acid residue was investigated to determine if these species follow similar fragmentation 
pathways as unmodified peptides.  Poly-alanine sequences were used as “filler” residues 
to minimize competing fragmentation pathways.  The peptides were cross-linked with 
either DSS or DST (Scheme 3.1), two widely used cross-linkers which react with 
primary amines such as free N-termini or the -amine of lysine residues.  Since the N-
termini of these peptides were acetylated, it can be assumed that the site of cross-linking 
is between K4 of each peptide.  A proline or aspartic acid residue was positioned on 
either the C- or N-terminal side of the cross-linked lysine to determine whether the cross-
Scheme 1. Chemical Structures of DSS and DST cross-linkers 
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link influenced the dissociation trends of the peptides containing either of these two 
residues.  The resulting doubly-charged cross-linked peptides are assumed to have both 
protons sequestered on the C-terminal arginine residues,30 whereas the triply-charged 
species possess a mobile proton.  The cross-linked peptides in both the 2+ and 3+ charge 
states were analyzed by CID to compare the effects of the proline or aspartic acid 
residues in different charge states.  The product ions formed were labeled according to 
the nomenclature suggested by Schilling et al.20 and Gaucher et al.23  In brief, the two 
intermolecularly cross-linked peptides are labeled  and , referring to the first and 
second peptide listed, respectively.  Cleavage along the backbone of the  peptide 
yielding a b-ion is labeled as bn, and similar notation is used other fragment ion types, as 
well as for the  peptide.  Product ions of both peptides cross-linked together are labeled 
with the fragmentation nomenclature for each cleavage (e.g., b4y7).  Lysine immonium 
ions which maintain the cross-link to the other peptide are labeled as KL, where L 
represents the cross-linker molecules (e.g., DSS or DST) and  is the other peptide.  Due 
to the repeating alanine sequences of the peptides studied, certain fragment ions cannot 
be specifically identified as either cleavage of the  peptide or the  peptide as the 
products are isobars, and are labeled with subscript / to represent such cases. 
 
3.4.1 Dissociation of DSS-Cross-linked Peptides 
Representative CID spectra of the homo-intermolecularly DSS-cross-linked 
peptides are shown in Figure 1.  For the control cross-linked peptide, [Ac-
AAAKAAAAR + DSS + Ac-AAAKAAAAR + 2H]2+, a series of singly charged non-
cross-linked y-ions were observed in increasing abundance as the site of cleavage moves 
closer to the cross-linked lysine residue (i.e., y5 > y4 > y3) (Figure 3.1a).  Similar to 
this y-ion series, the abundances of singly charged cross-linked b-ions increased as the 
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amide bond cleavage site moved towards K4, with the exception of the b8 fragment ion 
which was observed as the most abundant b-ion.  Without the mobile proton several 
double cleavage products, such as b4y8 and b5b7, were also formed at similar 
abundances to the single cleavage fragment ions.  Cross-linked lysine immonium ions 
Figure 3.1  CID spectra of DSS intermolecularly cross-linked peptides.  Precursor ions 
were (a) [AKA + AKA + DSS + 2H]2+, (b) [AKA + AKA + DSS + 3H]3+, 
(c) [AKD + AKD + DSS + 2H]2+, (d) [AKD + AKD + DSS + 3H]3+, (e) 
[PKA + PKA + DSS + 2H]2+, and (f) [PKA + PKA + DSS + 3H]3+.  An 
asterisk (*) is used to signify the precursor ion.  Several double cleavage
product ions could not be uniquely identified due to isobars inherent to the
peptide sequences and are labeled with one possible identity preceded by ‡. 
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were detected after the loss of neutral ammonia, as had previously been observed by 
Gaucher et al.,23 and cleavage of the cross-link amide also occurred, yielding the L13 
ion of m/z 980.5.  Dissociation of the triply-charged species yielded a more easily 
interpretable product ion spectrum in which greater than 95% of the fragment ions were 
single cleavage b- and y-type ions (Figure 3.1b).  A full series of y-ions and b-ions were 
observed, both modified (y6 – y8 and b4 – b8) and non-cross-linked (y1 – y5 and b2 
– b3), but the relative abundances of these fragment ions did not follow any strict trend.  
Triply-charged cross-linked y-ions were observed and the cross-linked b-ions were also 
detected in the higher, 2+, charge state when compared to the dissociation of the 
analogous doubly-charged precursor ions.  In general, for both the b- and y-ions, as the 
cleavage site moved further away from the cross-link, the fragment ion abundance 
increased.  At a much lower abundance, the KL-17 product ion was also detected. 
CID of the homo-intermolecularly DSS-cross-linked Ac-AAAKDAAAR peptide 
yielded very few sequence ions for the doubly-protonated precursor ion, as shown in 
Figure 3.1c.  With both protons sequestered on the C-terminal arginine residues, aspartic 
acid directed fragmentation dominates and the two products of cleavage C-terminal to D5 
are observed at a high abundance – y4 and b5.  The other three cross-linked b-ions are 
also detected, but at a much lower abundance.  Only one other y-ion is observed in the 
product ion spectrum.  Cleavage N-terminally to the aspartic acid residue yielded the 
product ions y5 and b4, but at a much lower abundance.  The triply-charged precursor 
ion possesses a mobile proton, and dissociation of this species is not dominated by a 
single pathway; rather, a full series of b- and y-ions were seen limited only by the low-
mass cut-off inherent to resonant excitation in ion traps (Figure 3.1d).  Unlike the CID 
spectrum for the Ac-AAAKAAAAR cross-linked peptide, no distinct trends were 
observed regarding fragment ion abundances.  Upon CID, the cross-linked [Ac-
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AAPKAAAAR + DSS + Ac-AAPKAAAAR + 2H]2+ peptide yielded an abundance of 
double cleavage products as evident in Figure 3.1e.  Cleavage of the amide bond N-
terminal to the proline residue, P3, dominated the dissociation of this ion producing 
cross-linked internal ions (y7PKA), lysine immonium ions linked to the y7 ion (KLy7 – 
17), and a series of bny7 fragment ions.  Most of these fragment ions are redundant as 
they do not provide additional information to identify the location of the cross-link nor 
sequence the constituent peptides.  Dissociation of the triply-charged species was 
similarly dominated by cleavage N-terminal to the proline residue yielding the y7 
fragment; in addition a high abundance of the y8 product was observed as shown in 
Figure 3.2 CID spectra of hetero-DSS-intermolecularly cross-linked peptide AKP + 
DSS + DKA in the (a) 2+ charge state and (b) 3+ charge state.  AKP is 
referred to as the  peptide and DKA as the  peptide; / nomenclature is 
used to signify that cleavage could have occurred on either peptide, as the
two possible fragment ions are isobaric.  An asterisk (*) is used to signify
the precursor ion. 
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Figure 3.1f.  No cleavage between P3 and K4 was detected for the DSS cross-linked Ac-
AAPKAAAAR, regardless of precursor ion charge state. 
The hetero-cross-linked peptides containing one proline and a single aspartic acid 
residue exhibited dissociation that followed both Asp- and Pro-directed pathways.  CID 
mass spectra of these doubly-charged DSS-cross-linked species were typically dominated 
by fragmentation C-terminal to the aspartic acid residue and to a lesser degree, N-
terminal to the proline.  A representative CID spectrum is shown in Figure 3.2a for [Ac-
AAAKPAAAR + DSS + Ac-AADKAAAAR + 2H]2+.  Cleavage of the amide bond 
between D3 and K4 of the  peptide (Ac-AADKAAAAR), thus resulting in the y62+ ion, 
is the most abundant pathway with the two proline-directed fragments being the next two 
most abundant ions, y5+ and b4+.  Also present, but to a much lesser degree, are the 
other cross-linked b-ions as well as a lysine immonium fragment cross-linked to Ac-
AADKAAAAR.  It should be noted that due to the alanine sequences present in both 
peptides which create isobaric species, certain fragment ions could not be identified 
conclusively as to whether the bond cleavage occurred within the  or the  peptide 
(e.g.., b5 has the same mass as the b5 fragment and as such is labeled as b5/ in Figure 
3.2a).  Dissociation of the triply-charged DSS cross-linked peptide results in an almost 
complete series of b- and y-type fragment ions, as evident in Figure 3.2a.  With the 
addition of the mobile proton, dissociation of the  peptide C-terminal to the Asp residue 
does not dominate the spectrum, and is in fact one of few sequence fragment ions not 
observed.  Proline-directed fragmentation still yields two of the most abundant product 
ions, b42+ and y5+.  This data suggests that in order to obtain fragmentation information 
essential to locate the site of cross-linking as well as to sequence the two linked peptides, 
dissociation of more highly charged cross-linked peptides would be beneficial. 
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3.4.2 Dissociation of DST-Cross-linked Peptides 
The DST-cross-linked peptides exhibited similar dissociation pathways as the 
DSS-linked species, as shown in Figure 3.3, with one notable exception in that cleavage 
of the C7–C8 bond of the DST cross-linker was observed for the doubly charged 
precursor ions (described later in this section).  The doubly-charged DST homo-
intermolecularly cross-linked Ac-AADKAAAAR peptide predominantly dissociated via 
Asp-directed fragmentation, C-terminal to D3, as seen in Figure 3.3a, yielding the y62+ 
ion.  At much lower abundances, double cleavage products, including ones involving 
cleavage C-terminal to the aspartic residues of both peptides (y6y6) and cross-linked b-
ions were observed.  CID of the triply charged species, presumed to have a mobile 
proton, yielded a full series of b- and y-type fragment ions, again only limited by the low-
mass cut-off (Figure 3.3b).  With the mobile proton, the Asp-directed fragmentation 
which dominated the CID mass spectrum of the doubly charged cross-linked peptide was 
circumvented.  Fragment ions unique to cross-linked peptides, including products from 
the dissociation of the cross-link amide bond (L9 and L5), and cross-linked lysine 
immonium ions (KL and KL-17) were also detected.  For all of the DST-cross-linked 
peptides analyzed, fragmentation of the C7–C8 bond of the DST cross-linker occurred, as 
illustrated in Scheme 3.2.  Dissociation of this bond yields product ions corresponding to 
+56 and +58 Da adducts of the unmodified peptides, and they are labeled as L7 and L7 
ions in Figure 3.3.  (It should be noted that there is a 1 m/z unit difference between the 
precursor ion and L7 fragment ions in Figures 3.3a – 3.3d.)  For the second proline-
containing peptide analyzed in this study, Ac-AAAKPAAAR, dissociation of the doubly-
charged DST-cross-linked peptide predominantly produced three fragment ions, L7 and 
the two fragments corresponding to proline directed dissociation, y5 and b4 (Figure
3.3c).  The triply-charged Ac-AAAKPAAAAR + DST + Ac-AAAKPAAAR ion also 
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showed preferential cleavage between K4 and P5, while the other b- and y-type ions had 
abundances similar to that observed for the 2+ charged precursor (Figure 3.3d).  
Figure 3.3 CID spectra of DST intermolecularly cross-linked peptides.  Precursor ions 
were (a) [DKA + DKA + DST + 2H]2+, (b) [DKA + DKA + DST + 3H]3+, 
(c) [AKP + AKP + DST + 2H]2+, (d) [AKP + AKP + DST + 3H]3+, (e) 
[PKA + AKD + DST + 2H]2+, and (f) [PKA + AKD + DST + 3H]3+.  The 
first peptide listed is referred to as the  peptide and the second peptide as 
; / nomenclature is used to signify that cleavage could have occurred on
either peptide.  Internal ions that could not be conclusively identified due to
isobaric species are labeled with .  An asterisk (*) is used to signify the 
precursor ion. 
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Regardless of the charge state, proline-directed fragmentation dominates the CID 
spectrum of the Ac-AAAKPAAAR cross-linked peptides. 
Collisional-induced dissociation of [Ac-AAPKAAAAR + DST + Ac-
AAAKDAAAR + 2H]2+ more clearly shows fragmentation of the C7–C8 bond of DST, 
producing the corresponding L7 and L7 ions, as shown in Figure 3.3e.  Aspartic acid-
directed fragmentation dominates the product ion spectrum yielding y4/+ and b5/+, and 
numerous proline-directed fragments were detected between m/z 600 and 1300, including 
internal ions of the form PKAn cross-linked to bn ions (labeled with ) and y7 
containing fragments.  The influences of both Asp and Pro were observed by the 
formation of certain product ions, including y7b52+, analogous to those observed for the 
DSS-cross-linked species.  The triply-charged DST hetero-cross-linked peptide yielded a 
series of doubly-charged cross-linked b-ions, a series of cross-linked y-ions, and a series 
of uncross-linked y-ions for both peptides, as evident in Figure 3.3f.  The aspartic acid 
effects were not observed when the precursor ion had a mobile proton, but fragment ions 
with N-terminal prolines were detected at high abundances, in particular y7/.  The DST 
specific cleavage of the C7–C8 bond was also observed, but at lower abundances 
compared to that observed for the analogous doubly-charged precursor ion.  Dissociation 
of the amide bond N-terminal to the cross-linked lysine for either constituent peptide, Ac-
AAPKAAAAR or Ac-AAAKDAAAR, to yield the expected y6 or y6 fragments did not 
occur, suggesting a cleavage bias due to the cross-link. 
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3.4.3 Fragment Ion Type Abundances 
The relative abundance of each fragment ion type was calculated in order to shed 
light on the general trends of the dissociation of these proline- and aspartic acid-
containing cross-linked peptides.  As shown in Figure 3.4a for the doubly-charged DSS-
cross-linked peptides, a-, b-, and y-type fragment ions, on average, accounted for 
Scheme 3.2 Diagram of observed bond cleavages of DST-cross-linked peptides. 
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approximately 75% of the total product ion abundance.  For aspartic acid-containing 
cross-linked peptides, this abundance increased to over 85% as Asp-directed 
fragmentation of these doubly-charged precursor ions, in which both protons are 
sequestered, produced predominantly single cleavage b- and y-type ions.  Multiple 
cleavage fragments, including internal ions, b/b, b/y, y/y, and linked lysine immonium 
ions, accounted for 19% of all the fragment ions.  For the doubly charged DSS-cross-
linked peptides, two types of fragment ions unique to cross-linked peptides, those 
involving cleavage of the cross-link amide bond and cross-linked lysine immonium ions, 
accounted for 2.5% and approximately 6% of the product ion abundance, respectively.  
Cross-linked peptides containing Ac-AAPKAAAAR yielded a high abundance of 
internal ions; approximately 11% of all the fragments observed were internal ions, 
compared to 2% for the non-Ac-AAPKAAAAR cross-linked peptides.  A majority of 
these internal ions had the proline residue at the N-terminus.  Dissociation of the various 
triply-charged DSS-linked peptides, all of which possess a mobile proton, yielded a much 
higher abundance of single-cleavage a-, b-, and y-type fragment ions – on average greater 
than 95% relative abundance, as shown in Figure 3.4b.  The total abundance of the cross-
linked lysine immonium ions was less than 1%, and cleavage of the cross-link amide 
bond was observed at less than 0.1% abundance.  For the triply-charged aspartic acid- or 
the proline-containing cross-linked peptides, there were no major differences in fragment 
ion abundances except that y-ions were observed at over 76% relative abundance for the 
Ac-AAPKAAAAR cross-linked species, due to preferential cleavage N-terminal to the 
proline residue yielding an unusually high abundance of y7 fragments.  No significant 
differences in the multiple cleavage products were detected between the various cross-
linked peptides.  
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Figure 3.4 Relative fragment ion abundance for the DSS cross-linked peptides in the 
(a) 2+ charge state and (b) 3+ charge state.  Each category represents the 
abundance of that product ion type relative to the total fragment ion
abundance minus neutral losses from the precursor ion.  Errors are less than
0.5% relative abundance. 
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Figure 3.5 Relative fragment ion abundance for the DST cross-linked peptides in the 
(a) 2+ charge state and (b) 3+ charge state.  Each category represents the
abundance of that product ion type relative to the total fragment ion
abundance minus neutral losses from the precursor ion.  Errors are less than
0.5% relative abundance. 
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The DST-cross-linked peptides, particularly for species without a mobile proton, 
as noted earlier, exhibited far more unique dissociation pathways compared to the DSS-
linked peptides.  Fragmentation of the C7–C8 bond of the DST cross-linker occurred for 
all of these cross-linked peptides in the 2+ charge state, accounting for over 21% of the 
total fragment ion abundance, as shown in Figure 3.5a, and these fragments do not 
provide any diagnostic information for determining the cross-link location or sequencing 
the peptide.  Similar to the DSS-cross-linked peptides, doubly-charged DST-linked 
species yielded on average 60% single cleavage b, y, and a-ions, with the remainder 
accounted for by multiple cleavage products and cross-linker specific product ions.  The 
latter product ions, excluding ones stemming from dissociation of the DST linker at the 
C7–C8 bond, were observed at approximately 15% relative abundance, similar to that for 
the DSS-cross-linked species.  Various internal ions were also observed at similar 
abundances for the DST-linked peptides than for the DSS-cross-linked products – 3% 
relative abundance compared to approximately 5%, respectively.  The DST-cross-linked 
products containing the Ac-AAPKAAAAR peptide did exhibit a higher degree of internal 
ion formation than the other peptides studied, but the difference was not as pronounced as 
that for the DSS-cross-linked products.  Dissociation of the triply-charged DST-cross-
linked peptides, as summarized in Figure 3.5b, yielded similar results as the analogous 
DSS-linked species.  Across the series, over 92% of the fragment ion abundance 
consisted of single bond cleavage a, b, and y-ions.  Fragment ions due to cleavage of the 
DST cross-linker at the C7–C8 bond totaled less than 1% relative abundance, suggesting 
that this fragmentation pathway is preferred only for precursor ions without a mobile 
proton.  The only modest difference between the fragmentation patterns of the triply 
charged DSS- and DST-linked peptides was an increased abundance of double cleavage 
products and cross-linked lysine immonium ions, from 3% to 6%. 
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The addition of the mobile proton to these DSS- and DST-cross-linked peptides 
increased the abundance of useful sequence ions, ones which are easily interpretable.  
Also, aspartic acid-directed fragmentation of the triply-charged ions did not occur, thus 
yielding a wider array of single cleavage products.  Proline-directed fragmentation still 
dominated the CID spectra of the triply charged cross-linked peptides, however, a full 
series of b- and y-ions were still observed, with the exception of cleavage C-terminal to 
proline residues.  The degree of multiple-cleavage products, particularly the abundance of 
internal ions for the proline containing peptides, was greatly reduced for dissociation of 
the more highly charged cross-linked peptide ions. 
 
3.4.4 Effect of Cross-linkers on Cleavage Bias Adjacent to the Modified Lysine 
As evident from the dissociation of the intermolecularly cross-linked peptides, the 
aspartic acid or proline residue tends to direct peptide fragmentation.  One earlier study 
indicated a qualitative enhancement of cleavage of the amide bond adjacent to the cross-
linked lysine for intramolecularly cross-linked peptides, so we aimed to investigate a 
possible preference for intermolecularly cross-linked species.23  The directionality bias of 
cleavage to the cross-linked lysine was determined for both the non-modified peptides 
(1+ and 2+) and the homo-intermolecularly cross-linked peptides (2+ and 3+) as shown 
in Figure 3.6.  A positive C-terminal cleavage bias value indicates that more fragment 
ions were formed from cleavage of the amide bond C-terminal to the cross-linked lysine, 
whereas a negative value indicates a bias towards forming product ions from dissociation 
of the N-terminal amide bond.  For species without a mobile proton (e.g., 1+ charge state 
for unmodified peptides, 2+ charge state for cross-linked peptides), the influences of 
proline and aspartic acid on y-ion formation were not greatly affected upon cross-linking 
(Figure 3.6a).  The y-ion C-terminal bias was only enhanced for the Ac-AAAKPAAAR 
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and Ac-AAAKAAAAR peptides after cross-linking.  All of the doubly-charged cross-
linked peptides preferentially dissociated via cleavage of the C-terminal amide bond to 
the lysine residue, except for the homo-intermolecularly cross-linked Ac-AADKAAAAR 
Figure 3.6 The C-terminal cleavage bias relative to the lysine residue, for both the
unmodified peptides in the 1+ and 2+ charge state and the homo-
intermolecularly cross-linked peptides in the 2+ and 3+ charge state, for (a) 
y-ions and (b) b-ions. 
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peptide; these species fragmented via Asp-direction dissociation C-terminal to D3, or N- 
terminally to the modified lysine residue.  With the addition of a mobile proton, the Asp-
containing cross-linked peptides did not exhibit any significant cleavage bias towards the 
formation of y-ions.  The cross-linked peptides with proline residues still displayed signs 
of a C-terminal fragmentation bias in the 3+ charge state; however, these results can be 
explained by preferential cleavage N-terminally to proline residues.  With the proline 
residue positioned N-terminally to the lysine (e.g., Ac-AAPKAAAAR), cleavage of the 
bond between P3 and K4 is suppressed, thus decreasing the y6 product ion abundance 
relative to y5 fragment ions.  For the other proline containing peptide, Ac-
AAAKPAAAR, formation of the y5 ion is enhanced relative to y6 due to Pro-directed 
dissociation between K4 and P5. 
Analysis of the b-ions detected showed that the unmodified peptides all 
preferentially dissociated N-terminally to K4 yielding b3 ions, as shown in Figure 3.6b, 
except for [Ac-AADKAAAAR + H]+ in which no b3 or b4 ions were detected (i.e., peak 
abundance was below the peak threshold).  For the doubly-charged unmodified peptides, 
the N-terminal cleavage bias increased over the singly-charged peptides, with the Ac-
AADKAAAAR peptide as the lone exception.  This particular unmodified peptide 
exhibited similar cleavage biases for both b and y-ions.  Interestingly, analysis of the b-
ions suggests there is a significant C-terminal cleavage bias for all of the cross-linked 
peptides.  The doubly-charged cross-linked peptides have both protons localized on the 
C-terminal arginines, so one would not expect to detect b3 ions which do not contain the 
cross-link or a charge.  Cleavage C-terminal to the lysine residue yields a b4 ion which 
contains the cross-linker as well as the  peptide with the sequestered proton at its C-
terminal arginine.  A high C-terminal cleavage bias for the formation of b-ions also was 
observed for all of the triply-charged cross-linked peptides.  Even with the additional 
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mobile proton, b3 ions were not detected at high abundances in the CID spectra.  Having 
a proline residue N-terminal to the lysine reduces the abundance of N-terminal fragment 
ions (e.g., b3), while a proline C-terminal enhances the formation of b4 ions.  In the 3+ 
charge state, the aspartic acid effect does not dominate the peptide fragmentation 
pathways, and any cleavage bias due to the aspartic acid residues is eliminated.  
However, the high C-terminal b-ion abundance relative to N-terminal fragments for the 
Asp-containing cross-linked peptides, as well as the Ac-AAAKAAAAR peptide, 
suggests that the presence of the cross-link affects the dissociation of the amide bonds 
adjacent to the modified lysine. 
The observed C-terminal cleavage bias could be due to the composition and 
position of the amino acids residues chosen for this study.  Cleavage C-terminal to the 
cross-linked lysine yields the y5 fragment ion (XAAAR) and a b4 fragment ion (Ac-
AAXK + cross-linker +  peptide), while N-terminal cleavage produces the b3 fragment 
(Ac-AAX) and the corresponding y6 fragment (KXAAAR + cross-linker +  peptide).  
The b3 fragment is unlikely to carry a charge without a basic residue present and thus 
would not be observed.  The b4, y6, and y5 fragments would all be detected as ions due 
to the presence of at least one C-terminal arginine residue.  The location of the arginines 
may explain the greater C-terminal cleavage bias observed for the b-ions compared to y-
ion formation, particularly for the triply-charged precursor ions without a proline residue.  
However, in most protein cross-linking experiments, cross-linked peptides with C-
terminal arginines will be produced after enzymatic digestions with trypsin, and the 
trends observed in this study should be considered in sequence identification software. 
For the unmodified peptides, the mobile proton is assumed to be located on the 
second most basic site, the -amine group of the lysine residue.  This proton, when 
mobilized upon ion activation, could easily promote charge-directed fragmentation at 
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either amide bond adjacent to the lysine residue.  However, after the cross-linking 
reaction which produces an amide bond involving the amino group of the lysine side 
chain, the third proton of the cross-linked peptide is likely not as localized as that of the 
mobile proton for the unmodified peptides.  Ongoing work in our lab examining infrared 
multiphoton dissociation of cross-linked peptides has shown enhanced photodissociation 
efficiencies for the triply-charged cross-linked peptides compared to the doubly-charged 
unmodified peptides, suggesting a lower activation energy for the less basic cross-linked 
species.  The gas-phase basicity differences and probable localization of protons between 
cross-linked and non-cross-linked peptides may help explain this enhanced C-terminal 
cleavage bias to the linked lysine residues. 
 
3.4.5 Dissociation of Other Cross-linked Peptides 
The peptides -MSH (Ac-SYSMEHFRWGKPV-NH2,  peptide) and neurotensin 
(Pyr-LYENKPRRPYIL,  peptide) were cross-linked by either DSS or DST to determine 
whether the same dissociation trends are observed for cross-linked peptides with more 
random sequences.  Since the two cross-linkers react with primary amines, it was 
assumed that the cross-link was formed between K11 of -MSH and K6 of neurotensin, 
and the product ion spectra of the DST- cross-linked species support this assumption 
(Figure 3.7).  Dissociation of the triply-charged precursor ion was dominated by 
cleavage C-terminal to the acidic residues, E5 of -MSH and E4 of neurotensin, yielding 
y83+ (m/z 937.8) and y93+ (m/z 978.7) as the three protons are localized by the three total 
arginine residues present in the two peptides (Figure 3.7a).  To a lesser degree proline-
directed cleavages were observed, producing b113+ (m/z 1080.0) and b93+ (m/z 982.7)  
Without a mobile proton, dissociation of the C7–C8 bond of the DST cross-link was 
observed producing L72+ and the corresponding L7+ product ions of m/z 865.6 and 
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1721.9, respectively.  Other cross-linker specific fragment ions were detected including 
cleavage of the cross-link amide bond yielding the unmodified constituent peptides 
(L52+ and L5+), and the constituent peptides modified by the DST cross-linker (L92+ 
and L9+).  Interestingly, cross-linked lysine immonium ions were observed at less than 
0.5% relative abundance for the triply-charged precursor ion, compared to approximately 
5% for the model cross-linked peptide species without a mobile proton.  CID of the 
quadruply-charged precursor ion [-MSH + DST + neurotensin + 4H]4+ yielded a full 
series of cross-linked y ions (y3 – y12), and a full series of uncross-linked b-ions (b2 
Figure 3.7 CID spectra of -MSH cross-linked to neurotensin by DST in the (a) 3+ 
charge state and (b) 4+ charge state.  Product ion spectra of -MSH cross-
linked to neurotensin by DSS in the (c) 3+ charge state and (d) 4+ charge 
state.  -MSH (Ac-SYSMEHFRWGKPV-NH2) is referred to as the 
peptide and neurotensin (Pyr-LYENKPRRPYIL) as the  peptide; the cross-
link is between K11 of -MSH and K6 of neurotensin.  An asterisk (*) is 
used to signify the precursor ion. 
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– b10), as shown in Figure 3.7b.  With an additional mobile proton, fragment ions 
stemming from the cleavage of amide bonds C-terminal to acidic residues were not 
observed.  Proline-directed fragmentation yielded the most abundant product ion b113+.  
Similar to the CID results of the model cross-linked peptides, cross-linker specific 
product ions were not observed at any significant abundance; instead b- and y-type 
fragment ions dominated the entire CID spectrum.  Most of the product ions were a result 
of backbone cleavage along -MSH, and not neurotensin, with the exception of amino 
acid specific fragmentation. 
The DSS-cross-linked species in the 3+ charge state produced similar fragment 
ions as the DST-cross-linked analog (Figure 3.7c).  Ions resulting from cleavage C-
terminal to the two glutamic acid residues dominated the CID spectrum (y83+ and y93+), 
and proline-directed products were also abundant (b113+ and b93+).  Cross-linker specific 
product ions were not observed for the DSS-cross-linked peptide at similar high 
abundances as the DST-cross-linked species without a mobile proton.  Such product ions 
accounted for less than 1% of the total fragment ion abundance.  Collision-induced 
dissociation of the quadruply-charged DSS-cross-linked peptide yielded higher sequence 
coverage, specifically a series of y-ions of the -MSH peptide cross-linked to intact 
neurotensin (Figure 3.7d).  Acidic residue directed cleavages were not observed for the 
precursor ion possessing a mobile proton; dissociation N-terminal to proline was still 
dominant yielding the b11 ions.  No cross-linker specific product ions, including cross-
linked lysine immonium ions, or fragments from the cleavage of the cross-link amide 




Intermolecularly cross-linked peptides, in general, dissociate via similar pathways 
to that of unmodified peptides.  For DSS- and DST-cross-linked peptide ions in which the 
protons were sequestered, aspartic acid-directed fragmentation dominated the product ion 
spectra, more so than fragmentation N-terminally to proline residues among the two 
linked peptides.  These doubly-charged cross-linked peptides yielded a high abundance of 
multiple cleavage products, including b/b, b/y, y/y, cross-linked lysine immonium ions, 
and internal ions, which complicated the interpretation of the CID spectra, but provided 
complementary sequence information.  In particular, for cross-linked peptides with a 
proline N-terminal to the linked lysine residue (i.e., a PK sequence), a high degree of 
cross-linked internal ions were formed.  The DST-cross-linked peptide ions without a 
mobile proton dissociated in a unique manner compared to the analogous DSS species, in 
which cleavage of the C7–C8 bond of the DST linker molecule was observed regardless 
of amino acid content. 
Dissociation of the cross-linked peptides possessing a mobile proton resulted in 
almost full sequence coverage (b- and y-type ions) of both peptides, allowing one to 
determine the site of cross-linking, as cleavage C-terminal to Asp residues was observed 
to a much lesser degree.  Dissociation N-terminal to the proline residues was still 
prevalent for the more highly charged cross-linked peptides.  Products unique to cross-
linked peptides, such as cross-linked lysine immonium ions, multiple cleavage fragments, 
and cleavage of the cross-linkers, including both the cross-linker amide bond and within 
the DST linker, accounted for less than 10% of the fragment ion abundance for the triply-
charged species, compared to upwards of 50% of the fragment ions for precursor ion 
without a mobile proton.  In addition, the cross-linked peptides exhibited a tendency to 
preferentially cleave C-terminally to the modified lysine residue, particularly in the 
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formation of b-ions, compared to the unmodified peptides.  Unless an aspartic acid 
residue is positioned N-terminally to the cross-linked lysine and the precursor ion does 
not have a mobile proton, this C-terminal cleavage bias was observed for all of the cross-
linked peptides regardless of the position of proline and aspartic acid residues. 
By incorporating these dissociation trends noted for cross-linked peptides into 
computer algorithms, one would expect the confidence in the assignment of product ions 
and subsequent peptide identification to increase.  In the presence of a mobile proton the 
intermolecularly cross-linked peptide tends to behave as two individual peptides, each 
modified at the lysine residue by the cross-linker and the other peptide.  However, as 
evident in dissociation of the cross-linked model peptides without a mobile proton, 
several unique types of fragment ions were identified.  Many commercial cross-linkers 
are primary amine specific, and after cross-linking, in which an amide bond is formed, 
the overall gas-phase basicity of the peptide or protein is reduced, thus decreasing the 
ionization efficiency of more highly-charged cross-linked peptides.  Particularly for 
tryptic peptides in which basic residues are not conserved, cross-linked peptides without 
a mobile proton dissociate via several pathways yielding multiple cleavage product ions 
(e.g., by), cross-linked lysine immonium ions, and fragments from the dissociation of 
the cross-link amide bond or of the cross-linker (e.g., L7 and L7 fragments of DST 
cross-linked peptides), as well as the typical b- and y-type product ions.  Computer 
algorithms which do not currently account for these product ion types may lead to 
incorrect peptide and protein identifications.  Also, these cross-linker specific product ion 
types can provide not only complementary but also confirmatory sequence information 
which can aid in identifying the location of the chemical cross-link. 
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Chromogenic Cross-linker for the Characterization of Protein Structure 
by Infrared Multiphoton Dissociation Mass Spectrometry 
4.1 OVERVIEW
A new IR chromogenic cross-linker (IRCX) has been developed to aid in rapidly 
distinguishing cross-linked peptides from unmodified species in complex mixtures.  By 
incorporating a phosphate functional group into the cross-linker, one can take advantage 
of its unique IR absorption properties, affording selective infrared multiphoton 
dissociation (IRMPD) of the cross-linked peptides.  In a mock mixture of unmodified 
peptides and IRCX-cross-linked peptides (intramolecularly and intermolecularly cross-
linked), only the peptides containing the IRCX modification were shown to dissociate 
upon exposure to 50 ms of 10.6 m radiation.  LC-IRMPD-MS proved to be an effective 
method to distinguish the cross-linked peptides in a tryptic digest of IRCX-cross-linked 
ubiquitin.  A total of four intermolecular cross-links and two dead-end modifications 
were identified using IRCX and LC-IRMPD-MS.  IRMPD of these cross-linked peptides 
resulted in secondary dissociation of all primary fragment ions containing the 
chromophore, producing a series of unmodified b- or y-type ions that allowed the cross-




As the field of proteomics continues to rapidly expand, there has been a growing 
interest in determining the three-dimensional structure of proteins as well as the 
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interfaces of protein-protein complexes.1, 2  Chemical cross-linking of proteins with mass 
spectrometric analysis has proven to be a useful method to determine low-resolution 
protein structural information and protein-protein interactions.3-6  Compared to X-ray 
crystallography and NMR spectroscopy, chemical cross-linking requires relatively low 
amounts of protein to probe distance constraints within a single protein7 or protein-ligand 
complexes.8-10  While the experimental procedure for chemically cross-linking proteins is 
well established, there are several analytical challenges that remain in the identification 
of the cross-linked peptides by mass spectrometric means. The two main difficulties in 
this technique have been the differentiation of cross-linked peptides from unmodified 
ones in enzymatic digests of cross-linked proteins and the ability to identify the specific 
location of the cross-link using tandem MS. 
To circumvent these limitations, much work has been dedicated to developing 
new cross-linkers to simplify identification by mass spectrometric methods.  For 
example, several cross-linkers that incorporate isotope labels have been designed to 
create doublet peaks within the mass spectra,11-14 thus allowing facile pinpointing of the 
cross-linked products. Other cross-linkers incorporate fluorophores to facilitate 
distinction of  modified proteins15 and peptides from the unmodified ones during LC-MS 
analyses,16, 17 while others  introduce chemically cleavable functionalities.18-20  Affinity 
tags such as biotin labels have also shown promise as a means to enrich the cross-linked 
peptides from complex mixtures prior to mass spectrometry.20-22  Cross-linkers have also 
been designed with gas-phase labile bonds such that traceable  fragment ions unique to 
cross-linked peptides are formed upon low energy activation during MS/MS analysis.20, 
23-25 
Interpretation of the cross-linked peptide product ion spectra, which typically 
contain diagnostic fragment ions both to locate the cross-link and sequence the peptides, 
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remains a difficult challenge even with available software.  Several algorithms have been 
written to aid in the identification of intact cross-linked peptides based on product ion 
spectra of these species, but they do not take into account all of the possible product ions 
specific to cross-linked peptides.26-31  Initial work by Schilling et al. demonstrated that 
dissociation of cross-linked peptides typically resulted in cleavage of an amide bond of 
one peptide, yielding one unmodified fragment and the corresponding fragment linked to 
the other peptide.26  A systematic study by Gardner et al. (Chapter 3) indicated that 
intermolecularly cross-linked peptides without a mobile proton yielded a high degree of 
internal ions, as well as other double cleavage products which make interpretation of the 
product ion spectra difficult.32  Thus, developing new chemical cross-linkers to reduce 
the complexity of the product ion spectra is still an ongoing area of interest.  Recent work 
by Soderblom et al. reported the design of a cross-linker in which a gas-phase labile bond 
was inserted in the chemical cross-linker, thus cleaving upon low-energy collisions to 
yield the two constituent peptides.33, 34  Bruce and coworkers developed a similar strategy 
using cross-linkers with two labile bonds that upon dissociation produce the two peptides 
in addition to a diagnostic reporter fragment ion.24, 25  After cleavage of the labile bond of 
these cross-linkers, the two modified peptides are then further interrogated via MS3 to 
sequence each peptide.   
The aim is to develop a chemical cross-linking technique in conjunction with 
photodissociation methods to eliminate the need for MSn experiments and streamline the 
analysis of cross-linked peptides.  Infrared multiphoton dissociation (IRMPD) has shown 
promise as an alternative means to activate and dissociate biomolecules in the gas 
phase35, 36 and has been shown to be an effective means to selectively dissociate 
phosphopeptides in both FTICR37, 38 and quadrupole ion trap (QIT) mass 
spectrometers.39, 40  Previous work in the Brodbelt group39 and by Flora and Muddiman37, 
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38, 41 have shown that the phosphate group has a high absorption at the wavelength of a 
continuous wave (cw) CO2 laser, 10.6 m.  Because of the large differences in absorption 
efficiency of phosphopeptides and unmodified peptides, phosphopeptides dissociate upon 
IR irradiation far more readily than unmodified peptides.   
IRMPD in QITs offers other advantages over conventional collisional activation 
methods.36, 42-47  IRMPD is a non-resonant activation process whose efficiency is 
independent of the rf trapping voltage, thus allowing a much broader m/z trapping range 
than conventional CID.  This feature is particularly important for detection of key 
terminal sequence ions in the low m/z range.   Ion losses due to collisions or unstable 
trajectories are eliminated as the photodissociation process does not affect the 
translational motion of ions.  The non-resonant nature of photodissociation methods also 
yields secondary and higher order product ions that might only be obtained by MSn 
approaches using CID. 
In this chapter, the development and application a novel IR-chromogenic cross-
linker which incorporates a phosphate chromophore that allows the identification of 
cross-linked peptides and facilitates the interpretation of the product ion spectra of the 
constituent peptides is reported.   Infrared multiphoton dissociation (IRMPD) in a linear 
quadrupole ion trap is used to selectively dissociate the cross-linked peptides, allowing 
for these peptides to be easily distinguished from unmodified peptides (i.e., ones that do 
not afford any protein contact information).  The resulting IRMPD spectra of 
intermolecularly cross-linked peptides are dominated by b- and y-type product ions of 
each constituent peptide.  Online liquid chromatography (LC)-IRMPD-MS has been 
applied for the screening of complex peptide mixtures, including tryptic digests of 





4.3.1 Chemicals and Reagents 
The peptides -MSH (Ac-SYSMEHFRWGKPV-NH2), Ac-RFMWMK-NH2, 
substance P (RPKPQQFFGLM-NH2), and neurotensin 1-6 (Pyr-LYENK) were purchased 
from Bachem (Torrance, CA).  The peptide angiotensin II (DRVYIHPF) was purchased 
from AnaSpec (San Jose, CA).  Ubiquitin from bovine red blood cells, proteomics grade 
trypsin, bradykinin (RPPGFSPFR), methionine-enkephalin (YGGFM), melittin and the 
cross-linker disuccinimidyl suberate (DSS) were obtained from Sigma (St. Louis, MO).  
N-hydroxysuccinimide, 4-hydroxybenzoic acid, and ethyl dichlorophosphate were from 
Aldrich (Milwaukee, WI).  Water (HPLC grade) and acetonitrile (HPLC grade) were 
from Riedel-de Haën (Seelze, Germany).  1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride was obtained from Pierce Biotechnology (Rockford, IL).  All 
other chemicals and solvents were purchased from Fisher Scientific (Fairlawn, NJ) except 
for formic acid (EM Science, Gibbstown, NJ). 
4.3.2 Synthesis of Dibenzoyloxysuccinimidyl Ethyl Phosphate 
The IR chromogenic cross-linker (IRCX, Figure 4.1a), dibenzoyloxysuccinimidyl 
ethyl phosphate, was synthesized by first preparing the intermediate N-(4-
hydroxybenzoyloxy)succinimide.  Under an argon atmosphere, dry tetrahydrofuran 
(THF) (45 mL) and dry dichloromethane (DCM) (45 mL) were added to 5 mmol of 4-
hydroxybenzoic acid, 8 mmol of N-hydroxysuccinimide, and 6.5 mmol of 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride.  The reaction was stirred under argon 
at room temperature for 24 hours and then extracted with H2O (1 
 60 mL), saturated 
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NaHCO3 (1 
 60 mL), and then a saturated brine solution (1 
 60 mL).  The final liquid 
extract was dried over Na2SO4, filtered, and dried under vacuum.  The intermediate was 
recrystallized in DCM at 20 °C overnight and filtered.   
Dibenzoyloxysuccinimidyl ethyl phosphate was prepared by dissolving 0.5 mmol 
of N-(4-hydroxybenzoyloxy)succinimide in dry THF at 0 °C, and then adding 0.25 mmol 
of ethyldichlorophosphate dropwise to the solution, followed by 10 mmol of dry 
triethylamine.  The reaction was allowed to warm to room temperature while stirring over 
2 hours, then heated to 60 °C and stirred for additional 4 hours.  The final solution was 
dried and concentrated under reduced pressure.  The product was washed with cold H2O, 
filtered, recrystallized in DCM, and filtered.  The cross-linker structure was confirmed by 
1H NMR using a 400 MHz Varian instrument. 1H NMR at 400 MHz in CDCl3 yielded: 
8.29 ppm (d, 4H), 7.39 ppm (d, 4H), 4.20 ppm (m, 2H), 2.94 (s, 8H), 1.71 (br, 3H); these 
findings are consistent with the proposed structure. ESI-IRMPD-MS of protonated IRCX 
(m/z 561) using 2.0 ms of irradiation yielded an abundant product ion corresponding to 
the loss of succinimide (m/z 464), and a less abundant ion of m/z 446 (loss of N-
hydroxysuccinimide) (data not shown).   
 
4.3.3 Chemical Cross-linking of Model Peptides 
Stock solutions of the model peptides were prepared at 5.0 mM in H2O. IRCX  
and DSS were freshly prepared at 20.0 mM in DMSO prior to cross-linking.  The 
peptides -MSH and Ac-RFMWMK-NH2 were intermolecularly cross-linked with IRCX 
at a 4:4:5 molar ratio of peptide: peptide: cross-linker in 20 mM HEPES, pH 8.0 to 
produce a final concentration of 1.7 mM in a total volume of 12 L.  Substance P was 
similarly intramolecularly cross-linked by IRCX or DSS at a 4:5 molar ratio in the same 
buffer.  All peptide cross-linking reactions were allowed to incubate at room temperature 
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overnight to increase the yield of cross-linked peptides.  The reactions were desalted by 
solid phase extraction using 50 mg tC18 Waters (Milford, MA) Sep-Pak cartridges. 
 
4.3.4 Chemical Cross-linking and Enzymatic Digestion of Ubiquitin 
The protein ubiquitin was intramolecularly cross-linked by IRCX at 1:5, 1:10, 
1:25 and 1:50 molar ratios of protein: cross-linker in a 20 mM HEPES buffer, pH 8.0 at a 
final protein concentration of 10 M.  The reactions were allowed to proceed at room 
temperature for 30 minutes. The cross-linking was quenched by the addition of 
NH4HCO3 to a final concentration of 10 mM for 15 minutes.  The reaction mixtures were 
desalted against a 5 kDa molecular weight cut-off Ultrafree Biomax membrane 
(Millipore, Billerica, MA).  Aliquots were removed for direct-ESI-MS analysis and the 
remaining cross-linked ubiquitin sample was diluted to 180 M in 100 mM NH4HCO3, 
pH 8.0.  Cross-linked ubiquitin was enzymatically digested with trypsin at a 1:10 ratio 
enzyme-to-protein (w/w) overnight at 37 °C.  The digested sample was then desalted by 
solid-phase extraction as described above and diluted to ~10 M in 50:50 H2O/MeOH. 
4.3.5 Mass Spectrometry 
All mass spectrometry experiments were performed on a modified ThermoFisher 
Scientific LTQ XL linear ion trap mass spectrometer using the XCalibur version 2.2 
software package and the standard ESI source.  For direct infusion experiments the ESI 
voltage was set to 4.5 kV and solutions were infused at 2.5 L/min.  Solutions were 
prepared at ~10 M in 49.5:49.5:1 H2O/MeOH/HOAc (v/v/v) for ESI-MS analysis.  For 
CID experiments, the precursor ions were activated for 30 ms at the default q-value of 
0.25.  Energy-variable CID experiments were performed by incrementally raising the 
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CID voltage, and the CID voltage necessary to reduce the precursor ion abundance to 
50% was determined.  For energy-variable CID, normalized collision energies (NCE) 
were converted to CID voltages to account for the differences in m/z of the precursor ions 
based on the calibration settings of the instrument.  The CID voltages for the IRCX-
cross-linked peptides were then corrected for their greater degrees of freedom compared 








      Equation 4.1 
where the degrees of freedom N = 3n – 6 and n is the number of atoms in the peptide 
cross-linked by either DSS or IRCX.48  All energy-variable CID experiments were 
performed in triplicate; the drifts in the CID voltages were determined to be less than 
0.08 mV. 
4.3.6 Infrared Multiphoton Dissociation 
IRMPD was performed using a model 48-5 Synrad 50-W CO2 continuous wave 
laser (Mukilteo, WA).  The back flange of the vacuum manifold of the instrument was 
modified with a CF viewport flange with a ZnSe window to allow the transmission of 
10.6 m radiation.  The unfocused laser beam was aligned on axis with the linear ion trap 
such that the beam passed through the 2-mm aperture of the exit lens to irradiate the ion 
cloud.  The laser was triggered during the activation step in the scan function by a TTL 
signal from pin 14 of the J1 connector on the digital printed circuit board.  All IRMPD 
experiments were performed at full power (50 W) with irradiation times varying between 
5 and 100 ms unless otherwise indicated.  The q-value of the precursor was set between 
0.1 and 0.15 to reduce the low-mass cut-off (LMCO) value to less than m/z 150.  The 
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pressure in the analyzer region was nominally 9.0 
 10-6 Torr and no changes to the He 
bath gas pressure were made. 
4.3.7 Analytical High-Performance Liquid Chromatography and Tandem Mass 
Spectrometry
Liquid chromatography was performed using a Hitachi L-7000 (Hitachi Ltd.) 
system including an L-7100 HPLC pump and L-7000 autosampler; the LC system was 
controlled using the Hitachi 3DQ software.  Reversed-phase HPLC was accomplished 
using a Symmetry300 (Waters, Milford, MA) C18 column (2.1 
 50 mm, 3.5 m packing) 
with a Symmetry300 C18 guard column (2.1 
 10 mm, 3.5 m packing).  For analytical 
separations, a gradient elution of mobile phases consisting of (A) H2O with 0.1% formic 
acid and (B) acetonitrile with 0.1% formic acid was used at a flow rate of 0.300 mL/min.  
After loading the sample (10 – 25 L injections of 10 M solutions), the mobile phase 
was held at 95% A for 2 minutes and then the peptides were eluted using a linear gradient 
from 95% A to 50% A over 58 minutes. 
Two types of online LC-IRMPD-MS experiments were performed.  The first data-
acquisition sequence employed collecting a full mass spectrum of m/z 300 – 2000, then 
an isolation spectrum of m/z 450 – 2000 in which all ions of m/z in this range were 
isolated for 50 ms but not subjected to any form of activation, and then an IRMPD 
spectrum of all ions of m/z 450 – 2000 with an irradiation time of 50 ms.  For the 
isolation and IRMPD spectra, the q-value was set to 0.18 for ions of m/z 450, thus 
establishing the lower m/z limit as 90.  The second LC-IRMPD-MS experiment employed 
data-dependent MS/MS in which IRMPD and CID spectra were acquired for the two 
most abundant ions observed in the full mass spectrum.  IRMPD was performed for 30 
ms with the q-value of the precursor ion set to 0.1 (lower m/z limit ranged from 50 to 175 
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depending on the precursor ion) and CID was performed for 30 ms at a normalized 
collision energy of 45% using a precursor ion q-value of 0.25 (lower m/z limit 115 – 
455). 
 
4.3.8 Identification of Cross-linked Peptides 
Product ion spectra of peptide ions exhibiting high IRMPD efficiency were 
manually identified aided in part with the software program ProteinXXX, the protein 
cross-linking function of GPMAW (General Protein Mass Analysis for Windows) version 
7.10 (Lighthouse Data, Odense, Denmark) (available at http://www.gpmaw.com).  This 
program was used to provide a list of intact masses of possible cross-linked tryptic 
peptides allowing for cleavage C-terminal to only arginine and unmodified lysine 
residues (i.e., no cleavage C-terminal to cross-linked or dead-end modified lysine 
residues).  The intact mass of the eluting species were matched to the list potential 
candidates and then the identity of the precursor ion was confirmed manually by IRMPD; 
all product ions were also identified manually. 
4.4 RESULTS AND DISCUSSION
4.4.1 Cross-linker Design and Characterization 
It has previously been demonstrated that phosphorylated peptides can be 
selectively dissociated via IRMPD in quadrupole ion trap.39, 40  The cross-linker (Figure 
4.1a) incorporated a phosphate chromophore due to its greater IR absorption efficiency at 
10.6 m.37-39, 41  The chromophore was placed in the center of the cross-linker, thus 
creating a phosphate tri-ester to avoid the neutral loss of phosphoric acid which is 
commonly observed upon ion activation of phosphorylated peptides.49-52  The cross-
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linker was designed as a homobifunctional reagent with two terminal NHS-esters that 
react with primary amines (e.g., -amine of lysine residues or free N-terminus) similar to 
most common commercial cross-linkers.  IRCX has a spanner arm-length of ~16 Å and 
could span a distance up to ~28 Å between -carbons of two lysine residues in proteins.  
Upon reaction of each NHS-ester with a primary amine, stable amide bonds are formed, 
yielding a cross-link corresponding to a mass addition of 330 Da (Figure 4.1b).  If one 
NHS-ester does not react with the protein or peptide and is hydrolyzed, a dead-end 
modification is produced, termed IRCX-OH as shown in Figure 4.1c, with a mass 
Figure 4.1 Structures of IRCX (A), an IRCX cross-link (B), and an IRCX-OH
modification (C). 
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addition of 348 Da.  Product ions formed upon dissociation of the cross-linked peptides 
were labeled according to previously suggested nomenclature.26, 53  Briefly, for 
intermolecularly cross-linked peptides, the two constituent peptides are labeled  and , 
referring to the first and second peptide, respectively.  Cleavage along the backbone of 
the  peptide yields products ions such as yn or bn, and similar nomenclature is used for 
the  peptide and other product ion types.  For intramolecularly cross-linked peptides, the 
nomenclature is identical to that of unmodified peptides.  In addition, lysine immonium 
ions which are linked to the other peptide are labeled KL, where L represents the cross-
linker and  is the other peptide.  Similar nomenclature is used for referring to internal 
ions of one peptide linked to the second peptide, or a fragment ion of the second peptide 
(e.g., b4Ly7). 
 
4.4.2 IRMPD Analysis of IRCX Cross-linked Peptides 
The peptides -MSH ( peptide) and Ac-RFMWMK-NH2 ( peptide) were 
incubated with IRCX yielding all three possible intermolecularly cross-linked products 
().  The two constituent peptides each have only a single reactive site 
for the cross-linking reaction, Lys-11 of -MSH and Lys-6 of Ac-RFMWMK-NH2 as the 
N-termini of each of these peptides are acetylated, allowing for the site of the cross-link 
to be known with certainty for these initial studies.  It was possible to readily screen for 
the cross-linked peptides in the product mixture by acquiring an isolation spectrum in 
which ions of m/z 400 – 2000 were isolated for 30 ms without activation by toggling off 
the isolation waveform, and subsequently acquiring an IRMPD mass spectrum of ions in 
the same m/z range by triggering the CO2 laser for those 30 ms (Figure 4.2).  Upon IR 
irradiation, only the peptide ions containing an IRCX cross-link or an IRCX-OH 
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Figure 4.2 Isolation (A and C) and IRMPD (B and D) mass spectra of IRCX cross-
linking product mixture of -MSH ( peptide) and Ac-RFMWMK-NH2 (
peptide).  IRCX cross-links are represented by  and IRCX-OH dead-end 
modifications by .  Ions were either isolated with the laser off (a and c) or
irradiated for 30 ms at 50 W (B and D).  Zoomed in region of m/z 700 –
1040 shown in C and D. 
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modification decreased in ion abundance, allowing rapid screening of the IRCX 
containing ions of interest.  All of the cross-linked peptide ions, regardless of charge 
state, reduced in ion abundance by greater than 95%, as well as the peptide ions with a 
dead-end IRCX-OH modification.  The unmodified peptides did not undergo 
photodissociation and no decrease in their ion abundances was observed.  After 
pinpointing the IRCX-cross-linked peptide ions, they can be more closely interrogated by 
IRMPD, CID, or both.  For example, the intermolecularly cross-linked peptide [-MSH 
 IRCX  Ac-RFMWMK-NH2 + 3H]3+ was analyzed by IRMPD to determine the 
location of the cross-link.  As shown in Figure 4.3a, the IRCX-cross-linked peptide 
underwent very efficient dissociation upon 12 ms of irradiation, and broad sequence 
coverage of each constituent peptide was observed.  CID of the same ion produced 
similar sequence coverage of each peptide; however, in contrast the triply and doubly 
charged b11 product ions of m/z 907.5 and 1360.4 dominated the spectrum.  Previous 
work as discussed in Chapter 3 has shown that a proline residue positioned N-terminal to 
the cross-linked lysine enhances dissociation of the amide bond between the lysine and 
proline, in this case producing the b11 fragment.32  Most of the product ions observed in 
the CID spectrum had relative abundances of less than 1%, making it difficult to 
distinguish these peaks from noise.  In addition, due to the limited m/z storage range 
during CID, the diagnostic y2 product ion of m/z 214.0 cannot be trapped and detected. 
Upon closer examination of the IRMPD spectrum in Figure 4.3a, there is a 
distinct difference between the relative abundances of the product ions containing the 
IRCX cross-link and those without the modification (e.g., bn+ and bn+ ions).  Fragment 
ions which contain the IRCX cross-link still retain the phosphate chromophore and thus 
can undergo IR photon absorption and secondary dissociation.  CID predominantly 
yielded product ions which retained the cross-link (e.g., series of yn2+ ions) whereas 
 92
these fragment ions were less abundant in the IRMPD spectrum.  Time-resolved IRMPD 
was performed in order to investigate the relative abundances of the product ion types 
observed by varying the irradiation time from 0 ms to 100 ms.  For each IRMPD 
spectrum acquired the peak areas of the various product ion types – those containing or 
not containing the IRCX cross-link – were measured and summed as a function of 
Figure 4.3 Product ion mass spectra of [-MSH  IRCX  Ac-RFMWMK-NH2 +
3H]3+ (A) IRMPD of m/z 978.5 (q=0.1, 12 ms, 50 W) and (B) CID of m/z
978.5 (q=0.25, 30 ms, 34.1 mV).  -MSH is referred to as the  peptide and
Ac-RFMWMK-NH2 as the  peptide.  The precursor ion is represented by
an asterisk (*). 
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irradiation time.  The time-resolved IRMPD plot in Figure 4.4 indicates that for 
irradiation times less than 10 ms the most abundant product ions observed were IRCX-
cross-linked fragments.  With longer irradiation times these product ions decreased in 
relative abundance, forming unmodified b- and y-type ions, and after ~30 ms of 
irradiation virtually no IRCX-containing product ions survived.  Using IRMPD one can 
thus circumvent many dead-end dissociation pathways such as dehydration because the 
primary IRCX-containing fragment ions undergo secondary dissociation to produce more 
informative fragment ions.  
 
 
Upon reaction with IRCX, the peptide substance P was intramolecularly cross-
linked between the free N-terminus and Lys-3.  The doubly-protonated IRCX-cross-
linked substance P underwent efficient photodissociation using 50 ms of irradiation at 
only 35 W (Figure 4.5a). This result, in conjunction with those described above, 
indicates that both intramolecularly and intermolecularly IRCX-cross-linked peptides can 
Figure 4.4  Time-resolved IRMPD (50 W) of [-MSH  IRCX  Ac-RFMWMK-NH2
+ 3H]3+ displaying the relative abundances of the precursor ion (), non-
IRCX containing product ions (), and IRCX containing product ions (). 
Ion abundances are all relative to the total ion abundance of the spectrum 
acquired with 0 ms of irradiation. 
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be readily photodissociated.  A series of singly charged b-ions were observed along with 
the dominant y8 ion, a result of cleavage C-terminal to the intramolecular cross-link 
which has previously been noted as a site of enhanced dissociation.53  Collision-induced 
dissociation of [substance P  IRCX + 2H]2+, as shown in Figure 4.5b, yielded similar 
sequence coverage as IRMPD, suggesting that either method is suitable for identifying 
the site of the cross-link.  However, in the CID mass spectrum the b-ions retaining the 
IRCX cross-link were observed in both the 1+ and 2+ charge state (e.g., b82+, b92+, and 
b102+), cluttering the product ion mass spectrum, and fragment ions of low m/z had much 
lower relative abundances than in the IRMPD mass spectrum.  Upon IR irradiation, the 
more highly charged IRCX-containing b-ions apparently undergo secondary dissociation 
at a faster rate than the singly-charged ions due to the presence of a mobile proton.  In 
addition, the expanded m/z storage range possible during IRMPD allowed the detection 
of the low-mass y1 ion which was not observed by CID.  For precursor ions of higher m/z, 
the low-mass cut-off inherent to CID would be alleviated by utilizing IRMPD, thus 
allowing other product ions to be observed that would otherwise be undetectable by CID. 
The CID voltages determined from energy-variable CID experiments performed 
on both DSS- and IRCX-cross-linked peptides indicate the IRCX-cross-linked species 
have higher dissociation energies than the DSS-cross-linked analogs.  For example, for 
the intermolecularly cross-linked -MSH and Ac-RFMWMK-NH2 in the 3+ charge state, 
the IRCX species had a higher CID voltage than the DSS analog by 3.7 mV (32.8 mV 
versus 29.1 mV).  Likewise, the doubly protonated IRCX-intramolecularly cross-linked 
substance P required a CID voltage of 1.8 mV greater than that of the analogous DSS-
peptide (24.9 mV versus 23.1 mV).  Moreover, the IRCX-containing peptides dissociated 
readily upon less than 30 ms of irradiation, whereas the DSS-cross-linked peptides did 
not undergo efficient IRMPD upon irradiation for 250 ms, indicating that the presence of 
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the phosphate chromophore results in a much greater IR absorption at 10.6 m (data not 
shown).   These collective results confirm that the successful and selective IRMPD of the 
IRCX-containing peptides is due to their high IR absorption efficiencies, not due to lower 
dissociation energies. 
4.4.3 Screening of IRCX-Cross-linked Peptides in a Mock Mixture by IRMPD 
IRMPD analysis was performed on a mock mixture of peptides to demonstrate 
selective dissociation of IRCX-cross-linked peptides.  The peptide mixture contained an 
equimolar amount (10 M) of (1) Pyr-LYENK, (2) YGGFM, (3) bradykinin, (4) 
Figure 4.5 Product ion spectra of [substance P  IRCX + 2H]2+ (A) IRMPD of m/z
839.3 (q=0.15, 50 ms, 35 W) and (B) CID of m/z 839.3 (q=0.25, 30 ms, 26.7 
mV).  The precursor ion is represented by an asterisk (*). 
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angiotensin II, (5) -MSH, (6) Ac-RFMWMK-NH2, (7) substance P, and (13) melittin.  
Also present were equimolar amounts (10 M) of the IRCX intermolecular cross-linked 
product mixture of -MSH with Ac-RFMWMK-NH2 and the intramolecular cross-linked 
product mixture of substance P.  Products observed in the ESI mass spectrum included 
(8) -MSH + IRCX-OH, (9) -MSH  IRCX  -MSH, (10) substance P  IRCX, (11) 
-MSH  IRCX  Ac-RFMWMK-NH2, and (12) Ac-RFMWMK-NH2  IRCX  Ac-
RFMWMK-NH2.  Using direct infusion ESI-MS, the mixture was rapidly screened by 
comparing the abundances of ions of m/z 450 – 2000 in the isolation mass spectrum  
Figure 4.6 Direct-infusion (A) isolation (25 ms) and (B) IRMPD (25 ms, 50 W) spectra
of a mock mixture of peptides.  The identities of the peptides are listed in
Table 4.1.  IRCX cross-linked peptide ions are labeled with . 
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Table 4.1 Relative ion abundance decreases upon IR irradiation (25 ms, 50 W) for a
mock mixture of peptides using direct infusion ESI-IRMPD-MS.  Ion 
abundances are relative to the total ion abundance in either the isolation or
IRMPD spectrum.  All measurements were in triplicate. 
Label Species m/z Isolation IRMPD
1 [Pyr-LYENK + H]+ 777.4 3.64 4 -9.8 3.7
2 [YGGFM + H]+ 574.2 3.97 4.08 -2.8 3.5
3 [bradykinin + 2H]2+ 530.7 6.09 6.13 -0.7 3.5
3 [bradykinin + H]+ 1060.5 0.42 0.9 -113 7.6
4 [angiotensin II + 2H]2+ 523.8 4.35 4.37 -0.4 3.6
4 [angiotensin II + H]+ 1046.5 0.48 0.67 -39.2 3
5 [-MSH + 3H]3+ 555.6 4.35 4.37 -0.4 3.2
5 [-MSH + 2H]2+ 832.9 2.17 2.34 -7.8 2.6
5 [-MSH + H]+ 1664.8 0.08 0.11 -40 19
6 [Ac-RFMWMK-NH2 + 2H]2+ 470.2 2.99 3.07 -2.7 1.9
6 [Ac-RFMWMK-NH2 + H]+ 939.5 0.58 1.15 -98.4 5.3
7 [substance P + 2H]2+ 674.4 9.02 9.35 -3.6 3.6
7 [substance P + H]+ 1347.7 1.19 2.31 -95 15
8 [ -MSH + IRCX-OH + 2H]2+ 1006.9 0.22 0.03 86.3 1.7
9
[ -MSH   IRCX   -MSH 
+ 4H]4+
915.4 0.07 0.01 84.6 3.5
10 [substance P   IRCX + 2H]2+ 839.4 2.13 0.03 98.6 0.2
10 [substance P   IRCX + H]+ 1677.7 0.39 0.51 -29.4 1.8
11
[ -MSH   IRCX            
Ac-RFMWMK-NH2 + 3H]3+








1104.5 0.89 0.09 89.8 1.1
13 [melittin + 5H]5+ 570.1 1.89 1.14 39.8 2
13 [melittin + 4H]4+ 712.4 17.2 17.3 -0.5 4
13 [melittin + 3H]3+ 949.6 4.69 5.65 -20.5 6.7
13 [melittin + 2H]
3+











(Figure 4.6a) to the IRMPD mass spectrum obtained using 25 ms of irradiation at 50 W  
(Figure 4.6b).  The abundances of the unmodified peptide ions are unaffected by IR 
irradiation, whereas the IRCX-cross-linked peptide ions readily photodissociate with 
reductions in ion abundance of ~90% with the exception of the singly-protonated 
intramolecularly cross-linked substance P ion (Table 4.1).  While the doubly-charged 
analog undergoes efficient IRMPD, the singly-protonated species which does not have a 
mobile proton actually increased in abundance upon IR irradiation in this experiment 
(relative abundance increased from 0.39% to 0.51%).  This charge-state dependence on 
IRMPD efficiencies provides a means to distinguish between intra- and inter-molecularly 
IRCX cross-linked peptides, in which the inter-molecularly cross-linked peptides of all 
charge-states exhibit high photodissociation efficiencies.  Most intramolecularly cross-
linked tryptic peptides will possess a free N-terminus and either an unmodified Lys or 
Arg at the C-terminus and thus will predominantly be observed as doubly-charged ions, 
leading to efficient IRMPD.  No discernable decrease in the ion abundances of the 
unmodified peptides was observed using irradiation times of greater than 250 ms; this 
indicates that the laser irradiation time and power has an ample range of usability to 
differentiate between IRCX-cross-linked peptides and unmodified ones. 
For more complex mixtures such as those expected for peptides with isobaric m/z 
values, an HPLC separation is required prior to IRMPD screening, as demonstrated for 
the same mock mixture.  As detailed in the experimental section, the scan sequence to 
accomplish this task includes acquisition of a full mass spectrum, then an isolation mass 
spectrum from m/z 450 – 2000, and then an IRMPD mass spectrum of all isolated ions.  
Selected ion chromatograms (SICs) for each of the species in the mixture were extracted 
and then plotted together to form a reconstructed ion chromatogram (RIC).  The 
reconstructed ion chromatograms for the isolation and IRMPD spectra are shown in 
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Figure 4.7, and the changes in ion abundances are summarized in Table 4.2.  The 
difference between the RICs for the isolation and IRMPD mass spectra is striking.  Upon 
IR irradiation, the unmodified peptide ions did not exhibit any decrease in ion abundance 
with the exception of [melittin + 5H]5+ which decreased in abundance by ~20% (based on 
peak areas in the SICs).  In contrast, the IRCX-cross-linked and modified peptide ions are 
reduced on the order of 60 – 100% in abundance after irradiation.  All of the species 
which eluted between 37 and 44 minutes contained either an IRCX cross-link or IRCX-
OH modification, and upon 25 ms of IR irradiation, the intact peptide ions containing the 
IRCX chromophore were no longer detected. 
 
Figure 4.7 Reconstructed ion chromatograms of (A) isolation (25 ms) and (B) IRMPD
(25 ms, 50 W) spectra from LC-IRMPD-MS of a mock mixture of peptides. 
The identities of the eluting species are listed in Table 4.2.  Ion 
chromatogram intensities of [-MSH + IRCX-OH + 2H]2+ (8) and [-MSH 
 IRCX  -MSH + 4H]4+ (9) were zoomed in 10
 in both (A) and (B). 
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Table 4.2 Ion abundance decreases upon IR irradiation from LC-IRMPD-MS 
reconstructed ion chromatograms of a mock mixture of peptides.  Percent
abundance decreases calculated from the decrease of the peak areas of the













1 11.8 [Pyr-LYENK + H]+ 777.4 2072.76 1853.8 10.6
2 20.7 [YGGFM + H]+ 574.2 5402.8 6251.49 -15.7
3 20.9 [bradykinin + 2H]2+ 530.7 2942.05 3595.3 -22.2
20.9 [bradykinin + H]+ 1060.5 49.78 53.84 -8.2
4 23.5 [angiotensin II + 2H]2+ 523.8 2806.8 3087.37 -10
23.5 [angiotensin II + H]+ 1046.5 131.89 122.36 7.2
5 26.8 [-MSH + 3H]3+ 555.6 5863.15 6994.73 -19.3
26.8 [-MSH + 2H]2+ 832.9 1533.24 1717.75 -12
26.8 [-MSH + H]+ 1664.8 5.28 7.12 -35
6 28 [Ac-RFMWMK-NH2 + 2H]2+ 470.2 7154.23 8144.27 -13.8
28 [Ac-RFMWMK-NH2 + H]+ 939.5 181.8 168.69 7.2
7 28.9 [substance P + 2H]2+ 674.4 7937.77 9496.41 -19.6
28.9 [substance P + H]+ 1347.7 179.17 189.83 -5.9
8 37.9 [-MSH + IRCX-OH + 2H]2+ 1006.9 190.39 0 100
9 38.3
[-MSH   IRCX  -MSH + 
4H]4+
915.4 53.83 0 100
28.3
[-MSH   IRCX  -MSH + 
3H]3+
1220.2 7.89 0.06 99.2
10 40.6, 41.4 [substance P  IRCX + 2H]2+ 839.4 2459.99 0.06 100
40.6, 41.4 [substance P  IRCX + H]+ 1677.7 77.85 31.29 59.8
11 40.9
[-MSH   IRCX   Ac-
RFMWMK-NH2 + 3H]3+
978.4 894.07 0 100
40.9
[-MSH   IRCX   Ac-
RFMWMK-NH2 + 2H]2+








1104.5 1165.07 12.79 98.9
13 44.7 [melittin + 5H]5+ 570.1 19847.59 16037.27 19.2
44.7 [melittin + 4H]4+ 712.4 18792.54 19778.43 -5.2
44.7 [melittin + 3H]3+ 949.6 4885.16 5050.55 -3.4
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4.4.4 LC-IRMPD-MS of IRCX Cross-linked Ubiquitin 
To test the utility of LC-IRMPD-MS for screening and identifying IRCX-cross-
linked peptides, a trypsin digest of IRCX-cross-linked ubiquitin was analyzed as a model 
cross-linked protein.  Upon incubation with IRCX, ESI-MS analysis indicated that 
ubiquitin was modified to different degrees.  For the lowest molar ratio of cross-linker to 
protein (5:1), the most abundant species present was unmodified ubiquitin; also observed 
at approximately the same abundance in the ESI mass spectrum was ubiquitin with a 
single dead-end modification as well as singly-cross-linked ubiquitin.  At a 25:1 molar 
ratio, upwards of two modifications were observed but the singly-cross-linked species 
was the most abundant.  Unmodified ubiquitin was still detected as the least abundant 
species.  The most abundant species observed in the full mass spectrum of 50:1 IRCX-
cross-linked ubiquitin corresponded to the introduction of a single cross-link and a single 
dead-end modification (Figure 4.8).  Also observed, but to lesser degrees, was ubiquitin 
with two IRCX cross-links, as well as ubiquitin possessing three total modifications 
(combination of two cross-links and one dead-end modification or one cross-link and two 
dead-end modifications).  All LC-IRMPD-MS analyses were performed on the product 
mixture of the 50:1 molar ratio of IRCX to ubiquitin to eliminate any unmodified 
ubiquitin from the sample.  No separation of the different IRCX cross-linked and 
modified ubiquitin products was performed, and all products were subjected 
simultaneously to trypsin digestion.  After digestion, the tryptic peptides were separated 
and analyzed by LC-IRMPD-MS in a similar manner to the mock mixture described 
above, acquiring isolation and IRMPD spectra of ions of m/z 450 – 2000.  The RICs for 
the isolation spectra and IRMPD spectra are shown in Figure 4.9, and the eluting species 
are summarized in Table 4.3.  The differences between the two chromatograms are 
dramatic – only the IRCX-cross-linked or modified peptides (species labeled 7 – 13) 
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exhibit IRMPD, and upon 50 ms of irradiation decrease in ion abundance to below the 
detection limit.  On average, the unmodified peptide ions exhibited an increase in ion 
abundance of about 20%, which is attributed to fluctuations in ion trapping during the 
isolation and IRMPD steps, as well as to differences in the number of ions being injected 
into the trap between the two scans, despite using the automatic gain control (AGC) 
Figure 4.8 Deconvoluted full mass spectrum of IRCX cross-linked ubiquitin (A) and 
ESI mass spectrum (B) from the 50:1 molar ratio (IRCX to ubiquitin) 
reaction.  IRCX cross-links and IRCX-OH dead-end modifications are 
represented by  and , respectively.  Ubiquitin is represented by M. 
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feature of the ion trap.  The IRCX-cross-linked peptides decreased by ~100%, with the 
exception of [T55LSDYNIQK63ESTLHLVLR72  IRCX  L43IFAGIK48QLEDGR54 + 
4H]4+, which was reduced in abundance by 92%.  The abundance of this quadruply-
charged cross-linked peptide likely did not decrease by 100% due to an isobar with the 
y10-173+ product ion, corresponding to cleavage C-terminal to the cross-linked Lys-48 of 
L43IFAGK48QLEDGR54 and incomplete secondary dissociation of this fragment ion.  
Even with this isobaric overlap, there is a consistent difference in IRMPD efficiencies 
that allows the IRCX-cross-linked peptides to be readily distinguished. 
Figure 4.9 Reconstructed ion chromatograms of (A) isolation (50 ms) and (B) IRMPD
(50 ms, 50 W) spectra from LC-IRMPD-MS of a tryptic digest of ubiquitin 
cross-linked by IRCX.  See Table 4.3 for identities of eluting species.  Ion 
chromatogram intensities of [43-48]+ (3), [55-72]3+ (6), [30-42  IRCX 
7-27]4+ (7), [55-72  IRCX  30-42]5+ (9), [1-11 + IRCX-OH]2+ (10), [55-
72 + IRCX-OH]3+ (11), and [55-72  IRCX  1-11]5+ (13) were zoomed in 
by 10
 in both (A) and (B). 
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Table 4.3 Ion abundance decreases upon IR irradiation from LC-IRMPD-MS 
reconstructed ion chromatograms of a tryptic digest of ubiquitin cross-linked 
by IRCX.  Percent abundance decreases calculated from the decrease of the
peak areas of the SICs from the isolation and IRMPD spectra. 
Label
Elution 








1 0.6 [30-42]3+ 509.0 IQDKEGIPPDQQR 31 14
2 15.5 [55-63]2+ 541.3 TLSDYNIQK -28 4
3 16.6 [43-48]+ 648.3 LIFAGK -4 5
4 22 [64-72]2+ 534.6 ESTLHLVLR -28 17
5 26 [12-27]2+ 894.6 TITLEVEPSDTIENVK -37 15
6 27 [55-72]3+ 710.8 TLSDYNIQKESTLHLVLR -66 24
7 31.6, 
33.2
[30-42   IRCX 
  7-27]4+







848.0 LIFAGK*QLEDGR + IRCX-OH 100 0
9 33.1
[55-72   IRCX 
+ 30-42]5+




[55-72   IRCX 
 30-42]4+
996.6 TLSDYNIQK*ESTLHLVLR 















[55-72   IRCX 
 43-54]5+
762.9 TLSDYNIQK*ESTLHLVLR 
IRCX   LIFAGK*QLEDGR
100 0
37
[55-72   IRCX 
 43-54]4+
952.8 TLSDYNIQK*ESTLHLVLR 
IRCX   LIFAGK*QLEDGR
92 5
37
[55-72   IRCX 
 43-54]3+
1269.6 TLSDYNIQK*ESTLHLVLR 
IRCX   LIFAGK*QLEDGR
99.4 0.8
13 37.8
[55-72   IRCX 
 1-11]5+
746.9 TLSDYNIQK*ESTLHLVLR 
IRCX   MQIFVK*TLTGK
100 0
37.8




IRCX   MQIFVK*TLTGK 99.9 0.1
a Site of  modification or cross-link represented by *. b Percent abundance decreases calculated from the 
decrease in the peak areas of the SICs from the isolation and the IRMPD mass spectra. Results obtained 
in triplicate.
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While comparing isolation and IRMPD spectra to determine which peptide ions 
undergo photodissociation upon IR irradiation allows rapid pinpointing of the IRCX-
cross-linked peptides, one cannot directly use these IRMPD spectra to locate the site of 
cross-linking because all ions of m/z 450 – 2000 are irradiated simultaneously in the 
screening step, creating complicated, overlapping dissociation patterns of all IRCX-cross-
linked peptides.  In order to obtain product ion information of individual cross-linked 
peptides, data-dependent MS/MS was utilized to isolate and subsequently perform 
IRMPD on the most abundant ions.   
None of the unmodified tryptic peptides of ubiquitin underwent IRMPD, again 
allowing for them to be distinguished from the IRCX-cross-linked peptides.  An example 
of an IRMPD mass spectrum of an unmodified peptide is shown in Figure 4.10a in 
which doubly-protonated T12ITLEVEPSDTIENVK27 does not photodissociate upon 30 
ms of IR irradiation; the precursor ion remains the only ion observed in the spectrum.  In 
contrast, IRMPD spectra acquired during the data-dependent LC-IRMPD-MS method for 
three IRCX-cross-linked peptides are shown in Figure 4.11, and in all cases the precursor 
ions readily photodissociate.  For example, the second cross-linked peptide to elute 
contains T55LSDYNIQK63ESTLHLVLR72 ( peptide) linked to 
I30QDK33EGIPPDQQR42 ( peptide) through Lys-63 and Lys-33.   IRMPD of this cross-
linked peptide ion provided ten unique sequence ions (Figure 4.11a).  No product ions 
containing the IRCX cross-link were observed, most likely a result of secondary 
dissociation of these fragment ions.  Almost a full series of y ions without the IRCX 
cross-link (e.g., y ions C-terminal of the cross-linked Lys-63) were detected, providing a 
sequence tag for identifying one of the two constituent peptides.  The highly abundant 
y6  ions, result of cleavage N-terminal to Pro-37, provide information necessary to 
determine that the  peptide contains P37PDQQR42.  However, the corresponding b7 
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Figure 4.10 Product ion mass spectra of peptides observed in data-dependent LC-
IRMPD-MS analysis of tryptic digest of IRCX-cross-linked ubiquitin.  (A) 
IRMPD of [T12ITLEVEPSDTIENVK27 + 2H]2+ of m/z 894.6 (residues 12-
27).  (B) CID of [T55LSDYNIQK63ESTLHLVLR72  IRCX 
I30QDK33EGIPPDQQR42 + 5H]5+ of m/z 797.8.  (C) CID of 
[T55LSDYNIQK63ESTLHLVLR72  IRCX  M1QIFVK6TLTGK11 + 5H]5+
of m/z 746.1.  (D) IRMPD of [L43IFAGIK48QLEDGR54 + IRCX-OH + 
2H]2+ of m/z 848.0.  For IRMPD, the precursor ion was irradiated for 30 ms,
50 W, at a q-value of 0.10.  For CID, the precursor ion was activated for 30
ms, at 45% normalized collision energy at a q-value of 0.25.  The lysine 
residues in bold font indicate the location of the cross-link or modification. 
The first peptide listed is the  peptide; the second peptide is referred to as 
the  peptide.  Precursor ions, if observed, are labeled with an asterisk (*). 
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Figure 4.11 IRMPD spectra (30 ms, 50 W, q=0.1) of tryptic peptides of ubiquitin cross-
linked by IRCX acquired during data-dependent LC-IRMPD-MS 
experiment: (A) [T55LSDYNIQK63ESTLHLVLR72  IRCX 
I30QDK33EGIPPDQQR42 + 5H]5+ of m/z 797.8, (B) 
[T55LSDYNIQK63ESTLHLVLR72  IRCX  M1QIFVK6TLTGK11 + 5H]5+
of m/z 746.1, and (C) [T55LSDYNIQK63ESTLHLVLR72  IRCX 
L43IFAGIK48QLEDGR54 + 5H]5+ of m/z 762.4.  The first peptide listed is 
the  peptide; the second peptide is referred to as the  peptide.  Precursor 
ions, if observed, are labeled with an asterisk (*). 
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product ion which contains the chromophore and the  peptide can undergo secondary 
dissociation to yield additional diagnostic fragment ions.  Along with the identity of the  
peptide and the intact mass of the cross-linked peptide, one can deduce the identity of the 
second peptide and finally the location of the cross-link, between Lys-63 and Lys-33.  In 
contrast, CID of the 5+ charge state of this cross-linked peptide yielded only seven 
identifiable product ions (y62+, y6+, y82+, y4+, y8+, y164+, and b73+), three of which 
correspond to cleavage N-terminal to Pro-37 (Figure 4.10b).  No sequential series of 
product ions was observed using CID, and most of the ions observed could not be 
identified as typical a-, b-, or y-type ions (including double-cleavage products).  The 
IRCX-cross-linked peptide containing T55LSDYNIQK63ESTLHLVLR72 ( peptide) and 
M1QIFVK6TLTGK11 ( peptide) readily photodissociated upon IR irradiation, yielding 
only fragment ions without the IRCX chromophore (Figure 4.11b).  Thirteen of the 14 
amide bonds C-terminal to the cross-linked lysines were cleaved by IRMPD, providing a 
sequence tag for both constituent peptides.  CID of this cross-linked peptide yielded a 
variety of product ions including both b- and y-type fragment ions with and without the 
cross-link (Figure 4.10c).  In addition several double-cleavage product ions were 
observed including a series of y16Lyn ions (i.e., y16 fragment linked to a y-ion of the  
peptide) which complicate interpretation of the CID mass spectrum.  IRMPD alone 
provides far more diagnostic product ions allowing for the cross-linked peptide to be 
identified.  For the cross-linked peptide ion [T55LSDYNIQK63ESTLHLVLR72  IRCX 
 L43IFAGK48QLEDGR54 + 5H]5+, all of y-ions C-terminal to the two cross-linked 
lysine residues were detected using IRMPD (Figure 4.11c).  Using these y-ions, one 
could easily sequence the C-terminal ends of the two constituent peptides via a de novo 
approach.  In addition, three bn product ions were detected providing confirmation of the 
identity of the  peptide, L43IFAGIK48QLEDGR54.  Two dead-end modifications, at Lys-
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48 and Lys-6, could also be identified.  The IRMPD mass spectrum for the species 
containing L43IFAGIK48QLEDGR54 modified by IRCX-OH at Lys-48 is shown in 
Figure 4.10d. Cleavage of all backbone amide bonds occurred, yielding a series of b-ions 
N-terminal to the modified lysine and a series of y-ions C-terminal to the modified lysine, 
all without the IRCX chromophore. 
A majority of the product ions observed upon IRMPD were y-ions without the 
IRCX cross-link, as opposed to b-ions.  Earlier work as discussed in Chapter 3 suggested 
that there is a preference for cleavage C-terminal to the cross-linked lysine for 
intermolecularly cross-linked peptides, possibly due to charge localization on the C-
terminal arginine residues.32  Dissociation at this amide bond of the  peptide would 
result in a y-ion with a protonated C-terminal arginine and a b-ion retaining the IRCX 
cross-link and the  peptide.  This b-ion would likely undergo secondary and higher 
order dissociation since it contains the phosphate chromophore, possibly producing an 
uncross-linked y-ion.  Any secondary product ion still retaining the chromophore may 
continue to absorb photons and dissociate, resulting in small fragments that are not 
observed (e.g., neutral fragments, m/z below the low-mass cut-off, etc.).  However, if a 
charge is retained on the N-terminus, uncross-linked b-ions would also be detected. 
In all of the IRMPD mass spectra of the IRCX-cross-linked and IRCX-OH 
modified peptides, a product ion of m/z 121 was detected  This fragment ion, observed 
only after significant secondary dissociation, corresponds in mass to a double-cleavage 
product – cleavage of the cross-link amide bond and between the PO bond nearest the 
cleaved amide bond.  The formation of this diagnostic product ion, which is not isobaric 
with any immonium ions of the amino acids, provides another means of distinguishing 
IRCX-cross-linked peptides from unmodified ones.  Using traditional CID, one would 
not observe this reporter ion as it has an m/z value below the low-mass cut-off.  
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Moreover, as a higher-order product ion, it is only observed after significant secondary 
dissociation afforded by IRMPD, not CID.   
In total, four cross-links and two dead-end modifications were identified using the 
IRCX and LC-IRMPD-MS strategy, as summarized in Table 4.4.  IRCX has a spacer-
arm length of ~16 Å and given the flexibility of lysine side chains, distances of ~28 Å 
between -carbons of lysines could be spanned.  For all four of the observed cross-links, 
the distance between the -carbons was less than 20 Å based on the x-ray crystal 
structure (PDB: 1AAR).  The two phenyl groups of IRCX create a more rigid cross-linker 
that may not be able to easily span short distances, as evident by the fact that no cross-
links spanning a distance of less than 13 Å were observed.  The rigidity of IRCX would 
not promote the formation of short cross-links as the one observed between Lys-6 and 
Lys-11 (x = 5.8 Å) in a previous study using DSS.54  Three of the four cross-links 
identified in the present study involved Lys-63, which is located on the surface of 
ubiquitin.  Upon creation of an amide bond between IRCX and Lys-63, the other NHS-
ester of IRCX could react with other surface-accessible lysines within 20 Å, including 
Lys-48, Lys-33, and Lys-6, yielding a mixture of cross-linked products, as observed.  
While other lysines are potential sites of cross-linking, Lys-63 is likely more reactive 
resulting in limited structural information.  Recently, a partial acetylation technique has 
been used to enhance the diversity of cross-linking reactions by blocking the more 
reactive lysine residues to provide more comprehensive distance constraints.55  Using 
such an approach may yield more informative cross-links between other lysine pairs.  The 
two dead-end modifications were located at Lys-48 and Lys-6, two other surface-




By incorporating a phosphate chromophore into the chemical cross-linker IRCX, 
it has been shown that both intra- and intermolecularly cross-linked peptides can be 
rapidly distinguished from unmodified peptides using IRMPD-MS.  Using 50 ms of 
irradiation, only the IRCX cross-linked or dead-end modified peptides underwent 
efficient photodissociation, thus allowing the identification of these key species by 
simply comparing ion abundances before and after exposure to IR irradiation.  This 
technique has been successfully applied to both direct-infusion ESI-IRMPD-MS and 
online LC-IRMPD-MS using data-dependent MS/MS experiments for a mock mixture of 
peptides and a tryptic digest of IRCX-cross-linked ubiquitin.  For the cross-linked 
ubiquitin sample, a total of four cross-links and two dead-end modifications were 
Table 4.4 Summary of cross-links and modifications of ubiquitin identified using 


































43-54 LIFAGIK*QLEDGR 1693.8 1694.8 2+ Lys-48 n/a
1-11 MQIFVK*TLTGK 1613.3 1613.8 2+ Lys-6 n/a
4140.4 4140 4+ 13.3
3982.8 3982 5+, 4+ 19.6
a Site of modification or cross-link represented by *. b Neutral monoisotopic mass in Da. c Distance 
between -carbons of lysine residues calculated from X-ray crystal structure of ubiquitin (PDB: 1AAR).
3805.7 3804.9 5+, 4+, 3+ 18.4
3724.9 3723.9 5+, 4+ 15.1
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observed, and the locations of the cross-links were unambiguously identified.  IRMPD of 
the intermolecularly cross-linked peptides yielded a series of y-ions C-terminal to the 
cross-linked lysines without the IRCX cross-link due to secondary dissociation of 
fragment ions containing the chromophore.  These product ions could then be used to 
sequence each of the two constituent peptides in a de novo manner, potentially providing 
a ready means to identify not only the cross-linked peptides but also the proteins in an 
intracellular chemical cross-linking experiment. 
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Ultraviolet Photodissociation Mass Spectrometry of Bis-aryl Hydrazone 
Conjugated Peptides 
5.1 OVERVIEW
Ultraviolet photodissociation (UVPD) at 355 nm was used to rapidly identify 
peptides which had been chemically conjugated through bis-aryl hydrazone (BAH) 
moieties.  The two biomolecules of interest were separately tagged to introduce either an 
aldehyde or a hydrazine and then were conjugated together through these functional 
groups to form the UV-chromogenic BAH-group.  In a mock mixture of peptides, UVPD 
was used to screen for the BAH-conjugated peptides in direct infusion ESI-UVPD-MS 
and online LC-UVPD-MS methods by comparing the abundances of the ions with the 
laser off and with the laser on.  Only the BAH-conjugated peptides were observed to 
photodissociate upon exposure to UV irradiation, thus affording excellent selectivity for 
the pinpointing the relevant conjugated peptides in a complex mixture of non-conjugated 
peptides.  UVPD analysis of conjugated model peptides indicated that the UVPD 
efficiencies of these species were charge state dependent. BAH-conjugated peptides that 
had a mobile proton which could protonate the basic BAH-moiety underwent more 
efficient photodissociation than the peptide ions with sequestered protons.  Ultraviolet 
photodissociation of BAH-cross-linked peptides also yielded more diagnostic sequence 




In the past decade the conjugation of proteins and peptides to other biomolecules 
has gained widespread attention as a means to couple the independent functionalities and 
properties of each individual component.  One area of particular interest has been in 
utilizing peptides or small proteins which can pass through biological membranes as 
delivery vehicles for peptides, proteins, drugs, oligonucleotides, or other therapeutic 
agents.1  Cell penetrating peptides or protein transduction domains have shown promise 
as an effective means for direct transcellular delivery without extensive degradation.2, 3  
One common method to conjugate biological species is a two-step protocol in which first 
each biomolecule is separately labeled to introduce either aldehyde or hydrazine moieties.  
The aldehyde-modified peptide is then linked to the hydrazide-modified ligand (or vice 
versa) forming a UV chromogenic bis-aryl hydrazone (BAH) bond, which absorbs well at 
354 nm.4  The coupling of aldehyde functionalities to hydrazides has been used to create 
many protein-peptide conjugates including a follicle-stimulating hormone mutant protein-
occludin peptide complex,5 immunogenic poly-glutamic acid-protein conjugates to 
anthrax,6 insulin-transferrin complexes,7 as well as oxylipid-protein,8 small molecule-
peptide,9 and many oligonucleotide-protein complexes.10-12  Analysis of these 
bioconjugates is typically performed using gel electrophoresis or spectrophotometric 
methods, but these methods do not provide specific information about the location of the 
cross-link.  LC-MS/MS methods are commonly used for more detailed structural analysis 
of bioconjugates, usually in conjunction with enzymatic digestion to convert large 
macromolecules into smaller constituents.7, 8, 13  Although creating more manageable 
components, the enzymatic digestion step also results in more complex mixtures 
containing many species that offer no direct information about the conjugation sites.  
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As the interest in using protein and peptide conjugates for therapeutic applications 
continues to expand, there are several ongoing analytical challenges related to 
characterization of the conjugates, especially in the context of the LC-MS/MS methods 
mentioned above that are used to analyzed the complex digests and decipher the 
conjugation sites.  Two of the most significant challenges include the ability to rapidly 
distinguish the conjugated peptides of interest from the uninformative peptides (e.g. 
dead-end modified or unmodified peptides) and interpretation of the product ion 
(MS/MS) spectra of the cross-linked peptide-peptide complexes to identify the site of 
conjugation.  Several mass spectrometric strategies have been developed to aid in the 
identification of cross-linked peptides, with much work devoted to the design and 
synthesis of novel cross-linkers.  Some methods have focused on distinguishing 
conjugated peptides from unmodified ones by incorporating affinity tags into the linkers 
to enrich the peptides of interest in complex mixtures,14-17 or using isotopically labeled 
cross-linking reagents to pinpoint conjugated peptide ions in the mass spectra,15, 18, 19 
introducing a reporter ion which is observed upon low-energy collision-induced 
dissociation (CID),20 or utilizing fluorogenic cross-linkers to differentiate between 
conjugated and unmodified peptides during a front-end LC separation.21-23  Other groups 
have aimed at simplifying interpretation of the product ion spectra of intermolecularly 
cross-linked peptides by incorporating gas-phase labile bonds which can be cleaved upon 
low energy CID, thus yielding two modified peptides that can then be individually 
sequenced by a second stage of CID.14, 24-26 
Each of these techniques, however, only focuses on one of the two challenges 
mentioned above – either distinguishing cross-linked peptides from uninformative ones in 
mixtures or sequencing the cross-linked peptides of interest.  As discussed previously in 
Chapter 4, an IR chromogenic cross-linker which contained a phosphate chromophore 
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promoted the selective infrared multiphoton dissociation (IRMPD) of cross-linked 
peptides for differentiation of cross-linked peptides from unmodified ones.27  IRMPD of 
these cross-linked peptides also yielded a series of y-type fragment ions C-terminal to the 
cross-linked lysine residues which allowed the two constituent peptides to be sequenced 
without the need for MSn methods.  However, this technique, as well as those described 
above, suffered in distinguishing between cross-linked peptides of interest and dead-end 
modified peptides (e.g. peptides that have reacted with the cross-linker but the other 
reactive site of the cross-linker has been hydrolyzed) which generally are not structurally 
informative.  In addition, phosphorylated peptides could be initially falsely classified as 
IRCX-cross-linked peptides as they also contain the same phosphate chromophore and 
thus would efficiently dissociate upon IR irradiation.28 
In this chapter, ultraviolet photodissociation at 355 nm in a quadrupole ion trap 
mass spectrometer is used to selectively photodissociate only the chromogenic bis-aryl 
hydrazone conjugated peptides.  In recent years, UVPD has been utilized as an alternative 
to CID as an ion activation technique for peptides.29-32  Compared to CID, UVPD in ion 
traps affords several advantages such as secondary dissociation of primary product ions 
and a potential reduction in ion losses due to scattering since photodissociation does not 
alter ion trajectories.  Moreover, as a non-resonant process, UVPD can be performed at a 
lower rf trapping voltage than CID which facilitates the detection of diagnostic low-mass 
product ions.  Photodissociation methods have also been used as a screening tool to 
selectively dissociate specific chromogenic species, such as phosphorylated peptides 
using IRMPD at 10.6 m,28, 33, 34 disulfide bonds at 157 nm,35 and tyrosyl-containing 
peptides at 220 and 262 nm.36, 37  UVPD is used as a selective dissociation method to 
screen the chromogenic BAH-conjugated peptides in complex mixtures, as demonstrated 
for a mixture of peptides, using both direct infusion ESI-MS and online LC-UVPD-MS 
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techniques.  Upon UV irradiation at 355 nm, only the BAH-conjugated peptides are 
shown to undergo photodissociation. In contrast, the non-conjugated aldehyde- and 
hydrazine-modified peptides or other non-BAH peptides do not absorb at 355 nm and 
thus do not photodissociate, offering a high degree of selectivity for the rapid 
identification of the conjugated peptides of interest. 
 
5.3 EXPERIMENTAL
5.3.1 Chemicals and Reagents 
The peptides Ac-RFMWMK-NH2, -MSH (Ac-SYSMEHFRWGKPV-NH2), 
neurotensin (Pyr-LYENKPRRPYIL), and substance P were purchased from Bachem 
(Torrance, CA).  The peptide angiotensin II was obtained from AnaSpec (San Jose, CA).  
The peptides bradykinin, YGGFM, and disuccinimidyl suberate (DSS) were purchased 
from Sigma (St. Louis, MO).  The peptides Ac-AAAKAAAAR and Ac-AAAKPAAAR 
were synthesized at the Protein Microanalysis Facility at the University of Texas at 
Austin and purified by reversed-phase HPLC.    Benzaldehyde and 2-hydrazinopyridine 
were obtained from Aldrich (Milwaukee, WI).  Succinimidyl 4-hydrazinonicotinate 
acetone hydrazone (SANH) and succinimidyl 4-formylbenzoate (SFB) were from Pierce 
Biotechnology (Rockford, IL).  All other chemical and solvents (HPLC grade) were 
purchases from Fisher Scientific (Fairlawn, NJ). 
 
5.3.2 Synthesis of Benzaldehyde-2-pyridinylhydrazone and UV-Vis Measurements 
The ultra-violet chromophore benzaldehyde-2-pyridinylhydrazone (B2PH) was 
synthesized by dissolving 1.0 mmol of 2-hydrazinopyridine in 2.0 mL of MeOH and then 
102 L (1.0 mmol) of benzaldehyde was added.  The solution was heated to 55 °C and 
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stirred for 16 hours.  The reaction mixture was then cooled to room temperature, and the 
yellow-orange precipitate of B2PH was vacuum filtered.  The final product was 
redissolved in MeOH and then diluted to 50 M for downstream analysis.  All UV-Vis 
measurements were obtained on an Agilent 8453 spectrophotometer (Santa Clara, CA). 
5.3.3 Chemical Cross-linking of Model Peptides. 
Model peptides were cross-linked together via a two-step conjugation method.  
All peptides were dissolved to 5.0 mM in H2O, and the modifying reagents SANH and 
SFB (Figure 5.1a and 5.1b) were each freshly prepared at 20.0 mM in DMSO.  Each 
Figure 5.1 Structures of the modifying reagents (A) succinimidyl 4-hydrazinonicotinate 
acetone hydrazone (SANH), and (B) succinimidyl 4-formylbenzoate (SFB), 
as well as the (C) bis-aryl hydrazone cross-link and observed bond 
cleavages.  The solution-phase molar absorptivity of the BAH-cross-link is 
reported.4  Numbering scheme in (C) refers to the number of atoms away
from the C atom of the peptide backbone in the -peptide.38 
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peptide was individually modified at its primary amines (e.g. free N-termini or lysine 
residues) by either SANH or SFB in 20 mM HEPES, pH 8.0 buffer at a 1:10 molar ratio 
of peptide to modifier (200 M: 2.0 mM).  The reactions were allowed to proceed at 
room temperature overnight to ensure complete modification of the peptides; the product 
mixture was then desalted using Waters tC18 SepPak cartridges (Milford, MA) and 
peptides were eluted with 100% MeOH.  The two modified peptides were then 
conjugated together at an equimolar ratio (~100 M) in 99/1 MeOH/HOAc acid at 55 °C 
overnight forming a bis-aryl hydrazone cross-link (Figure 5.1c).  The conjugated 
peptides were subsequently diluted to ~10 M in 49.5:49.5:1 H2O/MeOH/HOAc (v/v/v) 
for ESI-MS analysis without any further purification. 
 
5.3.4 Analytical High-Performance Liquid Chromatography 
Liquid chromatography was performed with a Waters 2695 Separations Module 
and 486 Tunable Absorbance Detector (Milford, MA), which were both controlled by the 
Millennium version 3.00 software package.  Reversed-phase HPLC was accomplished 
using a Symmetry300 C18 column (2.1 
 50 mm, 3.5 m packing) using a gradient 
elution consisting of (A) H2O with 0.1% formic acid and (B) acetonitrile with 0.1% 
formic acid at a flow rate of 0.300 mL/min.  The mobile phase was held at 95% A for two 
minutes after sample injection (typically 10 L of ~10 M solutions) and then linearly 
reduced to 60% over 60 minutes.  Analytes were detected by UV-Vis absorption 
spectroscopy at 355 nm as well as by mass spectrometry. 
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5.3.5 Mass Spectrometry and Ultraviolet Photodissociation 
Mass spectrometry experiments were performed on a modified ThermoFinnigan 
LCQ Deca XP quadrupole ion trap mass spectrometer (San Jose, CA) using the XCalibur 
version 1.3 software package as previously described.30  For all direct infusion 
experiments the solutions were infused at 2.5 L/min using an ESI voltage of 4.5 kV.  
Ultraviolet photodissociation (UVPD) was performed with a Spectra-Physics Quanta-Ray 
GCR-11 Nd:YAG laser with a HG-2 harmonics generator (Mountain View, CA) to 
produce the tripled harmonic photons at 355 nm.  Briefly, a CF viewport flange was 
welded to the vacuum manifold of the LCQ Deca XP instrument and fitted with a quartz 
window to allow the transmission of UV radiation.  The unfocused laser beam was 
aligned on-axis with a 5-mm hole drilled through the ring electrode to irradiate the ion 
cloud.  For all direct infusion UVPD-MS experiments, the laser was operated at full 
power (~65 mJ/pulse), unless otherwise noted, at a repetition rate of 10 Hz in the Q-
switched mode.  The LCQ instrument TTL signal output from pin TP 15-3 Sync_TP was 
used to trigger a Model 505-2C low-voltage pulse generator (Berkeley Nucleonics Corp., 
San Rafael, CA) which in turn was used to pulse the laser.  Typically, the activation time 
was set to 1000 ms to produce ten laser pulses unless indicated otherwise.  The 
instrument control files were modified to allow triggering of the laser during LC-MS/MS 
analyses.  Precursor ions were activated at a qz-value of 0.25 for CID and 0.10 for UVPD.  
Energy-variable CID experiments were performed by stepping-up the CID voltage to 
determine the voltage necessary to dissociate the precursor ion to 50% relative abundance 
as previously described.27  Online LC-UVPD-MS was performed by either isolating ions 
of m/z 450 – 1200 without any form of activation or by subjecting all ions of m/z 450 – 
1200 to ten pulses of UV irradiation at 355 nm.  In order to acquire an isolation spectrum, 
a precursor ion of interest was selected for activation at a normalized collision energy of 
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0.0% and the isolation waveform was turned off, allowing ions to be effectively isolated 
and detected. 
 
5.4 RESULTS AND DISCUSSION
5.4.1 Bis-aryl Hydrazone Chromophore and UVPD Screening Strategy 
The conjugation strategy employs a two-step conjugation method in which the 
two biomolecules of interest are first tagged by either SANH that introduces a hydrazine 
group or by SFB which incorporates an aromatic aldehyde (Scheme 5.1).  The two 
modified biomolecules are then cross-linked together through a specific reaction between 
the hydrazine and aldehyde to form a bis-aryl hydrazone.  As shown in this study, the 
two-stage conjugation reaction affords a high degree of UVPD selectivity when 
analyzing mixtures containing unmodified, dead-end modified, and conjugated peptides.  
Ultraviolet photodissociation can be used to rapidly screen for BAH-conjugated peptides 
in which only the peptide ions that readily absorb radiation at 355 nm dissociate.  
Unmodified peptides, as well as those with dead-end SFB- or SANH-modifications, will 
not photodissociate as they do not contain the critical BAH-chromophore.  The selective 
photodissociation of all BAH-cross-linked peptides allows ready differentiation between 
diagnostic conjugated peptides and unmodified ones as well as uninformative dead-end 
modified species. 
Prior to conducting peptide conjugation experiments with the SANH and SFB 
reagents, the chromophore of the bis-aryl hydrazone cross-link was duplicated in a model 
compound by synthesis of  benzaldehyde-2-pyridinylhydrazone (B2PH, Figure 5.2b) and 
characterized by UV-Vis spectroscopy and UVPD-MS.  The UV-Vis absorbance 
spectrum of this molecule at 50 M in MeOH did not reveal an absorption band around 
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355 nm, the wavelength of a tripled Nd:YAG laser, as shown in Figure 5.2a.  To convert 
B2PH to its protonated form, acetic acid (1% v/v) was added to the solution and a red-
shift in the absorption profile was observed.  In fact, the maximum peak absorption 
shifted from 325 nm to 347 nm, and the molar absorptivity at 355 nm (the wavelength 
that corresponds to the tripled harmonic of a Nd:YAG laser) increased from 6600 L mol-1 
cm-1 to 19000 L mol-1 cm-1.  Neither of the two reagents, SANH nor SFB, exhibited high 
absorbance near 355 nm, suggesting that peptides containing these modifications would 
not undergo efficient UVPD.  Although the UV absorption profiles of B2PH in solution 
are not expected to perfectly mirror the UV absorption profiles in the gas phase, these 
initial results do suggest that the bis-aryl hydrazone moiety exhibits a strong dependence 
on whether it is protonated or not, and the high absorptivity at 355 nm in solution shows 
Figure 5.2 (A) UV-Vis spectra of 50 M benzaldehyde-2-pyridinylhydrazone in MeOH 
(dashed gray line) and in 99/1 MeOH/HOAc (v/v) (solid black line). (B) 
Structure of benzaldehyde-2-pyridinylhyrazone and product ions observed 
by UVPD-MS. 
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remarkable agreement with our gas-phase UVPD results.  ESI-MS of B2PH yielded a 
single peak of m/z 198.1 corresponding to the protonated molecule.  Benzaldehyde-2-
pyridinylhydrazone was subjected to UVPD-MS, and upon two pulses of 355 nm 
radiation at ~18 mJ/pulse (~28% power), the abundance of the precursor ion decreased by 
60% and two abundant product ions were observed of m/z 94 and of m/z 67 (Figure 
5.2b).  The efficient UV photodissociation of B2PH at low laser powers suggested that 
bis-aryl hydrazone cross-linked peptides should also undergo UVPD. 
For the spectra discussed in this report, all product ions of the conjugated or 
cross-linked peptides were labeled according to previously suggested nomenclature.38, 39  
Briefly, the two constituent peptides are labeled  and , and dissociation along the 
backbone of the -peptide yields product ions such as yn or bn.  Lysine immonium ions 
Scheme 5.1 Two-step conjugation and UVPD screening strategy 
 128
linked to the other peptide are labeled as KL where L refers to the linker, and fragment 
ions due to dissociation of the linker moiety are labeled as Ln referring to cleavage n 
bonds away from the C atom of the -peptide (see Figure 5.1c for observed bond 
cleavages and numbering scheme).  Similar nomenclature is used for product ions of the 
-peptide. 
 
5.4.2 UVPD-MS of BAH-Conjugated Model Peptides 
The peptides Ac-AAAKAAAAR (-peptide) and neurotensin (-peptide) were 
chosen as model peptides to evaluate the feasibility of the UVPD strategy, and each were 
modified by SFB or SANH, respectively, and then cross-linked together.  The mass 
spectrum (with a wide isolation range of m/z 600 – 1200) of the conjugated product 
mixture is shown in Figure 5.3a in which each of the two modified peptides were 
detected, corresponding to a mass addition of 132 Da for SFB and 135 Da of SANH 
(after deprotection of the acetone moiety), as well as the conjugated peptide-peptide 
complex in the 3+ and 4+ charge states with the BAH-linker adding 249 Da.  In addition, 
unmodified neurotensin (2+), and fragment ions of the -peptide conjugated to 
neurotensin were observed.  (These latter ions are attributed to in-source dissociation due 
to the high tube lens voltage necessary to effectively transmit ions within the isolated m/z 
range of 600 to 1200 and were not observed when trapping the entire range from m/z 300 
to 2000 as shown in Figure 5.4; no ions were observed above m/z 1400. The necessity of 
using a high tube lens voltage is an artifact of the limited flexibility of the LCQ software 
when implementing a simultaneous broad trapping and activation experiment as opposed 
to conventional CID in which a selected precursor ion is isolated and activated.)  The 
cross-link was formed between Lys-4 of Ac-AAAKAAAAR and Lys-6 of neurotensin as 
each peptide only has a single primary amine that can react with the SANH and SFB 
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reagents.  Upon ten pulses of UV irradiation of all ions of m/z 600 – 1200, only the ions 
which contained the BAH-linker underwent photodissociation and were reduced in 
abundance (Figure 5.3b).  By comparing the relative abundances of each ion in the two 
Figure 5.3 (A) Wide m/z isolation and (B) UVPD mass spectra (10 pulses) of m/z 600 -
1100 of the reaction mixture of Ac-AAAKAAAAR + SFB/SANH + 
neurotensin.  The first peptide listed is referred to as  and the second 
peptide as .  BAH-cross-links are represented by . 
Figure 5.4 ESI mass spectrum of the product mixture of Ac-AAAKAAAAR + 
SFB/SANH + neurotensin.  The first peptide listed is referred to as  and 
the second peptide as .  BAH-cross-links are represented by . 
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spectra, one can rapidly determine which ions correspond to BAH-conjugated peptides.  
The unmodified doubly-charged neurotensin ion actually increased in ion abundance 
upon UV irradiation, most likely due to dissociation of the conjugated peptide-peptide 
complexes yielding the neurotensin peptide ion as a product ion.  Of particular 
importance is that the dead-end modified peptides, [+ SANH + 3H]3+ of m/z 603.5 and 
[+ SFB + H]+ of m/z 974.5 did not decrease in abundance.  As reported in Chapter 4, an 
IR chromogenic cross-linker and IRMPD were utilized to selectively dissociate cross-
linked peptides, but the uninformative dead-end modified peptides also contained the 
phosphate chromophore and would photodissociate as well, thus preventing the 
distinction of cross-linked peptides from dead-end modified peptides.27  Since the BAH-
chromophore is formed only upon specific conjugation of SFB- and SANH-modified 
peptides, the dead-end modified peptides do not efficiently photodissociate at 355 nm.  
Both SANH- and SFB-modified peptides were individually examined by UVPD-MS to 
determine if these ions would photodissociate.  Neurotensin modified by SANH was 
examined in the 2+ and 3+ charge states, and both doubly-charged SFB-modified 
neurotensin and -MSH were analyzed (Figure 5.5).  For all four of these species, the 
intact surviving precursor ion is the only ion of significant abundance observed after 10 
pulses of UV irradiation at full power, confirming their lack of UV absorptivity which 
confers selectivity to the UVPD strategy. 
After demonstration that UVPD can be used to rapidly screen BAH-conjugated 
peptides in simple peptide mixtures, UVPD was then compared to CID to determine its 
utility for sequencing the two constituent peptides and locating the site of conjugation.  
UVPD of [-MSH  BAH  Ac-RFMWMK-NH2 + 4H]4+ (m/z 714.3) yielded a full 
series of conventional b-ions of the -peptide (Ac-RFMWMK-NH2), as well as several 
product ions due to dissociation of the backbone of the -peptide (-MSH) (Figure
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5.6a).  In addition, the cross-linker specific fragment ions of KL and L18 were 
observed.  The presence of the b10 ion without the BAH-linker and the adjacent b11 ion 
retaining the cross-link allows one to locate the site of conjugation to Lys-11 of the -
peptide.  Similarly the b and y ions can be used to pinpoint the cross-link to Lys-6 of 
the -peptide.  Unambiguous determination of the cross-link location is necessary even 
with a priori knowledge of the peptide sequence, as recent work has identified that NHS-
esters not only react with lysine residues and free primary amines but also with tyrosines, 
serines, and threonines.40  CID of this conjugated peptide ion ([-MSH  BAH  Ac-
RFMWMK-NH2 + 4H]4+ of m/z 714.3) did not produce as many informative sequence 
fragment ions – the most dominant pathway was dehydration (Figure 5.6b).  Only a total 
Figure 5.5 UVPD mass spectra (10 pulses) of (A) [neurotensin + SANH + 2H]2+ of m/z
905.0, (B) [neurotensin + SANH + 3H]3+ of m/z 603.3, (C) [neurotensin + 
SFB + 2H]2+ of m/z 903.4, and (D) [-MSH + SFB + 2H]2+ of m/z 899.3. No 
photodissociation was observed.  
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of three product ions were detected, and while the b5 and y1 ions can be used to 
unambiguously assign the location of conjugation to Lys-6 of the -peptide, the other 
fragment KL does not provide any sequence information.  For this conjugated peptide-
peptide complex, UVPD clearly yields a more informative product ion spectrum with 
diagnostic fragment ions that can be used to pinpoint the cross-link location on both 
constituent peptides, whereas this peptide predominantly dissociated through a dead-end 
neutral loss pathway by CID. 
Figure 5.6 (A) UVPD (10 pulses) and (B) CID (0.344 V) mass spectra of [-MSH 
BAH  Ac-RFMWMK-NH2 + 4H]4+ of m/z 714.3. The first peptide listed is 
referred to as  and the second peptide as .  Precursor ions are signified 
with an asterisk (*).  Schematic of bond cleavages refers to product ions
observed in UVPD mass spectrum. 
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5.4.3 Screening of BAH-Conjugated Peptides in Mock Mixtures 
To demonstrate the selective UVPD of BAH-conjugated peptides in a more 
complex mixture, a mock mixture of peptides was analyzed.  The mock mixture 
contained an equimolar amount (~10 M) of bradykinin, angiotensin II, neurotensin, 
substance P, YGGFM, and the cross-linking product mixtures of Ac-AAAKAAAAR + 
SFB/SANH + Ac-AAAKPAAAR, Ac-AAAKAAAAR + SFB/SANH + neurotensin, and 
-MSH + SANH/SFB + Ac-RFMWMK-NH2.  This mock mixture of peptides was 
rapidly screened via direct infusion ESI-UVPD-MS by comparison of a wide m/z range 
isolation spectrum and the UVPD mass spectrum (Figure 5.7).  Ions without the BAH-
chromophore were unaffected by UV irradiation and were observed in both the isolation 
and UVPD mass spectra.  The more highly-charged BAH-conjugated peptide-peptide 
complexes exhibited high UVPD efficiency and their abundances substantially decreased 
in the UVPD mass spectra (Figure 5.7b).  The abundances of these highly-protonated 
BAH-conjugated peptides diminished on average by ~70%, whereas the abundances of 
the lower-charged conjugated peptide ions decreased by only ~20 – 30% (Table 5.1).  
The SFB-, SANH-, and unmodified peptides did not exhibit any significant decrease in 
abundance upon exposure to UV irradiation at 355 nm.  The differences in ion 
abundances of these various species between the wide m/z isolation and UVPD mass 
spectra could be discerned with as few as 5 pulses of UV irradiation and up to 20 pulses, 
thus indicating a wide usable range of experimental conditions for distinguishing between 
BAH-conjugated peptides and uninformative species. 
To demonstrate the utility of UVPD to screen BAH-conjugated peptides in more 
complex samples, the same mock mixture was also analyzed by online LC-UVPD-MS.  
In this method, a wide m/z isolation mass spectrum and then a UVPD mass spectrum 
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were acquired in an alternating fashion throughout the LC separation.  Selected ion 
chromatograms (SICs) of the eluting species were extracted from the total ion 
chromatograms of the isolation and UVPD mass spectra.  These SICs were then re-
plotted on the same time axis to create reconstructed ion chromatograms (RIC) as shown 
in Figure 5.8.  The peak areas of each component in the mixture were measured in the 
isolation and UVPD SICs to calculate the decreases in ion abundance upon UV 
irradiation (given as percentages) (Table 5.2).  Comparison of the two RICs allow ready 
determination of which ions possess the BAH-chromophore as these species decreased in 
abundance by an average of 73%.  If the BAH-containing peptide ions are further 
Figure 5.7 (A) Wide m/z range isolation and (B) UVPD (10 pulses) mass spectra of m/z
600 – 1100 of a mock mixture of BAH-cross-linked (), SFB- (), SANH-
(), and un-modified peptides ().  Ion identities are listed in Table 5.1. 
 135
Table 5.1 Changes in relative ion abundances upon UV irradiation (10 pulses) for a











1 [-MSH + SANH + 3H]3+ 600.5 3.41E+05 3.25E+05 -4.8 0.9
2
[Ac-AAAKAAAA  BAH  neurotensin + 
4H]4+ c
647.4 2.36E+05 7.06E+04 -70.1 0.6
3
[Ac-AAAKAAAAR  BAH 
Ac-AAAKPAAAR + 3H]3+
654.1 4.68E+05 1.24E+05 -74 2
4 [-MSH  BAH  K + 3H]3+ 666.6 2.45E+05 7.87E+04 -68 2
5 [substance P + 2H]2+ 674.4 8.00E+05 7.71E+05 -4 3
[Ac-AAAKAAAAR  BAH  neurotensin - 
H2O + 4H]4+
687.5 7.81E+04 1.70E+04 -78 8
6
[Ac-AAAKAAAAR  BAH  neurotensin + 
4H]4+
692.0 7.03E+04 1.19E+04 -83 6
7
[-MSH  BAH  Ac-RFMWMK-NH2 - H2O + 
4H]4+
710.1 2.08E+05 2.21E+04 -89 4
8 [-MSH  BAH  Ac-RFMWMK-NH2 + 4H]4+ 714.3 1.06E+05 1.46E+04 -86 1
9 [Ac-AAAK  BAH  neurotensin + 3H]3+ c 769.5 8.73E+04 2.05E+04 -77 2
10 [Ac-RFMWM + H2O + H]+ c 811.3 6.50E+04 9.38E+04 44 9
11 [neurotensin + 2H]2+ 836.9 2.11E+05 2.27E+05 8 3
12
[Ac-AAAKAAAAR  BAH  neurotensin + 
3H]3+
922.0 1.55E+05 1.29E+05 -17 4
13 [-MSH  BAH  Ac-RFMWMK-NH2 + 3H]3+ 951.5 6.19E+04 4.99E+04 -19 2
14 [Ac-AAAKAAAAR + SFB + H]+ 974.3 1.21E+05 1.17E+05 -3 4
[Ac-AAAKAAAAR  BAH 
Ac-AAAKPAAAR + 2H]2+
980.3 3.29E+04 2.34E+04 -29 4
15 [Ac-AAAKPAAAR + SANH + H]+ 1003.3 5.02E+04 8.43E+04 68 13
16 [Ac-AAAKPAAAR + SANH + H2O + H]+ 1020.2 4.29E+04 4.33E+04 1 5
[angiotensin II + H]+ 1046.3 9.24E+03 8.96E+03 -3 4
[bradykinin + H]+ 1060.3 9.22E+03 1.05E+04 13.8 0.5
17 [Ac-RFMWMK-NH2 + SFB + H]+ 1068.2 4.41E+04 4.41E+04 0 7
[Ac-RFMWMK-NH2 + SFB + H2O + H]+ 1086.2 1.81E+04 1.87E+04 3 8
[substance P + H]+ 1347.3 6.62E+03 6.80E+03 2.8 0.7
a  Values are the average of data obtained in triplicate. b  Standard deviation of the percent abundance 
changes. c  Ion is isobaric with a product ion of a cross-linked peptide
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categorized by charge state, the more highly-charged species reduce in abundance by ~94 
 4% and the species in the corresponding lower charge states (i.e. without a mobile 
proton) decrease by ~43  25%.  The non-chromogenic peptide ions exhibited an average 
decrease in peak area of only 0.7%. 
UV-Vis absorption measurements at 355 nm of the eluting peptides also provided 
another means to aid in distinguishing the BAH-conjugated peptides from unmodified 
peptides and dead-end-modified peptides.  All of the peptides with a BAH-cross-link had 
Figure 5.8 Reconstructed total ion chromatograms from (A) wide m/z range isolation 
and (B) UVPD (10 pulses) spectra of LC-MS/MS analysis of a mixture of 
peptides.  Ions of m/z 475 – 1100 were either isolated or UV irradiated. 
BAH-conjugated peptides are labeled with , SFB-modified with , and 
SANH-modified with .  Ion identities are listed in Table 5.2. 
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an absorbance of at least 0.029; unmodified, SFB-modified, and SANH-modified 
peptides showed no absorbance at 355 nm (Table 5.2).  However, for co-eluting species 
in which one peptide is conjugated and the other is not, the UV-Vis measurements in 
combination with a standard mass spectrum would not provide enough information to 
determine which of the two species contains the BAH-chromophore.  Only by utilizing 
UVPD can one differentiate between two or more co-eluting species that absorbed well at 
355 nm. 
It should be noted that another type of dead-end modified peptides were observed 
in some of the UVPD-MS experiments corresponding to a reaction between free SANH 
(in which the NHS-ester was hydrolyzed) with SFB-modified peptides or vice versa 
creating a chromogenic dead-end modified peptide, termed BAH-OH (+267 Da mass 
shift).  These peptides exhibited high UVPD efficiencies but lower than that of the BAH-
conjugated peptides.  A UVPD mass spectrum of [-MSH + BAH-OH + 3H]3+ is shown 
in Figure 5.9 and several informative product ions were observed allowing identification 
of the precursor as a BAH-OH modified peptide.  In fact, one product ion observed was 
the unmodified peptide, [-MSH + 2H]2+, of m/z 833.5 which corresponds to the loss of 
the BAH-OH modification.  Since these species do undergo relatively efficient 
photodissociation, they could yield false positives in the isolation/UVPD screening 
process.  However, these dead-end modified peptides can be reduced to a minimum 
through rigorous sample clean-up to remove any excess free SANH or SFB from the 
reaction mixtures prior to MS analysis; in addition, these species were observed to 
increase in concentration in the samples over time and thus it is recommended that the 




Table 5.2 Changes in ion abundance upon UV irradiation from LC-UVPD-MS 








































































































































































































































































































































































































































































































































































































































































































































































































5.4.4 Charge state dependence of UVPD 
Upon closer examination of the decreases in ion abundances when comparing the 
wide m/z isolation mass spectra to the UVPD mass spectra in the direct infusion ESI-MS 
and LC-UVPD-MS experiments, it is clear that the more highly-charged BAH-
conjugated peptide ions underwent more efficient photodissociation than those in lower 
charge states.  The quadruply protonated BAH-conjugated peptide complex of m/z 692.0 
in Figure 5.3 corresponding to [Ac-AAAKAAAAR  BAH  neurotensin + 4H]4+ 
decreased in relative abundance by ~90% whereas the triply-charged analog was reduced 
by only ~20%.  This phenomenon was further investigated by conjugating the model 
peptides Ac-AAAKAAAAR + SFB with Ac-AAAKPAAAR + SANH and individually 
analyzing the doubly- and triply-charged cross-linked products by UVPD-MS.  
Ultraviolet photodissociation of the resulting conjugated peptide in the 3+ charge state 
yielded a wide array of product ions as evident in Figure 5.10a.  Cross-linked b- and y-
Figure 5.9 UVPD mass spectrum of [-MSH + BAH-OH + 3H]3+ of m/z 645.5 using 
10 laser pulses at 355 nm.  The precursor ion is indicated with an asterisk
(*) and the peptide is referred to as .  Product ions which retain the BAH-
OH modification are indicated with superscript  and water (H2O) loss is 
indicated by superscript o. 
 140
type ions as well as specific cross-linked fragment ions such as lysine immonium ions 
linked to one peptide (e.g. KL) and those arising from cleavage of the linker amide bond 
(e.g. L18) were observed.  In addition a full series of conventional b- and y-type ions 
were also detected for each constituent peptide.  However, UVPD of the analogous 
doubly-protonated conjugated peptide resulted in minimal product ion formation (Figure 
5.10b).  Only a single identifiable fragment ion was observed (y5) at a relative 
abundance of less than 1.5%.  It is believed that this charge-dependent UVPD efficiency 
is due to the protonation state of the bis-aryl hydrazone moiety.  The doubly-protonated 
Figure 5.10 UVPD mass spectra of Ac-AAAKAAAAR  BAH  Ac-AAAKPAAAR 
in the (A) 3+ (m/z 653.7) and (B) 2+ (m/z 980.0) charge states using 7 and 
15 pulses of UV irradiation, respectively.  The first peptide listed is referred 
to as  and the second peptide as / nomenclature is used for product 
ions which could have resulted from cleavage of either peptide.  Precursor
ions are signified with an asterisk (*). 
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conjugated peptide of Ac-AAAKAAAAR  BAH  Ac-AAAKPAAAR is assumed to 
have both protons sequestered at the two C-terminal arginine residues.  However, the 
triply-protonated species has one additional mobile proton, presumably partially localized 
at the basic BAH-chromophore, thus protonating N12 (see Figure 5.1 for numbering 
scheme). 
It is speculated that the additional mobile proton alters the resulting gas-phase 
absorption profile of the BAH-conjugated peptide, in this case increasing the UVPD 
efficiency at 355 nm.  This effect parallels the solution-phase absorption properties of 
B2PH as indicated in the UV-Vis spectra of this molecule in neutral and acid-spiked 
solutions (Figure 5.2a).  The difference in UVPD efficiencies cannot simply be 
explained by a decrease in the energy necessary to dissociate the 3+ versus 2+ precursor 
ions because peptides cross-linked by the non-chromogenic DSS molecule did not exhibit 
any UVPD in any charge state (data not shown).  In addition, lower CID voltages were 
required to dissociate these DSS-cross-linked analogs than the BAH-cross-linked 
peptides as determined by energy-variable CID in which the abundances of the selected 
precursor peptide ions were monitored as the CID voltage was raised.  The triply-charged 
BAH-conjugated peptide needed a 25% greater CID voltage than the DSS-cross-linked 
species to reach the 50% dissociation level (0.326 V vs. 0.259 V).  Preliminary studies of 
pulse-resolved UVPD, in which fragment ion abundances were measured as a function of 
the number of UVPD pulses, suggest that the primary product ions also exhibit this 
charge-dependent photodissociation efficiency (e.g. primary product ions with a mobile 
proton undergo absorption and photodissociation upon subsequent pulses of UV 
irradiation whereas product ions with protons sequestered at arginine residues do not 




Using a two-step conjugation method in which the chromogenic bis-aryl 
hydrazone functionality was formed upon reaction of two modified biomolecules, we 
have been able to rapidly distinguish cross-linked peptides from dead-end and 
unmodified peptides by UVPD-MS.  Ultraviolet photodissociation of the cross-linked 
peptides provided more diagnostic sequence ion information than CID, allowing one to 
readily identify the cross-linked residues of the constituent peptides.  The UVPD 
efficiencies were also observed to be charge-dependent as protonation of the hydrazone 
bond was necessary for rapid photodissociation, mirroring the solution-phase UV-Vis 
absorption profile of the BAH-chromophore in neutral and acidic solutions.  Only BAH-
conjugated peptides were observed to undergo efficient UV photodissociation at 355 nm 
allowing for facile and selective identification of these ions of interest.  Unmodified 
peptides, as well as SFB- and SANH-modified peptides, do not contain the BAH-
chromophore and thus were not observed to photodissociate under any conditions.  
Online LC-UVPD-MS and direct-infusion ESI-UVPD-MS techniques were successfully 
applied to a mock mixture of peptides.  By using a laser with a higher repetition rate 
and/or a higher peak power, it would be possible to increase the duty cycle of this method 
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Sequencing of Bis-arylhydrazone Cross-Linked Peptides by Electron 
Transfer Dissociation to Assess Protein-Protein Interactions 
6.1 OVERVIEW 
Electron transfer dissociation (ETD) was used to sequence bis-aryl hydrazone 
(BAH) cross-linked peptides through preferential cleavage of the hydrazone bond.  
Between 50% and 80% of the observed ETD fragment ion abundance was accounted for 
by product ions due to cleavage of the N12–N13 hydrazone, yielding the two constituent 
peptides – one an even-electron product ion termed L12, the other an odd-electron 
radical ion termed L11• – which allowed each peptide to be individually sequenced by 
MS/MS methods and the site of cross-linking to be identified.  The proposed pathway for 
the dissociation of the hydrazone bond involves transfer of the electron directly to the 
protonated hydrazone functionality and subsequent rearrangement to yield the L12 and 
L11• products.  Collision induced dissociation (CID) of the even-electron L12 product 
yielded a series of b- and y-type ions; CID of the odd-electron L11• product resulted in a 
wide range of fragment ions including a-, b-, c-, y-, and z-type ions. 
 
6.2 INTRODUCTION
As the field of proteomics advances, there is a growing need to more clearly 
understand the relationship between protein structure and protein function.  To this end it 
is vital to not only identify but map protein-protein interactions.1-3  Traditional protein 
structure determination methods such as X-ray crystallography and NMR spectroscopy 
are time-consuming and require relatively large amounts of protein.  In an effort to 
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overcome these disadvantages, chemical cross-linking with mass spectrometric analysis 
has become a more widespread technique that provides low-resolution structural 
information about proteins and protein-protein complexes.4-6  Chemical cross-linking 
generally involves covalently connecting pairs of amino acid residues that are spatially 
constrained within a single protein (intramolecular cross-linking) or between two proteins 
(intermolecular cross-linking) to determine relative distances between residues or identify 
interacting interfaces in protein complexes.  In recent years, cross-linking with mass 
spectrometry (MS) analysis has been used to determine the fold of a single protein,7 the 
quaternary structure of protein-ligand complexes,8-11 elucidate conformational changes in 
protein structure upon activation,12 as well as ligand modulation of protein-protein 
interactions.13 
While chemical cross-linking has shown significant promise as an alternative 
means to map protein interactions, there are several persistent analytical hurdles 
associated with this method.  The rapid and accurate identification of cross-linked 
peptides in complex mixtures arising from the proteolytic digestion of cross-linked 
proteins and the interpretation of product ion (MS/MS) spectra of cross-linked peptides 
remain two of the greatest challenges.  To facilitate identification of cross-linked peptides 
in complex mixtures – containing not only the cross-linked species of interest but also 
unmodified and dead-end cross-linked peptides – several mass spectrometric methods 
have been developed with a focus on the synthesis of novel cross-linkers that allow the 
selective capture or identification of cross-linked peptides.  Affinity tags such as biotin 
have been incorporated into cross-linkers to enrich cross-linked species,14-17 isotopically 
labeled cross-linking reagents as well as 18O labeling have been used to identify cross-
linked peptide ions in the mass spectra by their unique isotopic signatures,15, 18-20 and 
fluorogenic cross-linkers and online fluorescent detection during a front-end LC 
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separation have been utilized as well.21-23  Yan et al. recently designed a novel tri-
functional photocleavable cross-linker with an acetyl protected thiol group that upon 
deprotection selectively reacts with a free iodo group on functionalized magnetic beads, 
allowing capture and enrichment of cross-linked peptides.24   
Recently an IR chromogenic cross-linked was designed and synthesized which 
contained a phosphate chromophore that promoted selective infrared multiphoton 
dissociation (IRMPD) of cross-linked peptides allowing facile differentiation of these 
species of interest from unmodified peptides (Chapter 4).25  In addition, IRMPD of these 
cross-linked peptides yielded a series of y-type product ions C-terminal to the cross-
linked residues which allowed for each constituent peptide to be sequenced without the 
need for MSn methods.  Other groups have focused on developing cross-linkers that 
display characteristic fragmentation patterns upon collision-induced dissociation (CID) 
by including gas-phase labile bonds.  The first method to employ cleavable bonds utilized 
them to produce “reporter” ions upon low energy CID to readily identify and screen for 
cross-linked peptides.26, 27  Chowdhury and co-workers designed a tri-functional cross-
linker with an affinity group for enrichment and an NO2 tag which was observed as a 
neutral loss upon CID.28  In a second strategy, these gas-phase labile bonds were 
incorporated into the cross-link itself such that the cross-link is cleaved upon CID, 
yielding each constituent peptide with a characteristic modification.14, 27, 29-32  Soderblom 
and Goshe incorporated an aspartyl-prolyl bond in the center of their cross-linker,29 while 
the Reid group used a fixed-charged cross-linker containing a sulfonium ion which 
induced dissociation on either side of the sulfur atom.31  These approaches required an 
additional stage of CID to sequence either the cross-linked peptide for the “reporter” ion 
technique or the modified constituent peptides for the latter method. 
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The gas-phase cleavable cross-linking reagents developed to date all use ergodic 
dissociation methods (e.g. IRMPD and CID) in which selective dissociation or bond-
cleavage may not be observed for all cross-linked peptides.  Cross-linked peptides have 
been shown to exhibit dissociation trends similar to that of unmodified peptides in which 
fragmentation is not only dependent on amino acid composition and sequence but also 
charge state.33, 34  For peptides with labile post-translational modifications (PTMs) such 
as phosphorylation, the losses of these modifications are often the preferred the 
dissociation pathways that may be favored over cleavage of the labile bond located 
within the cross-linker.   
While preferential cleavage of the most labile bonds is often observed upon CID 
of peptides, electron capture dissociation (ECD)35 or electron transfer dissociation 
(ETD),36 two non-ergodic dissociation methods, promote alternative fragmentation 
pathways.  For peptide cations, one of the proposed mechanisms as shown in Scheme 6.1 
involves electron capture at the protonation sites (e.g., amines of lysines or N-termini or 
guanidino group of arginines) which results in the ejection and transfer of a hydrogen 
atom to a carbonyl oxygen.37  Subsequent dissociation of the N–C bond of the peptide 
backbone is observed which produces the characteristic c- and z•-type ions observed by 
ECD and ETD.  However, preferential cleavage of disulfide bonds was observed in early 
top-down dissociation studies of proteins by ECD.38  This high propensity of S–S bond 
dissociation is attributed to the high affinity of this bond for the hydrogen atom (H•).  
While cleavage of disulfide bonds was favored for the specific protein studied, in the 
ECD product ion mass spectra almost complete sequence coverage of the protein was 
also obtained due to backbone cleavages of the N–C bonds.37  The McLuckey group 
analyzed disulfide-bonded peptides by ETD, and for most of triply charged peptide 
cations studied, cleavage of the disulfide bond accounted for ~70% – 80% of the ETD 
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product ions.39  For quadruply charged peptide cations, lower yields (~33%) of the 
observed product ions arose from disulfide bond dissociation.   
In this chapter, electron transfer dissociation of bis-arylhydrazone cross-linked 
peptides is explored in a linear ion trap mass spectrometer.  Earlier studies as discussed in 
Chapter 5 showed that BAH-cross-linked peptides could be selectively dissociated by 
ultraviolet photodissociation as a means to rapidly screen for these species in complex 
Scheme 6.1 Electron capture dissociation (ECD) mechanism yielding c- and z-type ions.
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mixtures.40  In the present study, upon reaction with fluoranthene radical anions, the 
BAH-cross-linked peptides were observed to undergo ETD with preferential cleavage of 
the N–N hydrazone bond.  Dissociation of the hydrazone bond yielded the two 
constituent peptides each with a unique mass tag at the cross-linking site, one an even 
electron species and the other an odd electron product.  The propensity for cleavage of 
the hydrazone bond by ETD is compared to the preferential dissociation of the disulfide 
bond of peptides cross-linked with dithiobis (succinimidyl propionate).  A mechanism for 
the preferential cleavage of the hydrazone bond is proposed and discussed.  Collision-
induced dissociation of the primary product ions due to cleavage of the hydrazone bond 
yield diagnostic sequence ions which allow the site of cross-linking to be unambiguously 
identified.   
 
6.3 EXPERIMENTAL
6.3.1 Chemicals and Reagents 
The peptides -MSH (Ac-SYSMEHFRWKGPV-NH2), neurotensin (Pyr-
LYENKPRRPYIL) and Ac-RFMWMK-NH2 were obtained from Bachem (Torrance, 
CA) and used without further purification.  The peptides Ac-AAAKAAAAR and Ac-
AAAKPAAAR were synthesized at the Protein Microanalysis Facility at the University 
of Texas at Austin and purified by reversed-phase HPLC.  Succinimidyl 4-
formylbenzoate (SFB), succinimidyl 4-hydrazinonicotinate acetone hydrazone (SANH), 
and dithiobis (succinimidyl propionate) (DSP) were obtained from Pierce Biotechnology 
(Rockford, IL).  All other reagents and chemicals were from Fisher Scientific (Fairlawn, 
NJ). 
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6.3.2 Peptide Chemical Conjugation and Cross-Linking 
Peptides were cross-linked together as previously described and is shown in 
Scheme 6.2.40  Briefly, peptides were first modified by either SANH or SFB at a 1:10 
molar ratio of peptide to derivatizing reagent (200 M: 2.0 mM) in a 20 mM HEPES, pH 
8.0 buffer.  After reacting overnight, the solutions were desalted via C18 solid-phase 
extraction using Waters tC18 SepPak cartridges (Milford, MA).  The modified peptides 
were conjugated together in 99:1 MeOH/acetic acid (v/v) at an equimolar ratio (100 M) 
at 55 °C overnight.  Model peptides were also cross-linked with DSP.  A fresh solution of 
DSP was prepared at 20 mM in DMSO and an aliquot was added to a solution containing 
the peptides to be cross-linked at a molar ratio of 3: 2: 2 (300 M cross-linker: 200 M 
-peptide: 200 M -peptide) 20 mM HEPES, pH 8.0 buffer.  The percent volume of 
DMSO in the cross-linking solution was 5%.  The peptides were cross-linked overnight 
and then desalted by C18 solid-phase extraction.  All conjugated and cross-linked peptides 
were diluted to ~10 M in 49.5: 49.5: 1 H2O/MeOH/acetic acid (v/v/v) for ESI-MS/MS 
analysis.  Samples were infused at a flow rate of 3.0 L/min using an ESI voltage of 4.0 
kV. 
6.3.3 Mass Spectrometry 
All mass spectrometry analyses were conducted on a ThermoFisher Scientific 
LTQ XL linear quadrupole ion trap mass spectrometer (San Jose, CA) equipped with the 
standard ESI source operated at 4.0 kV and ETD capabilities allowing for the chemical 
ionization and injection of fluoranthene radical anions.  The mass spectrometer was 
controlled with the XCalibur 2.0.7 software package.  Collision-induced dissociation 
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Scheme 6.2 Two step BAH-conjugation procedure via SFB- and SANH-modification..  
experiments were performed by activating the precursor ions for 30 ms at a q-value of 
0.25.  Electron transfer dissociation was performed by injecting 1 
 105 reagent anions 
into the trap and the reaction time was varied between 0.03 and 100 ms.  The precursor 
ion population for CID and ETD was set to 1 
 104 ions.  Time-resolved ETD 
experiments were performed by plotting the relative abundances of the observed product 
ions as a function of the ETD reaction time.   
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6.3.4 Identification of Cross-Linked Peptides 
The ETD spectra of these cross-linked peptides were manually identified, as were 
the MS3 CID spectra.  Product ion spectra of cross-linked peptides were labeled 
according to the proposed nomenclature.41  Briefly, the two constituent peptides are 
labeled as  and  and for the purposes of this chapter, the -peptide is designated as the 
one which was modified by SFB and the -peptide by SANH and bis-arylhydrazone 
cross-linked peptides are referred to as  + BAH +  (i.e., BAH = SFB/SANH).  
Dissociation of the peptide backbone of the -peptide would yield e.g. bn, cn, yn, and 
zn product ions.  Similar notation is used for dissociation of the -peptide.  Lysine 
immonium ions cross-linked to either peptide are labeled as KL or KL.  Product ions 
due to dissociation along the cross-linker are labeled based on the number of atoms away 
from the alpha-carbon of the cross-linked lysine of the peptide which retains the charge 
as shown in Scheme 6.3 with the numbering beginning from the -peptide; similar 
numbering is used beginning from the -peptide. 
 
 
Scheme 6.3 Fragmentation nomenclature for BAH-cross-linked peptides. 
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6.4 RESULTS AND DISCUSSION
6.4.1 Electron Transfer Dissociation of Bis-arylhydrazone Cross-Linked Peptides 
Bis-arylhydrazone cross-linked peptides were analyzed by CID and ETD to assess 
the ability to sequence the constituent peptides and locate the sites of the cross-links.  For 
example, the peptide Ac-AAAKAAAAR (-peptide) was cross-linked to neurotensin 
(Pyr-LYENKPRRPYIL, -peptide) through SFB/SANH conjugation.  Collision-induced 
dissociation of this cross-linked peptide in the 4+ charge state, as shown in Figure 6.1a, 
Figure 6.1 (A) CID and (B) ETD (100 ms) product ion mass spectra of [Ac-
AAAKAAAAR + BAH + neurotensin + 4H]4+ of m/z 692.3.  The first 
peptide listed is referred to as  and the second peptide as .  The precursor 
ion is represented by an asterisk (*). 
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predominantly resulted in cleavage of backbone amide bonds of the -peptide (Ac-
AAAKAAAAR), yielding a series of yn (y2 – y5) and complementary cross-linked bn 
ions (bn ion of the -peptide cross-linked to intact neurotensin) .  One lysine immonium 
ion (from the -peptide) cross-linked to neurotensin was also detected (KL2+ ion).  
However, no product ions stemming from cleavage of the peptide backbone of 
neurotensin were observed in the CID mass spectrum, meaning that no diagnostic -
peptide ions were formed.  In contrast, ETD of the same cross-linked peptide yielded 
three abundant product ions of m/z 896.9, 973.4, and 1793.7 (Figure 6.1b)  which arose 
from dissociation of the N12–N13 bond of the bis-aryl hydrazone cross-link (atom 
labeling shown in Scheme 6.3).  This yielded the two constituent peptides each with a 
unique mass tag at the cross-linked lysines, designated as the L12 ion (-peptide + 131 
Da, SFB tag, m/z 896.92+) and the complementary L11 ion (-peptide + 119 Da, SANH 
tag, m/z 973.4).  The third most abundant product ion of m/z 1793.7 is the singly charged 
(i.e., charge reduced) analog of the L12 product.   
Figure 6.2 ETD mass spectra of [-MSH + BAH + Ac-RFMWMK-NH2 + 4H]4+ of m/z
714.1 (40 ms reaction time).  The first peptide listed is referred to as  and 
the second peptide as .  The precursor ion is represented by an asterisk (*).
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A second BAH-cross-linked peptide contained -MSH as the -peptide and Ac-
RFMWMK-NH2 as the -peptide.  Upon ETD, the [-MSH + BAH + Ac-RFMWMK-
NH + 4H]4+ ion of m/z 713.6 yielded three dominant product ions of m/z 898.4, 1059.3 
and 1796.5, as shown in Figure 6.2.  Cleavage of the N12–N13 hydrazone bond produces 
the L12 ion (-peptide + 131 Da, SFB tag, m/z 898.42+) and the complementary L11 
ion (-peptide + 119 Da, SANH tag, m/z 1059.3).  The product ion of m/z 1796.7 is the 
charge reduced L12 species. 
 Upon ETD of each of these cross-linked peptides, the abundance of the L12 and 
L11 product ions is greater than that of the charge reduced precursor ions (i.e., 
[M+4H]3+•) or any conventional c- or z•-type sequence ions typically formed by ETD.  
The ability to preferentially cleave a bond within a cross-linker to yield the two 
constituent ions is of particular interest as it simplifies data analysis and allows one to 
utilize well-established database search algorithms such as SEQUEST42 and Mascot43 to 
identify the cross-linked peptides. In our study, the formation of the complementary and 
highly diagnostic L12 and L11 ions is observed upon ETD of all cross-linked peptides, 
a significant feature of the present strategy. 
A proposed route for the preferential dissociation of the hydrazone bond is shown 
in Scheme 6.4.  Previous studies of hydrazone-containing molecules, as discussed in 
Chapter 5, indicate the UV absorption profile shifts in both the gas-phase and solution-
phase upon protonation of the hydrazone functionality, which is presumed to be due to its 
high gas-phase basicity.  Assuming that the N12 atom of the bis-arylhydrazone cross-link 
is protonated, the electron could likely be transferred to this functionality, resulting in a 
hypervalent species in which the extra electron would initially be localized at the C11 
atom of the charge reduced species.  Upon rearrangement, the N12–N13 bond is cleaved 
producing the complementary L12 and L11• product ions.  While the radical is 
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displayed as localized on the amine group of the final L11• product ion in Scheme 6.4, 
the radical can be resonance stabilized by the adjacent pyridinyl ring.  The mass shifts 
observed for these two product ions are consistent with the proposed pathway in which 
the L12 species is an even-electron product (+131 Da, SFB tag) and L11 (+119 Da, 
SANH tag) possesses the extra electron.  There may be a high propensity for cleavage of 
the hydrazone bond by ETD because the mechanism does not require the migration of a 
hydrogen atom (H•) to initiate dissociation as is necessary to produce conventional c- and 
z•-type ions (see Scheme 6.1). 
 
Scheme 6.4 Proposed mechanism for the dissociation of the hydrazone bond. 
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6.4.2 Preferential Cleavage of Hydrazone by ETD 
Preferential cleavage of the hydrazone bond was observed for the cross-linked 
peptides described above as well as for other model cross-linked peptides (data not 
shown).  In addition, pairs of peptides were also reversed with respect to the orientation 
of conjugation (i.e., the -peptide and -peptide were reversed).  For example, the -
MSH and Ac-RFMWMK-NH2 peptides were conjugated to create [-MSH + BAH + Ac-
RFMWMK-NH2] and [Ac-RFMWMK-NH2 + BAH + -MSH] products.   Time-resolved 
ETD experiments were performed to determine the appropriate reaction conditions to 
produce the greatest abundance of the diagnostic L12 and L11• ions. The relative 
abundances of the various types of product ions observed in the ETD mass spectra were 
plotted as a function of ETD reaction time for -MSH + BAH + Ac-RFMWMK-NH2 as 
well as the same cross-linked peptides conjugated in the reverse orientation, Ac-
RFMWMK-NH2 + BAH + -MSH, in the 3+ and 4+ charge states (Figure 6.3).  For the 
cross-linked peptides in the 4+ charge state, the L12 and L11• product ions were 
observed to be the most abundant ions in the ETD mass spectra, in fact greater in 
abundance than the charge reduced precursor ions when the ETD reaction time was 
greater than 25 ms (Figure 6.3a and 6.3c).  Greater than 70% of the total ion current was 
comprised of these key L12 and L11• ions in the ETD mass spectra of the 4+ charged 
cross-linked peptides.  In the ETD mass spectra of the triply charged cross-linked 
peptides, the L12 and L11• ions are the most abundant fragment ions (i.e., products of 
the ion-ion reaction that are due to bond cleavage), but not the most abundant product
ions.  The most abundant product ions arise from electron transfer that yields the charge 
reduced precursor ([M+3H]2+•) and proton transfer from the precursor to the reagent 
anion that yields [M+2H]2+ (Figure 6.3b and 6.3d).  The relative abundance of the 
hydrazone cleavage products, L12 and L11•, was ~25% maximum upon ETD of the 
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triply charged precursors.  Uninformative  neutral loss products (e.g., side chains losses 
from Arg residues including loss of NH3) and c/z•-type ions accounted for a maximum of 
Figure 6.3 Relative ion abundances plotted as a function of ETD reaction time for -
MSH + BAH + Ac-RFMWMK-NH2 in the (A) 4+ and (B) 3+ charge states. 
and for Ac-RFMWMK-NH2 + BAH + -MSH in the (C) 4+ and (D) 3+ 
charge states.  The first peptide listed is referred to as  and the second 
peptide as .  Ion abundances are relative to the total ion current in each
ETD product ion spectra. 
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~6% of the total ion abundance in the ETD mass spectra of the 4+ charged cross-linked 
peptide ions and only 2% - 3% each in the mass spectra of the 3+ charged precursors.  
Charge reduction due to electron attachment without dissociation accounted for almost 
50% of the ion abundance in the ETD mass spectra of the 3+ charged precursors.   
We speculate that the differences in the relative abundances of the hydrazone 
cleavage products (L12 and L11• ions) for the 4+ and 3+ charge states of the cross-
linked peptides (i.e., such as for the -MSH/AcRFMWMK-NH2 pair) correlate with 
whether the hydrazone functionality is protonated.  For the 4+ charge state, the hydrazone 
functionality is likely protonated, thus facilitating the pathway outline in Scheme 6.4.  In 
contrast, for the  triply charged cross-linked peptides, it is likely that the two Arg residues 
are protonated, and then the third proton is localized at either the hydrazone functionality 
or His-6 of -MSH (Ac-SYSMEHFRWGKPV-NH2), with the latter likely leading to 
c/z•-type ion production or charge reduction. 
The only noticeable difference upon ETD of the two reverse orientation cross-
linked peptides, [-MSH + BAH + Ac-RFMWMK-NH2] and [Ac-RFMWMK-NH2 + 
BAH + -MSH],  is that the abundance of the hydrazone cleavage product containing the 
-MSH peptide (L12 in Figure 6.3a and 6.3b, L11• in Figure 6.3c and 6.3d) was 
always 1.5 to 2 times greater than the complementary product containing the Ac-
RFMWMK-NH2 peptide (L11• in Figure 6.3a and 6.3b, L12 in Figure 6.3c and 
6.3d).  This phenomenon was further investigated by measuring the ratio of L12 to 
L11• product ions for other charge states of the cross-linked -MSH/Ac-RFMWMK-
NH2 and Ac-RFMWMK-NH2/-MSH peptides, and the results are summarized in Table 
6.1.  The product ion comprised of the -MSH peptide consistently had a 1.7 to 7 times 
greater abundance than its Ac-RFMWMK-NH2 counterpart.  This asymmetric 
partitioning between complementary product ions was initially presumed to be due to 
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differences in the gas-phase basicities of the two peptides as the -MSH (Ac-
SYSMEHFRWGKPV-NH2) peptide contains two basic residues, His-6 and Arg-8, 
compared to Ac-RFMWMK-NH2 which possesses a single unmodified basic residue, 
Arg-1.  (Since each peptide only has a single primary amine, the lysines are presumed to 
be the cross-link sites. Upon modification of the lysines with SFB or SANH, these basic 
primary amines are converted to amide groups.)  To remove the influence of the peptide 
sequence on the asymmetric partitioning, ETD of the cross-linked peptide Ac-
AAAKAAAAR + BAH + Ac-AAAKAAAAR was examined.  On average, the 
abundance of the L12+ product ion was 1.5 times greater than the L11+• product ion 
which indicates that there is a difference in the inherent reactivities or stabilities of these 
two product ions.  The lower abundance of the odd-electron L11• product ion may be 
Table 6.1 Ratio of abundance (peak areas) of L12: L11• product ions by ETD of 
BAH-cross-linked peptides.  The first peptide listed is the -peptide and the 
second peptide is the -peptide. 
Peptide 25 ms 50 ms 80 ms 100 ms Average Std. Dev.
Ac-AAAKAAAAR + BAH 
+ Ac-AAAKAAAAR
3+ 1.54 1.52 1.46 1.46 1.50 0.04
Ac-AAAKAAAAR + BAH 
+ Ac-AAAKPAAAR
3+ 1.539 1.552 1.573 1.580 1.56 0.02
-MSH + BAH + Ac-
RFMWMK-NH2
4+ 1.878 1.743 1.668 1.634 1.73 0.11
-MSH + BAH + Ac-
RFMWMK-NH2
3+ 7.180 4.958 3.778 2.982 4.7 1.8
Ac-RFMWMK-NH2 + BAH 
+ -MSH
4+ 0.548 0.554 0.565 0.586 0.56 0.02
Ac-RFMWMK-NH2 + BAH 
+ -MSH
3+ 0.075 0.147 0.178 0.175 0.14 0.05
L12/L11•  RatioCharge 
State
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due to its greater reactivity as the radical may initiate secondary dissociation, yielding 
smaller fragment ions; this issue is under further study. 
 The preferential cleavage of the hydrazone bond was compared to the propensity 
for disulfide bond cleavage for peptides cross-linked through disulfide bonds.  For these 
comparative experiments, peptides were cross-linked by DSP which contains a disulfide 
bond at the center of the cross-linking reagent (Scheme 6.5a).  ETD mass spectra of -
MSH + DSP + Ac-RFMWMK-NH2 in the 4+ and 3+ charge states are shown in Figure
6.4.  ETD of the cross-linked peptide in the 4+ charge state predominantly resulted in 
cleavage of the disulfide bond, producing the complementary L9 and L9 ions (Figure 
6.4a).  Cleavage of the S–S bond is shown schematically based on the proposed 
mechanism for dissociation of disulfide-containing peptides (Scheme 6.5b).38  A high 
abundance of the charge reduced precursor was also observed upon ETD of the DSP-
Scheme 6.5 (a) DSP cross-linker and (b) dissociation of disulfide bond upon ETD. 
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cross-linked peptides (4+).  Upon ETD of the triply charged cross-linked peptide, charge 
reduction via electron attachment without subsequent dissociation was the dominant 
pathway, with only minor production of the L9 product ion stemming from cleavage of 
the disulfide bond (Figure 6.4b).  The complementary L9 fragment ion was not 
detected.  
 The propensity for cleavage of the N12–N13 bond of BAH-cross-linked peptides 
relative to the cleavage of the S–S bond of DSP-cross-linked peptides is summarized in 
Table 6.2.  Upon ETD of the BAH-cross-linked peptides in the 4+ charge state (i.e., in 
which the hydrazone functionality is presumed to be protonated), between 65% and 70% 
of the product ions were due to cleavage of the N12–N13 bond, leading to the diagnostic 
Figure 6.4 ETD product ion mass spectra of -MSH + DSP + Ac-RFMWMK-NH2 in 
the (A) 4+ and (B) 3+ charge states.  The ETD reaction times were 50 ms
and 75 ms, respectively. The first peptide listed is referred to as  and the 
second peptide as .  The precursor ion is represented by an asterisk (*). 
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L12/L11• products   Upon ETD of the DSP-cross-linked peptides in the 4+ charge 
state, only 43% of the product ions were due to disulfide bond cleavage.  For the 3+ 
charge state, the value dropped to approximately 20% to 25% for the BAH-cross-linked 
peptides and 6% for the DSP-cross-linked peptides.  These results indicate that there is a 
clear preference for the dissociation of the hydrazone bond by ETD. 
 
6.4.3 Sequencing of Cross-Linked Peptides by ETD-CID MSn Methods 
The high propensity for the hydrazone bond cleavage upon ETD provides a means 
to individually sequence the two constituent peptides of intermolecularly BAH-cross-
Table 6.2 Product partitioning between ETD, electron transfer without dissociation
(ETnoD), proton transfer (PT), and hydrazone (N–N) or disulfide bond 
cleavage (S–S) of BAH- or DSP-cross-linked peptides, respectively.  The 
ion-ion reaction time was 80 ms.
Charge % ETnoD          % N-N or S-S         
Cross-Linked Peptide State % ETD + % PT % (ETD + ETnoD + PT)
Ac-AAAKAAAAR + BAH 
+ Ac-AAAKAAAAR
3+ 95.54 4.46 64.86
Ac-AAAKAAAAR + BAH 
+ Ac-AAAKPAAAR
3+ 96.07 3.93 69.63
-MSH + BAH +                 
Ac-RFMWMK-NH2
4+ 90.10 9.90 70.65
-MSH + BAH +                 
Ac-RFMWMK-NH2
3+ 48.00 52.00 24.88
Ac-RFMWMK-NH2 + 
BAH + -MSH
4+ 92.75 7.25 66.21
Ac-RFMWMK-NH2 + 
BAH + -MSH
3+ 42.15 57.85 20.01
Ac-RFMWMK-NH2 + DSP 
+ -MSH
4+ 62.05 37.95 42.89
Ac-RFMWMK-NH2 + DSP 
+ -MSH
3+ 12.20 87.80 5.97
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linked peptides through an MS3 strategy as shown in Scheme 6.6.  After conjugation of 
the two peptides of interest, ETD of the cross-linked species yields the two peptides with 
each containing a unique mass tag based on its original conjugation reagent – 131 Da for 
the peptide covalently modified by SFB (L12), or 119 Da for the peptide modified by 
SANH (L11•).  These key primary product ions, L12 and L11•, formed upon ETD are 
excellent candidates for subsequent CID in order to sequence each constituent peptide 
individually.  Subsequent CID (MS3) of each modified peptide produces diagnostic 
fragment ions that allow sequencing of each peptide and location of the site of cross-
linking.  Although Scheme 6.6 for simplicity shows the conjugation of peptides, the 
strategy is geared for more compelling protein applications, in which the conjugation of 
proteins is followed by enzymatic digestion to produce cross-linked peptides that can be 
used to track and identify the conjugation pattern of the targeted proteins.   
The sequence coverage obtained by the ETD-CID method was compared to CID 
alone for the cross-linked complex containing -MSH (Ac-SYSMEHFRWGKPV-NH2) 
and Ac-RFMWMK-NH2, first with -MSH as the -peptide and Ac-RFMWMK-NH2 as 
the -peptide, then reversed.  The CID mass spectra of these crosslinked peptides are 
shown in Figure 6.5. CID predominantly results in cleavage of amide bonds near the 
cross-linked lysines, yielding cross-linker-containing fragment ions such as lysine 
immonium ions linked to the other peptide (e.g. KL or KL) or ions due to cleavage of 
the cross-link amide bond (e.g. L18 or L18; see Scheme 6.3).  Only a single abundant 
peptide sequence ion was observed, the b5 ion of Ac-RFMWMK-NH2 (b5), and no 
fragment ions of -MSH were detected.  The CID results did not provide sufficient 
diagnostic sequence information to identify the peptides nor locate the sites of the cross-
links.   
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The ETD-CID results are shown in Figure 6.7.  In this case, the [L12 + H]+ and 
[L11 + 2H]2+• produced upon ETD of the (Ac-RFMWMK-NH2 + BAH + -MSH) 
complexes were selected for CID.  CID of the even-electron L12 ion (Ac-RFMWMK-
NH2 + 131 Da) yielded a variety of a-, b-, and y-ions, the types of product ions which are 
typically observed upon CID of peptides (Figure 6.6a).  Full sequence coverage (as 
defined as number of observed backbone cleavages divided by the number of backbone 
bonds) of the Ac-RFMWMK-NH2 peptide was obtained, and the cross-link site was 
confirmed at Lys-6 through the observation of the unmodified b5 ion and the y2 ion which 
contains the 131 Da mass tag.  In fact, all of the y-ions contained the cross-linker mass 
tag.  Likewise, there were no ions arising from cleavage of the amide bond connecting 
Figure 6.5 (A) CID mass spectrum of [-MSH + BAH + Ac-RFMWMK-NH2 + 4H]4+
of m/z 714.1 (11% NCE). (B) CID mass spectrum of [Ac-RFMWMK-NH2 + 
BAH + -MSH + 4H]4+ of m/z 714.1 (11% NCE).  The first peptide listed is 
referred to as  and the second peptide as .  The precursor ion is 
represented by an asterisk (*). 
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the SFB moiety and the lysine side chain.  CID of the odd-electron L11• ion (-MSH + 
119 Da) yielded a-, b-, c-, y- and z-type ions – a mixture of product ions which are 
generally observed upon CID (a-, b-, and y-ions) and ETD (c/z•-ions) of conventional 
peptides (Figure 6.6b).  The c- and z-type ions are most likely produced by radical-
driven backbone cleavages in which the radical is mobilized upon collisional activation.  
Since the radical can also be stabilized by delocalization within the pyridinyl ring, 
dissociation of backbone amide bonds also occurs, yielding the b- and y-ions which are 
Figure 6.6 CID mass spectra (MS3) of product ions from ETD of [Ac-RFMWMK-NH2
+ BAH + -MSH + 4H]4+ of m/z 714.1 (30 ms reaction time).  The first 
peptide listed is referred to as  and the second peptide as . (A) MS3 CID 
mass spectrum of [L12 + H]+ of m/z 1070.2 (17% NCE).  (B)  MS3 CID 
mass spectrum of [L11 + 2H]2+• of m/z 892.6 (15% NCE).  Product ions 
which retain the modification are labeled with .  The precursor ion is 
represented by an asterisk (*). 
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conventional charge-directed fragment ions. While spectral interpretation can be more 
difficult when a greater array of types of fragment ion are produced, in this case near 
complete sequence coverage (91.7%) of the -peptide was obtained.  The 119 Da 
(SANH) mass tag was retained upon CID of this L11• peptide, thus allowing the cross-
linking site to be pinpointed to the Lys-11 site based on the detection of the unmodified 
b10 and modified b11 ions.   
Figure 6.7 CID mass spectra of product ions from ETD of [-MSH + BAH + Ac-
RFMWMK-NH2 + 4H]4+ of m/z 714.1 (30 ms reaction time). The first 
peptide listed is referred to as  and the second peptide as .  (A) MS3 CID 
mass spectrum of [L11 + H]+• of m/z 1059.3 (18% NCE).  (B)  MS3 CID 
mass spectrum of [L12 + 2H]2+ of m/z 898.2 (14.5% NCE).  Product ions 
which retain the modification are labeled with .  The precursor ion is 
represented by an asterisk (*). 
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CID of the L11• and L12 ions formed upon ETD of the same peptide cross-
linked in the opposite orientation, (-MSH + BAH + Ac-RFMWMK-NH2), also provided 
near complete sequence coverage of the two peptides (Figure 6.7).  For the L11• ion 
(Ac-RFMWMK + 119 Da, SANH tag), radical-induced cleavages (z-ions) and traditional 
charge-directed fragments (a-, b-, and y-type ions) were observed upon CID (Figure
6.7a), similar to the types of products observed for the other L11• ion described above.  
CID of the L12 ion (-MSH + 131 Da, SFB tag), as shown in Figure 6.7b, 
predominantly yielded b- and y-type ions along with one c- and one z-type fragment ion.  
The observation of an unmodified b10 ion along with a b11 ion containing the 131 Da SFB 
tag pinpoints the cross-link to Lys-11 of -MSH.  Full sequence coverage of the -
peptide (Ac-RFMWMK-NH2) was observed by the ETD-CID method, and all but one 
backbone bond was cleaved of the -peptide (-MSH; 91.7% sequence coverage).   
For both the L11• and L12 ions created upon ETD of the cross-linked peptides, 
the SFB and SANH mass tags were retained upon collisional activation, allowing 
conclusive identification of the site of the cross-link.  It is critical that the cross-linker 
mass tags are retained upon ion activation; if the cross-link amide bonds are cleaved upon 
CID, then all tracking information about the unique location of the site of cross-linking is 
lost.  These key amide bonds are in fact cleaved upon CID of the cross-linked peptides, 
and thus the sites of cross-linking cannot be determined for the constituent peptides by 
direct CID.  Another advantage of the ETD-CID strategy as opposed to direct CID is that 
double-cleavage cross-linked product ions are not observed.  CID of cross-linked 
peptides often yields product ions which are due to cleavage of multiple backbone amide 
bonds as discussed in Chapter 3, such as combined dissociation of an amide bond of the 
-peptide and an amide bond of the -peptide, producing fragment ions of the form 
bnLyn.  While these types of product ions can be informative, they are difficult to 
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identify and typically require manual interpretation.  In contrast, the ETD-CID technique 
allows the two constituent peptides to be sequenced individually and simplifies spectral 
interpretation. 
Collision-induced dissociation of the charge-reduced products arising from 
electron transfer (but without dissociation) of the cross-linked peptides was also 
performed to determine if preferential cleavage of the hydrazone bond could be observed 
from the non-dissociative electron transfer product (Figure 6.8).  An example of this type 
of charge-reduced ion (m/z 951.6) was noted in Figure 6.2 upon ETD of [Ac-
RFMWMK-NH2 + BAH + -MSH]4+.  Typically, supplemental activation in the form of 
resonant collisional excitation44 or IR irradiation45, 46 of charge-reduced peptides yields c- 
and z•-type fragment ions.  It is thought that the c and z• ions are initially held together by 
non-covalent interactions in the charge-reduced products, and supplemental activation 
releases them as free fragment ions. In the present study, CID of the charge-reduced [Ac-
RFMWMK-NH2 + BAH + -MSH]3+• ion resulted in a broad array of c- and z•-type ions, 
in addition to even electron b- and y-type fragment ions (Figure 6.8).  The abundances of 
Figure 6.8 ET-CID mass spectrum of [Ac-RFMWMK-NH2 + BAH + -MSH + 4H]3+• 
of m/z 951.6 (12.5% NCE).  The first peptide listed is referred to as  and 
the second peptide as . 
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L12 and L11• ions was low.  These results suggest that only a small fraction of the 
charge-reduced cross-linked peptides are comprised of the L12 and L11• ions held 
together by non-covalent bonds.   
The sequence information obtained upon CID of the L9 and L9 product ions 
formed upon ETD of the DSP-cross-linked peptides was compared to the ETD-CID 
results for the analogous BAH-cross-linked peptides.  CID of the L9 product ion formed 
upon ETD of -MSH + DSP + Ac-RFMWMK-NH2 produced many unidentifiable 
product ions in addition to neutral losses stemming from the CO–CH2–CH2–SH 
modification at Lys-11 of -MSH (data not shown).  The L9 product ion (i.e., Ac-
RFMWMK-NH2 + CO–CH2–CH2–SH) yielded a complex array of a-, b-, c-, y-, and z-
type ions.  The amide bond between the cross-linked Lys residue and the CO–CH2–CH2–
SH tag was also cleaved upon CID of the complementary L9 and L9 ions, and thus the 
tracking information to identify the site of cross-link was lost.  In general, lower sequence 
coverage was obtained using the ETD-CID technique for the DSP-cross-linked peptides 
compared to the BAH-cross-linked peptides.  In addition, upon ETD of these cross-linked 
peptides greater preferential cleavage of the hydrazone bond compared to disulfide bond 
cleavage was observed, thus showcasing the compelling advantages of ETD for the 
analysis of hydrazone-conjugated peptides.   
 
6.5 CONCLUSIONS
Electron transfer dissociation of intermolecularly bis-arylhydrazone cross-linked 
peptides resulted in preferential dissociation of the N12–N13 hydrazone bond.  Cleavage 
of the hydrazone bond yields the two constituent peptides – one an even-electron product 
with a 131 Da mass tag (L12) and the other an odd-electron product with a 119 Da mass 
tag (L11•).  Greater than 65% of the ion current is comprised of these two key products 
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for BAH-cross-linked peptides that possess a mobile proton which is presumed to be at 
least partially localized at the hydrazone functionality.  The hydrazone bond cleaves more 
efficiently than the disulfide bond in analogous DSP-cross-linked peptides.  The high 
propensity for dissociation of the N12–N13 hydrazone bond is presumed to be due to 
capture of the electron directly at the protonated hydrazone functionality and subsequent 
rearrangement. This pathway does not require the migration of a hydrogen atom to 
initiate dissociation as is proposed for the conventional production of c- and z•-type 
fragment ions upon ETD of peptides.  Upon subsequent CID, these primary ETD product 
ions, L12 and L11•, afford near complete sequence coverage of each constituent 
peptide.  CID of the L11• ion yielded a-, b-, c-, y-, and z-type ions, and CID of the 
complementary L12 ion produced predominantly a-, b-, and y-type ions, with 
conclusive identification of the cross-linking site.  CID of the intact cross-linked peptides 
did not afford full sequence coverage of each peptide nor identification of the cross-link 
site.   The ETD-CID technique decouples the two constituent peptides and treats the 
cross-linked peptide instead as two modified peptides which can be sequenced 
individually, thus allowing the potential use of database search algorithms for peptide 
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Infrared Multiphoton Dissociation of Peptide Cations in a Dual 
Pressure Linear Ion Trap Mass Spectrometer 
7.1 OVERVIEW
A dual pressure linear ion trap mass spectrometer was modified to permit infrared 
multiphoton dissociation (IRMPD) in each of the two cells – the first a high pressure cell 
operated at nominally 5 
 10-3 Torr and the second a low pressure cell operated at 
nominally 3 
 10-4 Torr.   When IRMPD was performed in the high pressure cell, most 
peptide ions did not undergo significant photodissociation; however, in the low pressure 
cell peptide cations were efficiently dissociated with less than 25 ms of IR irradiation 
regardless of charge state.  IRMPD of peptide cations allowed the detection of low m/z 
product ions including the y1 fragments and immonium ions which are not typically 
observed by ion trap collision induced dissociation (CID).  Photodissociation efficiencies 
of ~100% and MS/MS (tandem mass spectrometry) efficiencies of greater than 60% were 
observed for both multiply and singly protonated peptides.  In general, higher sequence 
coverage of peptides was obtained using IRMPD over CID.  Further, greater than 90% of 
the product ion current in the IRMPD mass spectra of doubly charged peptide ions was 
composed of singly charged product ions compared to the CID mass spectra in which the 
abundances of the multiply and singly charged product ions were  equally divided.  
Highly charged primary product ions also underwent efficient photodissociation to yield 





As the field of proteomics continues to expand, there has become a growing need 
for more advanced mass spectrometric techniques for the characterization of biological 
molecules.1, 2  Tandem mass spectrometry methods have played a crucial role in the 
sequencing of proteolytic peptides and identification of proteins.3, 4  The most common 
means of fragmenting gas-phase peptide ions is collision-induced dissociation (CID) in 
which selected ions gain internal energy through collisions with rare gas atoms.5  
However, the amino acid sequence and charge state can greatly influence dissociation; 
CID is often limited by incomplete backbone fragmentation, preferential backbone 
cleavage at proline or acidic residues,6, 7 or dominant loss of labile groups which results 
in  low peptide sequence coverage.8  These limitations of CID have sparked interest in the 
development of alternative and more universal ion activation and dissociation methods in 
recent years.9, 10  New electron-based activation methods such as electron capture 
dissociation (ECD)11 and electron transfer dissociation (ETD)12 have shown significant 
promise as each method maintains labile side-chain modifications during ion activation; 
however, both techniques are limited to the analysis of multiply charged peptides.13  
More recently, electron ionization dissociation (EID) has been developed which utilizes 
fast electrons to dissociate singly charged peptide cations but the backbone fragment 
yields obtained were generally less than 5%.14 
There has also been considerable interest in exploiting photons for ion activation, 
including infrared multiphoton dissociation (IRMPD),15-19 ultraviolet photodissociation 
(UVPD),20-24 and more recently the use of femtosecond pulsed lasers,25 and hybrid 
UVPD-CID methods.26  One of the primary advantages of performing IRMPD in 
quadrupole ion traps (QITs)16-19, 27-29 is the ability to fine-tune the energy deposition by 
varying the irradiation time or number of laser pulses, the laser power or flux, and 
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wavelength.  In addition, compared to CID, photodissociation is largely independent of 
the rf trapping voltage during ion activation which provides a broader m/z trapping 
range,18, 30 an advantage also recognized for ETD.  Energy deposition by conventional 
CID is more efficient at higher rf trapping voltages (i.e., q-values) which prevents storage 
of product ions of m/z below the low-mass cut-off (LMCO), which is approximately the 
lower 28% of the m/z trapping range relative to the precursor ion.  CID can be performed 
at lower q-values but with lower dissociation efficiencies.  In addition, pulsed Q-
dissociation (PQD)31 and high amplitude short time excitation (HASTE)32 have shown 
promise as alternative collision based fragmentation methods which do not suffer as 
greatly from the low-mass cut-off problem; however both of these techniques afford 
modest MS/MS efficiencies.  IRMPD can be efficiently performed at low rf trapping 
voltages because the activation process is not defined by the rf trapping parameters, 
allowing observation of many informative low-mass fragments including immonium ions 
and y1 fragment ions of peptides.  Photodissociation is also a non-resonant process in 
which the precursor ion and all product ions are irradiated and activated simultaneously; 
thus, dead-end dissociation pathways such as dehydration are largely circumvented as 
these primary product ions can undergo secondary dissociation to yield more diagnostic 
fragments.  In addition, the photon absorption process does not affect the translational 
motion of ions and alleviates ion losses due to unstable trajectories that might be 
encountered in traditional CID. 
Infrared multiphoton dissociation has not been widely implemented in quadrupole 
ion traps due to low fragmentation efficiencies of certain analytes including peptides and 
proteins.  For optimal performance, quadrupole ion trap mass spectrometers are typically 
operated at a pressure of ~1 – 5 mTorr of He to effectively trap ions and reduce their 
kinetic energy via collisions with the buffer gas atoms.33  This high pressure, however, 
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can cause ion deactivation through collisional cooling at a nearly equivalent or greater 
rate than that of ion activation by IR photon absorption, ultimately resulting in the 
observation of low dissociation efficiencies for IRMPD.10, 34  Several methods have been 
developed to improve the efficiency of IRMPD in quadrupole ion traps.  The pressure in 
the QIT has been adjusted during the scan function through pulsed gas introduction35 or 
dynamic pressure control36 in which the bath gas is introduced during ion accumulation 
and then pumped away prior to IR irradiation.  Payne et al. utilized thermally-assisted 
IRMPD30 and Hashimoto and coworkers collisionally-activated the precursor ions during 
IR irradiation37 to increase the internal energy of the ions to provide efficient 
photodissociation at standard QIT operating pressures.  Newsome and Glish recently 
reported focusing the IR laser to the center of the ion trap as a simple means to improve 
IRMPD of peptides by increasing the overlap of the ion cloud with the laser beam and 
exposing the ions to a higher photon flux.19  Previous work in the Brodbelt group has 
focused on the development of chemical derivatization techniques that attach 
chromogenic labels to increase the IR absorption cross sections or reduce the critical 
energies for dissociation.38-40  Super-charged peptides can also be efficiently 
photodissociated in a linear quadrupole ion trap due to a reduction in the dissociation 
threshold and an increase in the number of mobile protons.41 
In this chapter, it is demonstrated that unmodified peptides can be efficiently and 
rapidly dissociated by IR irradiation in the low pressure cell of a dual pressure linear ion 
trap (LIT).  The dual pressure LIT comprises a low pressure cell and high pressure cell to 
combine the advantages of both pressure regimes.42  High trapping, isolation, and CID 
efficiencies are obtained in the high pressure cell (~5×10-3 Torr), while the low pressure 
cell (~3×10-4 Torr) offers improved scanning speed and mass resolution.  Little 
photodissociation of peptide ions occurs in the high pressure cell, while highly efficient 
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IRMPD is observed in the low pressure cell yielding complete dissociation of the 
precursor ions  with less than 25 ms of irradiation.  Higher sequence coverage of peptides 
is obtained by performing IRMPD in the low pressure cell as compared to traditional CID 
in the high pressure cell. 
 
7.3 EXPERIMENTAL
7.3.1 Chemicals and Reagents 
All materials and peptides were used without further purification.  The peptides 
RPKPQQFFGLM-NH2 (substance P), FSWGAEGQR, YGGFLK, ASHLGLAR, and 
AGCKNFFWKTFTSC (somatostatin-14) were obtained from Bachem (King of Prussia, 
PA).  DRVYIHPF (angiotensin II), ADSGEGDFLAEGGGVR (fibrinopeptide A), and 
RPPGFSPFR (bradykinin) were purchased from American Peptide Co. (Sunnyvale, CA).  
All solvents and other chemicals including melittin (honey bee venom) were from Sigma-
Aldrich (St. Louis, MO). 
 
7.3.2 Mass Spectrometry and Infrared Multiphoton Dissociation 
All samples were prepared at ~10 μM in 49.5:49.5:1 H2O/MeOH/acetic acid 
(v/v/v) and infused at 3 μL/min using the standard electrospray ionization source.  Unless 
indicated otherwise, all mass spectrometry experiments were performed on a modified 
LTQ Velos dual pressure linear ion trap (Thermo Fisher Scientific, San Jose, CA).  A 
schematic of the instrument is shown in Figure 7.1; details of the instrument have been 
described previously.42  In brief, the octapole preceding the linear ion trap was reduced in 
length to accommodate an additional linear ion trap.  The two traps are of a symmetrical 
design and have independent DC power supplies for the six total sections, but have a 
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single common rf power supply.  The pressure of each cell of the dual pressure LIT was 
regulated by the conductance limits of the front, center, and back lenses.  The high 
pressure cell was maintained at 5 to 6 mTorr He and the low pressure cell at ~0.3 mTorr 
He.  Precursor ions were isolated and cooled in the high pressure cell while mass analysis 
was performed in the low pressure cell; ion activation and dissociation could be 
performed in either cell.  The ion source optics include a progressively spaced stacked 
ring ion guide for the improved ion transmission.43  Photodissociation was implemented 
on this dual LIT in a manner similar to that described previously.44  The back flange of 
the mass spectrometer was modified with a ZnSe window to transmit IR irradiation 
through a 1.8 mm stainless steel aperture on-axis with the dual pressure LIT.  For all 
IRMPD experiments, the laser power was maintained at 100% (50 W); both the 
irradiation time (0 – 250 ms) and the q-value (0.05 – 0.25) of the precursor ion were 
varied.  Collision-induced dissociation experiments were conducted solely in the high 
pressure cell; ions were activated for 30 ms at a q-value of 0.25.  IRMPD was performed 
with a model 48-5 Synrad 50-W CO2 continuous wave laser (Mukilteo, WA) which emits 
at 10.6 m.  Other time-resolved IRMPD and MS3 experiments were performed on a 
standard LTQ XL mass spectrometer (i.e. single trap) modified for photodissociation 
operating at ~2.5 mTorr He. 
7.3.3 Data Analysis 
IRMPD was performed in each of the two cells.  Dissociation efficiencies were 
















    Equation 7.1 
where P is the abundance of the surviving precursor ion after ion activation, and Fi is the 
abundance of each product ion.  The efficiency of the tandem MS experiment (i.e., 












     Equation 7.2 
where P0 is the abundance of the precursor ion prior to any IR irradiation or collisional 
activation, and Fi is the abundance of each product ion.45  The sum of the product ion 
abundance (i.e., Fi) was determined by subtracting the abundance of any remaining 
precursor ion from the total ion abundance for the efficiency calculations.  Ion 
abundances were determined by calculating the peak areas using Origin 7.0.  Time-
resolved IRMPD experiments were performed by incrementally increasing the irradiation 
time and the abundances of different ion types were plotted against irradiation time.  
Similarly, q-value resolved IRMPD was performed by sequentially raising the activation 
q-value and acquiring IRMPD mass spectra at each q-value.  All time-resolved and q-
value resolved IRMPD experiments were performed in triplicate.  The precursor ion 
abundance was plotted relative to the initial precursor abundance without any ion 
activation or irradiation (P0), while the product ion abundances were plotted relative to 
the total ion current (sum of all fragment ions and precursor, P) in each IRMPD mass 
spectrum.  The abundances and number of product ions in each charge state were also 
determined by summing the abundances (i.e., peak areas) or counting the number of 
product ions in each charge state.  If a peak’s charge state could not be resolved, its area 
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was not included in the abundance calculation nor was it counted.  All spectra are an 
average of ten scans.  Peptide fragment nomenclature includes superscripts “*” and “°” to 
designate ammonia loss and water loss, respectively.  Immonium ions are labeled with 
the single letter amino acid residue with a subscript i.   
7.4 RESULTS AND DISCUSSION
7.4.1 IRMPD in the Low Pressure Cell vs. High Pressure Cell 
The primary drawback to performing IRMPD in quadrupole ion traps has been 
low dissociation efficiencies due to competition between ion activation through IR 
photon absorption and deactivation through collisions with the buffer gas.  To evaluate 
the performance of IRMPD in the low pressure cell of the dual pressure LIT, a series of 
model peptides was analyzed.  Product ion mass spectra of the peptides in various charge 
states were acquired by performing IRMPD in each of the two cells.  IRMPD of doubly 
Figure 7.1 Schematic of a dual pressure linear ion trap mass spectrometer modified for 
infrared multiphoton dissociation. 
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protonated ADSGEGDFLAEGGGVR (fibrinopeptide A) performed in the high pressure 
cell using 250 ms of irradiation (Figure 7.2a) resulted in less than 1.5% dissociation 
efficiency (precursor to product); in fact, only a single product ion was observed 
corresponding to dehydration of the precursor ion.  The results in the high pressure cell 
mirror those obtained in a single linear ion trap operated at ~2.5 mTorr He (using the 
same laser and similar set-up) in which peptides were not observed to photodissociate 
even with long irradiation times of 250 ms44 due to the high rate of collisional cooling.  In 
contrast, when IRMPD was performed in the low pressure cell, only 12.5 ms of 
irradiation was required to dissociate the precursor to less than 6% relative abundance 
(Figure 7.2b).  All possible b-type ions and 14 out of 15 possible y-type ions were 
observed in the IRMPD tandem mass spectrum acquired in the low pressure cell.  Low 
m/z products including immonium ions, which can be produced through secondary 
Figure 7.2 IRMPD of [ADSGEGDFLAEGGGVR + 2H]2+ of m/z 769.2 performed in 
the (A) high pressure cell (250 ms irradiation, q = 0.25, 50 W) and (B) low 
pressure cell (12.5 ms irradiation, q = 0.09, 50 W).  The precursor ion is 
indicated with a star () and internal ions are labeled with #. 
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dissociation of larger b- and y-type ions, are observed.  The non-resonant nature of 
IRMPD also resulted in a high degree of secondary neutral losses from b- and y-type 
fragment ions, including multiple losses of water (e.g., b9o and b9oo in Figure 1B). 
The IRMPD efficiencies obtained for each of the model peptides when 
dissociated in the low pressure and high pressure cell are shown in Table 7.1.  In the high 
pressure cell, only three of the peptide ions ([RPPGFSPFR + 3H]3+, [RPKPQQFFGLM-
NH2 + 3H]3+, and [ADSGEGDFLAEGGGVR + 3H]3+) exhibited a photodissociation 
efficiency of greater than 50%, even using a long irradiation time of 250 ms and a more 
optimum q-value of 0.25 which should promote better overlap between the ion cloud and 
the laser beam (discussed in more detail in a later section).  The greatest IRMPD 
efficiencies in the high pressure cell were obtained for three peptides in their highest 
charge states, an observation consistent with previous work on super-charged peptide 
cations,41 while a majority of the lower-charged peptide cations exhibited dissociation 
efficiencies of less than 5% in the high pressure cell.  When performing IRMPD in the 
low pressure cell, only one of the peptides dissociated with an efficiency less than 70%.  
All of these IRMPD mass spectra were acquired using less than 25 ms irradiation and 
using low q-values, the latter factor allowing successful storage and detection of the very 
lowest m/z product ions.  In fact, 23 of the 25 peptide precursor ions displayed 
dissociation efficiencies of greater than 90% at q-values of 0.10 or lower.  In general, the 
more highly charged peptides require shorter irradiation times to yield dissociation 
efficiencies of ~90%; however, to a lesser extent the q-value of the precursor ion also 
influences the irradiation time necessary to produce high IRMPD efficiencies. 
The time-resolved IRMPD plots in Figure 7.3 (for DRVYIHPF) and Figure 7.4 
(for ADSGEGDFLAEGGGVR) also show the effect of irradiation time on the 
photodissociation and MS/MS efficiencies.  As shown in Figure 7.3a, [DRVYIHPF + 
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2H]2+ required less than 20 ms of irradiation to yield ~100% photodissociation efficiency 
and the corresponding triply charged precursor only required  ~12 ms of irradiation 
(Figure 2B).  The more highly charged peptides dissociated more readily and this is 
attributed to higher Coulombic repulsion and greater proton mobility.  For 
Table 7.1 IRMPD efficiencies of model peptides dissociated in the low pressure and 














2+ 15 0.1 98 250 0.25 2.6
1+ 25 0.1 94 250 0.25 1.5
1+ 35 0.07 76 --- --- ---
1+ 50 0.07 94 --- --- ---
2+ 12.5 0.1 93 250 0.25 2.9
1+ 40 0.06 70 250 0.25 3
1+ 50 0.06 82 --- --- ---
2+ 12.5 0.09 98 250 0.25 6.3
1+ 25 0.06 80 250 0.25 0.8
3+ 7.5 0.1 97 250 0.25 26
2+ 15 0.1 96 250 0.25 1.3
1+ 25 0.1 92 250 0.25 4.3
3+ 7.5 0.1 98 250 0.25 94
2+ 17.5 0.09 92 250 0.25 0.9
1+ 20 0.09 96 250 0.25 4.9
3+ 5 0.1 97 250 0.25 96
3+ --- --- --- 50 0.1 87
2+ 17.5 0.07 93 250 0.25 2.6
1+ 30 0.07 96 250 0.25 2.7
3+ 12.5 0.09 99 250 0.25 57
2+ 25 0.06 99 250 0.25 1.3
2+ 12.5 0.09 94 --- --- ---
1+ 25 0.06 91 250 0.25 3
3+ 12.5 0.09 97 250 0.25 5.4
2+ 13.5 0.09 90 250 0.25 0.9
2+ 22.5 0.06 90 --- --- ---
1+ 25 0.06 93 250 0.25 22
5+ 9 0.09 96 250 0.25 17
4+ 20 0.07 98 250 0.25 1.3
3+ 15 0.1 96 250 0.25 3




























ADSGEGDFLAEGGGVR (fibrinopeptide A), complete dissociation of the singly 
charged precursor ion required less than 25 ms of irradiation, and the doubly charged 
analog required ~20 ms of irradiation at a q-value of 0.10 (Figure 7.4b and 7.4d, 
respectively). At lower q-values, longer irradiation times were required to dissociate 
fibrinopeptide A, indicating a q-value dependence on the photodissociation efficiencies 
(Figures 7.4a and 7.4c).  For both of these peptides – fibrinopeptide A and angiotensin II 
– maximum MS/MS efficiencies between 48% and 78% were obtained using a q-value of 
0.10.  The maximum MS/MS efficiencies were obtained when the dissociation 
efficiencies were between 75% and 96%.  With longer irradiation times, the MS/MS 
efficiencies began to steadily decrease which was a result of a decrease in the total 
product ion abundance.  This latter decrease is attributed to the production of low m/z 
Figure 7.3 Time-resolved IRMPD plots of DRVYIHPF (angiotensin II) activated at a 
q-value of 0.10.  Precursor ion abundances (relative to initial precursor
abundance without any irradiation, squares ), photodissociation
efficiencies (triangles ) and MS/MS efficiencies (circles ) of (A) 
[M+2H]2+ and (B) [M+3H]3+. 
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fragment ions through secondary and higher order dissociation which fall below the 
LMCO in these spectra (~m/z 50 – 100).  The MS/MS efficiencies obtained in the dual 
pressure LIT compare favorably to those measured in a standard three-dimensional 
Figure 7.4 Time-resolved IRMPD plots of singly and doubly protonated
ADSGEGDFLAEGGGVR (fibrinopeptide A) activated at q-values of 0.06 
and 0.10. (A) 1+, q=0.06; (B) 1+, q=0.1; (C) 2+, q=0.06; and (D) 2+, q=0.10
showing relative precursor ion abundance (squares ), photodissociation 
efficiencies (triangles ) and MS/MS efficiencies (circles ).  The 
abundances of the precursor ion are relative to the abundance of the
precursor ion in the IRMPD mass spectrum of 0.0 ms irradiation. 
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quadrupole ion trap for singly charged peptide ions using a focused IR laser in which a 
maximum MS/MS efficiency of 43% was obtained.19   
 
7.4.2 Comparison of IRMPD to CID 
IRMPD performed in the low pressure cell was compared to conventional CID 
results obtained in the high pressure cell for the series of model peptides.  Shown in 
Figure 7.5a is the IRMPD mass spectrum of [RPPGFSPFR + 3H]3+, and the 
complementary CID mass spectrum is shown in Figure 7.5b.  The CID mass spectrum is 
dominated by neutral water loss from the precursor ion, whereas the ion current is 
distributed among a variety of diagnostic product ions in the IRMPD mass spectrum.  
Immonium ions and several internal fragment ions are observed in the IRMPD mass 
spectrum that are not detected in the CID mass spectrum.  Also, many y-type ions in 
Figure 7.5 (A) IRMPD (7.5 ms irradiation, q = 0.1, 50 W) and (B) CID (30 ms, q = 
0.25, 8% normalized collision energy) mass spectra of [RPPGFSPFR + 
3H]3+ of m/z 354.3.  The precursor ion is indicated with a star () and 
internal ions are labeled with #. 
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conjunction with water losses are detected in the IRMPD spectrum which, presumably 
arise from secondary dissociation of the initial y-type ions upon absorption of additional 
IR photons.  Experimental evidence suggests that a majority of the product ions observed 
in the IRMPD mass spectrum are actually produced upon secondary dissociation of 
[RPPGFSPFR – H2O + 3H]3+ ions.  The [RPPGFSPFR – H2O + 3H]3+ ions were isolated 
and subjected to a discrete second stage of activation via IRMPD or CID, and the 
resulting MS3 product ion spectra are shown in the Figure 7.6.  CID of [RPPGFSPFR – 
H2O + 3H]3+ yielded three yo-type ions (i.e., y-type ions with a water loss) as well as the 
phenylalanine immonium ion (Fi) and the b2 ion (Figure 7.6a – 7.6c).  In fact, most of the 
product ions observed in the MS3 product ion spectra match those detected in the IRMPD 
mass spectrum shown in Figure 7.5a.  These results indicate that triply charged 
bradykinin (RPPGFSPFR) primarily undergoes dehydration, and then this dehydrated 
product subsequently dissociates to yield informative sequence ions.  Wideband CID of 
[RPPGFSPFR + 3H]3+ was also performed, and it provided higher sequence coverage 
than CID alone and similar coverage to MS3 and IRMPD experiments (Figure 7.6d).  
However, as this technique employs a broadband excitation waveform to collisionally 
activate the m/z region between the precursor ion and neutral loss (e.g. H2O, NH3) 
product ions, no ions were observed between m/z 330 and 360 including any diagnostic 
sequences ions such as y62+ of m/z 355.7 which is detected in the IRMPD mass spectrum 
(Figure 7.5a).  For peptide ions which predominantly dissociate through a single 
pathway (e.g., dehydration), non-resonant ion activation techniques such as 
photodissociation provide a means to increase the number of diagnostic product ions. 
The percentages of b- and y-type fragments, as defined by the number of b- and y-
type fragment ions detected divided by the total number of possible b- and y-type 
fragments, observed in the IRMPD and CID mass spectra of the model peptides are 
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Figure 7.6 MS3  and wideband CID product ion mass spectra of [RPPGFSPFR – H2O + 
3H]3+.  (A) CID of [M+3H]3+ (30 ms, 15% NCE, q=0.25) and subsequent 
CID of [M-H2O+3H]3+ (30 ms, 15% NCE, q=0.25).  (B) IRMPD of
[M+3H]3+ (20 ms, 50 W, q=0.1) and subsequent CID of [M-H2O+3H]3+ (30 
ms, 15% normalized collision energy, q=0.25).  (C) IRMPD of [M+3H]3+
(20 ms, 50 W, q=0.1) and subsequent IRMPD of [M-H2O+3H]3+ (100 ms, 
50 W, q=0.25).  (D) Wideband CID of [M+3H]3+ (30 ms, 18% NCE, 
q=0.25)   The precursor ion is indicated with a star () and M represents 
RPPGFSPFR (bradykinin).  These product ion spectra were acquired using a 
standard LTQ XL mass spectrometer (single linear ion trap instrument)
modified for photodissociation (He pressure ~2.5 mTorr). 
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summarized in Figure 7.7.  (If a fragment was observed in two or more charge states, it 
was only counted once to more accurately give an account of the sequence coverage.)   
For almost every peptide investigated, a higher percentage of b- and y-type ions was 
observed by IRMPD. IRMPD showed significant increases in the number of b- and y-
type fragments observed for all charge states of RPPGFSPFR (bradykinin) and 
RPKPQQFFGLM-NH2 (substance P), as well as for singly charged DRVYIHPF 
(angiotensin II) and ASHLGLAR.  For [RPPGFSPFR + 3H]3+, the percentage of b- and 
y-type ions more than doubled for IRMPD in comparison to CID, with fourteen b- and y-
type ions observed upon IRMPD but only six b- and y-type ions upon CID.  In the two 
instances that CID outperformed IRMPD (i.e. singly and doubly charged 
Figure 7.7 Percent of b- and y-type ions of model peptides observed by IRMPD 
(performed in the low pressure cell; black bars) and CID (performed in the
high pressure cell; gray bars).  IRMPD mass spectra were acquired using q-
values between 0.07 and 0.10 (depending on the precursor m/z) to reduce the 
low-mass cut-off to less than m/z 100.  A value of 100% would indicate that 
all b- and y-type ions were detected (including b1) as all amide bonds were 
considered to be potential sites of cleavage. 
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FSWGAEGQR), it was due to formation of a single additional b- or y-type fragment.   
Increases in the CID activation time did not yield increased sequence coverage or 
significant changes in the relative abundances or types of product ions observed.  For 
doubly charged fibrinopeptide A (ADSGEGDFLAEGGGVR), almost identical CID mass 
spectra were obtained when applying the collisional activation waveforms for between 25 
– 100 ms; at shorter activation times, little dissociation was observed (data not shown).  
Similarly, variation in the normalized collision energy (20 – 100%) did not produce 
greater secondary dissociation or alter the product ion distribution for 
ADSGEGDFLAEGGGVR or DRVYIHPF peptide cations once the dissociation 
threshold (typically less than 20% NCE) was reached (data not shown). 
 
7.4.3 Charge State Distribution of Product Ions 
One of the more striking differences observed between the IRMPD and CID mass 
spectra of multiply protonated peptides is that almost all of the product ions in the 
IRMPD mass spectra are singly charged as compared to the CID mass spectra in which 
product ions of multiple charge states are typically observed.  The IRMPD and CID mass 
spectra of [ADSGEGDFLAEGGGVR + 3H]3+ illustrate this observation in Figure 7.8a 
and 7.8b, respectively.  In the CID mass spectrum, product ions are seen in the 2+ and 1+ 
charge states, with some sequence ions observed in both charge states (e.g., b9, b10, b11, 
and y10).  However, in the IRMPD mass spectrum not a single product ion is observed to 
be multiply charged – all product ions are singly charged.  One example of this lack of 
multiply charged peptide fragment ions is particularly evident in the range between m/z 
440 and 610 in which more than ten abundant product ions are observed in the CID mass 
spectrum in the 1+ and 2+ charge states whereas only four fragment ions are detected in 
the IRMPD mass spectrum, all singly charged.   
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The distributions and numbers of singly, doubly, and triply charged product ions 
were determined for the IRMPD and CID mass spectra of an array of peptide ions.  The 
distributions (abundances expressed as percentages) of product ions in each charge state 
are shown in Figure 7.9a and 7.9b for fragment ions produced by IRMPD and CID, 
respectively.  Moreover, the number of products ions in each charge state (relative to the 
total number of fragment ions observed in each spectrum) are shown in Figure 7.9c and 
7.9d (IRMPD and CID data, respectively).  For the doubly charged precursor ions, the 
singly charged product ions comprise 96.6  3.3% of the product ion current (defined as 
the total ion current minus the abundance of any surviving precursor) in the IRMPD mass 
spectra, whereas in the CID mass spectra the average abundance of singly charged 
fragment ions was 50  23%.  Doubly charged and singly charged product ions accounted 
for 30  27% and 67  30% of the product ion current, respectively, in the IRMPD mass 
Figure 7.8 (A) IRMPD (12.5 ms irradiation, q = 0.09, 50 W) and (B) CID (30 ms, q =
0.25, 25% normalized collision energy) mass spectra of 
[ADSGEGDFLAEGGGVR + 3H]3+ of m/z 512.9.  The precursor ion is 
indicated with a star () and internal ions are labeled with #. 
 198
Figure 7.9 Ion abundances of singly (black bars), doubly (gray bars), and triply charged
fragment ions (white bars) relative to the total ion abundance (upper panels
A and B) and number of fragment ions in each charge relative to the total 
number of product ions (lower panels C and D) observed in IRMPD (left 
panels A and C) and CID (right panels B and D) mass spectra. 
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spectra of the triply charged peptide ions; triply charged product ions accounted for an 
insignificant abundance.  In contrast, the product ion current in the CID mass spectra, on 
average, was composed of 22  23% of singly charged fragment ions, 45  22% of 
doubly charged fragment ions, and 33  30% of triply charged fragment ions.  The lack 
of multiply charged product ions in the IRMPD mass spectra was further substantiated 
when the number of product ions in each charge state was counted and expressed as a 
percentage of the total number of product ions.  Greater than 96% of the product ions 
were singly charged in the IRMPD mass spectra of doubly charged peptides, and more 
than 80% were singly charged in the IRMPD mass spectra of the triply charged peptides.  
In the CID mass spectra of doubly charged peptides, 75% of the product ions were singly 
charged, and for the triply charged peptides, the distribution of product ions was 35%, 
48%, and 17% for singly, doubly, and triply charged product ions.  Overall, CID yields 
product ions in a greater variety of charge states, whereas more than 80% of the fragment 
ions are singly charged in the IRMPD mass spectra with these ions accounting for over 
85% of the product ion current.  The lack of multiply charged product ions in the IRMPD 
mass spectra could be useful for potential de novo sequencing or database searches in 
which only singly charged fragment ions would be considered. 
The relative product ion abundances of 1+, 2+, and 3+ charged product ions of 
[DRVYIHPF + 2H]2+ and [DRVYIHPF + 3H]3+ are plotted as a function of irradiation 
time in Figure 7.10.  As the irradiation time increases from 0 to 4 ms, the abundances of 
both the 1+ and 2+ product ions of doubly protonated DRVYIHPF (angiotensin II) 
increase almost linearly; however, for irradiation times longer than 5 ms, the relative 
abundance of the 2+ charged product ions decreases to less than 1% of the total product 
ion current at irradiation times exceeding 20 ms (Figure 7.10a).  For [DRVYIHPF + 
3H]3+, at short irradiation times, doubly charged product ions are actually observed at a 
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higher abundance than singly charged fragments (Figure 7.10b).  At irradiation times 
longer than 3 ms, however, the abundance of 2+ product ions declines as these species 
are apparently converted into singly charged product ions via secondary dissociation.  
The only triply charged product ion observed in the IRMPD mass spectra of 
[DRVYIHPF+ 3H]3+ is the dehydrated precursor ion.  By monitoring the abundances of 
individual product ions in specific charge states as produced upon IRMPD, it is observed 
that product ions in higher charge states consistently dissociate more readily than those 
same product ions in lower charge states (e.g. b112+ versus b11+ from 
ADSGEGDFLAEGGGVR, see Figures 7.11 and 7.12).  The difference in PD 
efficiencies of doubly vs. singly charged product ions is attributed to a number of factors.  
In addition to experiencing greater Coulombic repulsion which could reduce the 
threshold for dissociation, most multiply charged product ions have a greater number of 
mobile protons which can facilitate their subsequent fragmentation. 
Figure 7.10 Time-resolved IRMPD plots of DRVYIHPF (angiotensin II) activated at a 
q-value of 0.10.  Relative product ion abundances of singly (squares ), 
doubly (circles ), and triply charged product ions (triangles ) of (A) 
[M+2H]2+ and (B) [M+3H]3+.  
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Figure 7.12 Photodissociation efficiencies determined from time-resolved IRMPD 
experiments of (A) b112+ (filled squares ) and b11 (filled circles ), and (B) 
y72+ (open squares ) and y7 (open circles ) of ADSGEGDFLAEGGGVR 
(fibrinopeptide A).  Product ions were activated at a q-value of 0.25 at a 
laser power of 50 W in a standard LTQ XL (single linear ion trap 
instrument) modified for photodissociation (He pressure ~2.5 mTorr). 
Figure 7.11 Relative abundances of selected product ions of (A) [DRVYIHPF + 2H]2+
and (B) [DRVYIHPF + 3H]3+ from time-resolved IRMPD experiments. 
Precursor ions were activated at a q-value of 0.1.  The immonium ion 
abundance in (A) is the sum of the abundances of the immonium ions of
isoleucine, histidine, and tyrosine.  Abundances are relative to the total ion 
current in each IRMPD mass spectrum. 
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7.4.4 Effect of Q-Value on IRMPD Efficiencies 
The photodissociation efficiencies of peptides is dependent on the activation q-
value.  While it has been widely assumed that photodissociation is completely 
independent of ion trap operating parameters, recent work by Remes and Glish showed 
that the q-value (i.e., rf trapping voltage) greatly influences ion position within the ion 
trap.45  At higher q-values, which create greater potential well depths, the ions spend 
more time in the center of the trap where there is better overlap between the ion cloud 
and the photon beam.  While a better overlap and consequently greater photodissociation 
efficiencies are observed at high q-values, these increases in performance are obtained at 
the expense of trapping low m/z fragment ions (i.e., at higher q-values the low mass 
cutoff is increased and a narrower range of ions can be effectively trapped and detected).  
To investigate the effect of the rf trapping level during photodissociation in the dual 
pressure LIT, IRMPD mass spectra were acquired at q-values between 0.10 and 0.24.  
The resulting plots for [DRVYIHPF + 2H]2+ and [DRVYIHPF + 3H]3+ are shown in 
Figure 7.13a and 7.13b, respectively.  For these experiments, the MS/MS efficiencies 
could not be directly calculated as changes in the IRMPD q-value can result in changes in 
the trapping efficiency of the LIT.  However, eq. (2) can be used to calculate MS/MS 
 
trapping efficiencies in which P0 was determined from the IRMPD mass spectrum 
acquired at the lowest q-value; these values are plotted as a function of q-value in Figure 
8.  For [DRVYIHPF+ 2H]2+, as the q-value is increased from 0.05 to 0.10, there is a 
drastic decrease in the relative abundance of the precursor ions and a corresponding 
increase in photodissociation efficiencies from less than 5% to over 75% (Figure 7.13a).  
At q-values of greater than 0.12, PD efficiencies of ~100% are obtained.  IRMPD 
experiments were not conducted at q-values of greater than 0.24 in these experiments as 
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no increase in photodissociation efficiencies was observed and the MS/MS efficiencies 
were observed to decrease at greater q-values.  In addition, at q-values above 0.25 effects 
of an increased low mass cutoff would be expected.  The MS/MS 
 trapping efficiencies 
increase to greater than 95% at q-values between 0.08 and 0.11 for doubly protonated 
angiotensin II (Figure 7.13a).  The total abundance of product ions falls at q-values 
greater than 0.09 as indicated by the decrease in the MS/MS 
 trapping efficiency.  This 
decrease is attributed to secondary dissociation of product ions resulting in formation of 
smaller ions of m/z below that of the low mass cutoff.  However, even at q-values as high 
as 0.24, the MS/MS 
 trapping efficiency is greater than 50%.  Similar results are 
obtained for triply protonated DRVYIHPF (angiotensin II) as shown in Figure 7.13b.  At 
q-values greater than 0.12, the photodissociation efficiencies are ~100%, and the 
precursor ion is completely dissociated.  The MS/MS 
 trapping efficiencies varied 
somewhat more erratically due to larger variations in the total ion current of each mass 
Figure 7.13 Photodissociation efficiencies (triangles ), MS/MS 
 trapping efficiencies 
(circles ), and relative precursor ion abundances (squares ) as a function 
of q-value of (A) [DRVYIHPF + 2H]2+ using 15.0 ms of IR irradiation and 
(B) [DRVYIHPF + 3H]3+ using 7.5 ms of irradiation.  Precursor ion 
abundances are relative to the initial precursor abundance at q = 0.05
without any irradiation. 
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spectrum, but the same general trend is observed in which the total abundance of the 
product ions increases with q-value and then gradually declines as lower m/z fragment 
ions are likely produced (but not detected).  (The q-value was also varied for CID 
experiments conducted in a single linear ion trap mass spectrometer for [DRVYIHPF+ 
2H]2+ and [DRVYIHPF+ 3H]3+, and at low q-values (< 0.15) almost no signal was 
observed.  This is attributed to the low potential well-depth in which the precursor ion 
resides. Upon collisional activation, the precursor ions are lost due to unstable 
trajectories.  Efficient dissociation (>75%) was observed only at q-values greater than 
0.20; data not shown.) 
The effect of the q-value on photodissociation is also shown in the time-resolved 
IRMPD plots of singly and doubly protonated ADSGEGDFLAEGGGVR (fibrinopeptide 
A) at two different q-values (Figure 7.4).  Approximately 19 ms of irradiation was 
required to reduce [ADSGEGDFLAEGGGVR + H]+ to 50% relative abundance when 
activated at a q-value of 0.06 (Figure 7.4a), but only 12 ms of IR irradiation was required 
at a q-value of 0.10 (Figure 7.4b).  For [ADSGEGDFLAEGGGVR + 2H]2+, 16 ms of 
irradiation was necessary to reduce the precursor to 50% abundance at q = 0.06 and only 
9 ms was required at q = 0.10 (Figure 7.4c and 7.4d, respectively).  These results clearly 
suggest that at higher q-values there is a greater overlap between the ion cloud and the 
laser beam, which results in higher photodissociation efficiencies.  Thus, upon further 
comparison of the IRMPD mass spectra in Figure 7.2a and 7.2b, the difference is even 
more striking as almost no dissociation was observed when IRMPD was performed in the 
high pressure cell even when the q-value was set to 0.25, whereas high sequence 
coverage and high PD efficiency were obtained in the low pressure cell at a q-value of 
0.09 using only 12.5 ms of irradiation. 
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7.4.5 Further Application and Implementation of IRMPD 
While these IRMPD studies were conducted on a small subset of model peptides, 
the results suggest that IRMPD on the dual pressure LIT would be well suited as a 
complementary technique to CID and ETD for the analysis of large scale proteomic 
samples (e.g. enzymatic digests of cell lysates).  In general, shorter irradiation times (~5 – 
10 ms) were required to completely dissociate triply charged peptide ions with masses of 
less than 2000 Da.  Longer irradiation times and slightly higher q-values were necessary 
to dissociate doubly charged peptides (~10 – 15 ms) than singly charged peptides (~20 – 
25 ms).  When peptide ions were irradiated for significantly longer intervals, the product 
ion mass spectra became cluttered with internal ions and low mass ions which could not 
be identified.  Further experiments need to be performed in order to determine 
appropriate irradiation conditions based on peptide precursor m/z to avoid extensive 
secondary dissociation for more widespread and commercial implementation of IRMPD, 
particularly for data-dependent LC-IRMPD-MS experiments.  However, a parallel study 
has shown that intact proteins readily dissociate upon IR irradiation in the low pressure 
cell indicating the IRMPD is a potentially useful method for top-down protein 
identification in ion trap mass spectrometers.46 
   
7.5 CONCLUSIONS
Infrared multiphoton dissociation has been successfully implemented in a dual 
pressure LIT mass spectrometer to afford rapid and efficient dissociation of peptides in 
the low pressure cell.  At lower trap pressures the rate of activation through IR photon 
absorption is greater than the rate of collisional cooling and thus peptides are readily 
dissociated.  Dissociation efficiencies approaching 100% and MS/MS efficiencies of 
greater than 60% were obtained using irradiation times of less than 25 ms at a q-value of 
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0.10.  The dissociation efficiencies were observed to be dependent on the q-value; at 
higher q-values the ions spend more time near the center of the trap and the ion cloud has 
a greater overlap with the photon beam, resulting in more rapid dissociation.  Compared 
to CID, IRMPD allows the observation of low-mass fragment ions such as immonium 
ions and provides slightly higher sequence coverage of the peptides.  The higher 
sequence coverage was attributed to secondary and higher order dissociation inherent to 
non-resonant activation methods such as photodissociation.  IRMPD predominantly 
yielded singly charged fragment ions which aids in de-cluttering the product ion spectra 
and simplifying spectral interpretation.  Highly charged product ions were observed to 
photodissociate more readily than the singly charged species which was attributed to a 
combination of factors including higher Coulombic repulsion, as well as the influence of 




(1) Winston, R. L.; Fitzgerald, M. C. Mass Spectrometry Reviews 1997, 16, 165-179. 
(2) Godovac-Zimmermann, J.; Brown, L. R. Mass Spectrometry Reviews 2001, 20, 1-
57. 
(3) Aebersold, R.; Mann, M. Nature 2003, 422, 198-207. 
(4) Biemann, K. Methods in Enzymology 1990, 193, 455-479. 
(5) Wells, J. M.; McLuckey, S. A. Methods in Enzymology 2005, 402, 148-185. 
(6) Vaisar, T.; Urban, J. Journal of Mass Spectrometry 1996, 31, 1185-1187. 
(7) Tsaprailis, G.; Somogyi, A.; Nikolaev, E. N.; Wysocki, V. H. International
Journal of Mass Spectrometry 2000, 195/196, 467-479. 
(8) Kapp, E. A.; Schutz, F.; Reid, G. E.; Eddes, J. S.; Moritz, R. L.; O'Hair, R. A.; 
Speed, T. P.; Simpson, R. J. Analytical Chemistry 2003, 75, 6251-6264. 
(9) Sleno, L.; Volmer, D. A. Journal of Mass Spectrometry 2004, 39, 1091-1112. 
(10) McLuckey, S. A.; Goeringer, D. E. Journal of Mass Spectrometry 1997, 32, 461-
474. 
(11) Zubarev, R. A.; Kelleher, N. L.; McLafferty, F. W. Journal of the American 
Chemical Society 1998, 120, 3265-3266. 
(12) Syka, J. E. P.; Coon, J. J.; Schroeder, M. J.; Shabanowitz, J.; Hunt, D. F. 
Proceedings of the National Academy of Sciences of the United States of America 
2004, 101, 9528-9533. 
(13) Swaney, D. L.; McAlister, G. C.; Wirtala, M.; Schwartz, J. C.; Syka, J. E. P.; 
Coon, J. J. Analytical Chemistry 2007, 79, 477-485. 
(14) Fung, Y. M. E.; Adams, C. M.; Zubarev, R. A. Journal of the American Chemical 
Society 2009, 131, 9977-9985. 
(15) Little, D. P.; Speir, J. P.; Senko, M. W.; O'Connor, P. B.; McLafferty, F. W. 
Analytical Chemistry 1994, 66, 2809-2815. 
(16) Stephenson, J. L., Jr.; Booth, M. M.; Shalosky, J. A.; Eyler, J. R.; Yost, R. A. 
Journal of the American Society for Mass Spectrometry 1994, 5, 886-893. 
(17) Brodbelt, J. S.; Wilson, J. J. Mass Spectrometry Reviews 2009, 28, 390-424. 
 208
(18) Colorado, A.; Shen, J. X.; Brodbelt, J. Analytical Chemistry 1996, 68, 4033-4043. 
(19) Newsome, G. A.; Glish, G. L. Journal of the American Society for Mass 
Spectrometry 2009, 20, 1127-1131. 
(20) Reilly, J. P. Mass Spectrometry Reviews 2009, 28, 425-447. 
(21) Thompson, M. S.; Cui, W.; Reilly, J. P. Angewandte Chemie, International 
Edition 2004, 43, 4791-4794. 
(22) Moon, J. H.; Yoon, S. H.; Kim, M. S. Rapid Communications in Mass 
Spectrometry 2005, 19, 3248-3252. 
(23) Joly, L.; Antoine, R.; Broyer, M.; Dugourd, P.; Lemoine, J. Journal of Mass 
Spectrometry 2007, 42, 818-824. 
(24) Wilson, J. J.; Brodbelt, J. S. Analytical Chemistry 2007, 79, 7883-7892. 
(25) Kalcic, C. L.; Gunaratne, T. C.; Jones, A. D.; Dantus, M.; Reid, G. E. Journal of 
the American Chemical Society 2009, 131, 940-942. 
(26) Ly, T.; Julian, R. R. Journal of the American Chemical Society 2008, 130, 351-
358. 
(27) Gabryelski, W.; Li, L. Rapid Communications in Mass Spectrometry 2002, 16, 
1805-1811. 
(28) Goolsby, B. J.; Brodbelt, J. S. Analytical Chemistry 2001, 73, 1270-1276. 
(29) Keller, K. M.; Brodbelt, J. S. Analytical Biochemistry 2004, 326, 200-210. 
(30) Payne, A. H.; Glish, G. L. Analytical Chemistry 2001, 73, 3542-3548. 
(31) Schwartz, J. C.; Syka, J. E. P.; Quarmby, S. T. Proceedings of the 53th ASMS 
Conference on Mass Spectrometry and Allied Topics. San Antonio, TX, June 
2005. 
(32) Cunningham, C.; Glish, G. L.; Burinsky, D. J. Journal of the American Society for 
Mass Spectrometry 2006, 17, 81-84. 
(33) Stafford, G. C., Jr.; Kelley, P. E.; Syka, J. E. P.; Reynolds, W. E.; Todd, J. F. J. 
International Journal of Mass Spectrometry and Ion Processes 1984, 60, 85-98. 
(34) Black, D. M.; Payne, A. H.; Glish, G. L. Journal of the American Society for 
Mass Spectrometry 2006, 17, 932-938. 
 209
(35) Boue, S. M.; Stephenson, J. L., Jr.; Yost, R. A. Rapid Communications in Mass 
Spectrometry 2000, 14, 1391-1397. 
(36) Hashimoto, Y.; Hasegawa, H.; Waki, I. Rapid Communications in Mass 
Spectrometry 2004, 18, 2255-2259. 
(37) Hashimoto, Y.; Hasegawa, H.; Yoshinari, K.; Waki, I. Analytical Chemistry 2003, 
75, 420-425. 
(38) Pikulski, M.; Wilson, J. J.; Aguilar, A.; Brodbelt, J. S. Analytical Chemistry 2006, 
78, 8512-8517. 
(39) Wilson, J. J.; Brodbelt, J. S. Analytical Chemistry 2006, 78, 6855-6862. 
(40) Vasicek, L. A.; Wilson, J. J.; Brodbelt, J. S. Journal of the American Society for 
Mass Spectrometry 2009, 20, 377-384. 
(41) Madsen, J. A.; Brodbelt, J. S. Journal of the American Society for Mass 
Spectrometry 2009, 20, 349-358. 
(42) Schwartz, J. C.; Syka, J. E. P.; Remes, P. M. Proceedings of the 56th ASMS 
Conference on Mass Spectrometry and Allied Topics. Denver, CO, June 2008. 
(43) Wouters, E. R.; Splendore, M.; Mullen, C.; Schwartz, J. C.; Senko, M. W.; 
Dunyach, J. Proceedings of the 57th ASMS Conference on Mass Spectrometry 
and Allied Topics. Philadelphia, PA, June 2009. 
(44) Gardner, M. W.; Vasicek, L. A.; Shabbir, S.; Anslyn, E. V.; Brodbelt, J. S. 
Analytical Chemistry 2008, 80, 4807-4819. 
(45) Remes, P. M.; Glish, G. L. Journal of Physical Chemistry A 2009, 113, 3447-
3454. 
(46) Madsen, J. A.; Gardner, M. W.; Smith, S. I.; Ledvina, A. R.; Coon, J. J.; 






Reduction of Chemical Noise in Electrospray Ionization Mass 
Spectrometry by Supplemental IR Activation 
8.1 OVERVIEW
Supplemental infrared (IR) activation was applied to reduce background chemical 
noise and increase analyte ion signal in a linear ion trap mass spectrometer.  Peptides, 
proteins, and small molecules were all introduced by electrospray ionization, and when 
regions of chemical noise were isolated and subjected to IR irradiation, protonated 
analyte molecules were observed in the product ion mass spectra.  By isolating the entire 
mass range (e.g., m/z 400 – 2000) and then irradiating all ions in the trap, supplemental 
IR activation increased the signal of singly protonated peptides by almost 70% and by 40 
– 55% for the lower charge states of cytochrome c.  This increase in analyte ion signal 
was less dramatic for the higher charge states of peptides and proteins.  The chemical 
noise present in the mass spectra is attributed to incomplete desolvation of the 
electrospray, as the abundance of the protonated peptides observed upon supplemental IR 
activation of the chemical noise decreased with higher inlet capillary temperatures.  
Collision activation was not as effective for desolvating the ions present in the chemical 
noise.   
 
8.2 INTRODUCTION
For successful implementation of electrospray ionization (ESI), desolvation of the 
analyte ions is necessary, and many methods have been developed to afford efficient 
desolvation including the use of drying gases,1-3 collisional activation,2, 3 and heated inlet 
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capillaries.4  These techniques are applied to not only aid in desolvation but also reduce 
the chemical noise in ESI mass spectra which is typically saturated with solvated ion 
clusters.  Other methods have been used to reduce the chemical noise that is due to 
specific contaminants including using heated shield interfaces5 and ion-molecule 
reactions to “filter” selected ions of interest.6, 7 To further eliminate chemical noise due to 
solvent clusters in quadrupole ion traps (QITs), broadband waveforms have been applied 
to gently collisionally activate and dissociate these solvated ions to convert them into free 
buffer-related ions for subsequent resonance ejection.8  The nature of the chemical noise 
background in matrix-assisted laser desorption/ionization (MALDI) has been investigated 
in some detail and has also been determined to be in part due to matrix and analyte-
matrix clusters;9, 10 in fact, MALDI-TOF-TOF experiments on chemical noise ions of m/z 
greater than that of the analyte ions yielded free analyte ions due to decay and 
desolvation of analyte-matrix clusters in the flight tube.10  In ESI mass spectra, 
background noise is often observed at virtually all m/z values and the source of this noise 
cannot often be determined.11  While using “soft” ESI conditions (e.g., low inlet capillary 
temperatures and small potential differences between the capillary and skimmer) 
enhances the production of very stable hydrated peptide ions with upwards of fifty water 
adducts, which have been extensively studied by the Williams group,12, 13 in this work we 
are investigating chemical noise in ESI mass spectra in which desolvating conditions are 
employed.  In this chapter, supplemental IR activation in a linear ion trap mass 
spectrometer to reduce the chemical noise background observed in ESI mass spectra is 
reported.  Rather than focusing on eliminating background ions of specific m/z, IR 
irradiation has been applied to activate ions of unresolved m/z observed in noise regions 
of the ESI mass spectra.  Upon supplemental IR activation of noise regions, analyte ions 
of high abundance are detected. 
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8.3 EXPERIMENTAL
8.3.1 Mass Spectrometry and Materials 
All experiments were conducted on a modified LTQ XL linear ion trap mass 
spectrometer (Thermo Fisher Scientific, San Jose, CA) with the standard ESI source 
which is directed at an angle to the inlet heated capillary.  A ZnSe optical window was 
mounted to the back plate of the vacuum manifold on axis with the linear ion trap to 
transmit IR irradiation as previously described.14  Supplemental IR activation was 
performed with a model 48-5 Synrad 50-W continuous wave CO2 laser (Mukilteo, WA) 
which emits radiation at 10.6 m.  For IR activation experiments, the irradiation time (0 – 
50 ms) and power (25 – 50 W) was varied.  Wide-range isolation and IR activation 
experiments were conducted by turning off the isolation waveform through the 
diagnostics panel of the LTQTune v2.5.0 software.  The laser was triggered through the 
LTQTune software only during the activation step in the scan function and not during ion 
accumulation, ion cooling, or ion transmission.  (It should be noted that the laser beam 
does interact with all ions along the optical path from the linear ion trap to the skimmer 
cone but the laser beam does not pass through the inlet heated capillary which is off-axis 
from the skimmer cone.)  The automatic gain control was turned off for all experiments 
and peak areas calculations were performed in triplicate.  All samples were prepared at 
10 M in 50:50:1 H2O/MeOH/HOAc (v/v/v), unless otherwise noted, and infused at 3 
L/min through a fused silica capillary (194 m O.D., 98 m I.D.).  The heated capillary 
temperature was maintained at 180 °C unless otherwise noted.  The nitrogen sheath gas 
flow was set to 20 (arbitrary units, corresponding to ~0.3 L/min) and no auxiliary gas 
flow was used.  The peptides bradykinin (1059.5 Da), angiotensin I (1295.6 Da), 
 213
fibrinopeptide A (1535.7 Da), the protein cytochrome c, and reserpine (608.3 Da) were 
all obtained from Sigma-Aldrich (St. Louis, MO).  All solvents and other chemicals were 
from Fisher Scientific (Fairlawn, NJ).   
  
8.4 RESULTS AND DISCUSSION
In the previous study discussed in Chapter 4, which employed infrared 
multiphoton dissociation (IRMPD) to differentiate and identify chromogenic cross-linked 
peptides from other non-cross-linked products, it was observed that the abundances of 
some of the unmodified peptide cations actually increased upon IR irradiation, 
particularly when comparing peak areas in the wide-range isolation and IRMPD mass 
spectra.14  In a second time-resolved IRMPD study of peptides discussed in Chapter 7, it 
was also noted that ion abundances of selected precursor ions increased upon exposure to 
short irradiation times prior to ion dissociation upon longer irradiation times.15  These 
increases in ion abundances upon IR irradiation were initially attributed to fluctuations in 
the ion current between the isolation and the IRMPD scans; however, as this phenomenon 
was consistently observed, other possible reasons for the increase in ion abundance were 
investigated. 
For this study, peptide samples were introduced by ESI using typical parameters 
to promote efficient ion desolvation; however, rather than isolating and activating a 
specific peptide ion, noise regions above the peptide ions or wide m/z ranges (including 
the peptide ions) were subjected to IR irradiation.  Typical wide range isolation and 
supplemental IR activation mass spectra of bradykinin are shown in Figure 8.1a and 
8.1b, respectively.  The wide range isolation mass spectrum is identical to the 
conventional ESI mass spectrum of bradykinin (Figure 1a), and the range from m/z 1000 
to 1100 is amplified to showcase the abundance of the protonated peptide.  Upon 30 ms 
 214
of supplemental IR irradiation at 25 W, a significant increase in the abundance of singly 
protonated bradykinin is observed (Figure 8.1b).  The peak area of [M+H]+ increased by 
68  17% (~2260 to ~3800 counts), while the abundance of doubly-charged bradykinin 
increased by 3.8  2.0% (~232000 to ~241000 counts).  The total ion current (TIC) in the 
IR activation mass spectra was on average 4.5  1.2% (~550,000 to ~575,000 counts) 
greater than that measured in the wide range isolation mass spectra.  These increases in 
peptide ion abundances parallel the decrease in the chemical noise, which is presumed to 
consist primarily of loosely bound solvated peptide ions of unresolved m/z.  In the 
amplified region of m/z 1300 – 1400, there is a distinct difference in the noise level 
between the wide range isolation mass spectrum and the IRMPD mass spectrum (Figure
8.1a and 8.1b). 
Similar increases in the abundances of the lower charge states of cytochrome c 
were observed upon supplemental IR irradiation as shown in the wide-range isolation and 
Figure 8.1 (a) Wide range isolation mass spectrum of m/z 400 – 2000 (30 ms) and (b) 
supplemental IR activation mass spectrum (30 ms, 25 W) of bradykinin (M).
Both spectra are normalized to the same intensity. 
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IR activation mass spectra in Figure 8.2a and 8.2b.  The abundances of the 8+ through 
10+ charge states of cytochrome c increased by 39 – 55% upon IR irradiation.  The peak 
areas of the 13+ through 15+ charge states only exhibited increases of ~10%, and the 
peak areas of the more highly charged cytochrome c ions changed by less than 5%.  IR 
irradiation also effectively decreased the noise level above m/z 1600.  The TIC increased 
by ~15% between the isolation and the IR activation mass spectra, and this could be due 
to dissociation of highly solvated ions that have m/z values that exceed the detectable 
mass range of the linear ion trap (maximum m/z of 2000) yet still have stable trajectories 
in the mass analyzer. 
The effectiveness of IR activation to dissociate these solvated ions was also 
compared to collisional activation.  The wide-range isolation mass spectrum of 
angiotensin I is shown in Figure 8.3a in which ions of m/z 1400 – 2000 were isolated.  
Upon IR irradiation, the entire noise region was drastically reduced in intensity and 
Figure 8.2  (a) Wide range isolation mass spectrum of m/z 600 – 2000 (50 ms) and (b) 
supplemental IR activation mass spectrum (50 ms, 50 W) of cytochrome c.
Both spectra are normalized to the same intensity. 
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protonated angiotensin in the 1+, 2+ and 3+ charge states were observed (Figure 8.3b).  
In fact, the abundances of the peptide ions were sufficiently high to allow subsequent 
collision induced dissociation (CID) MS3 experiments to confirm their identity (data not 
shown).  As shown in Figure 8.3c, collisional activation of the range from m/z 1450 to 
1550 (centered on m/z 1500 with an activation window of 100 u) also resulted in a 
decrease in the chemical noise of ions in resonance with the auxiliary collisional 
activation waveform, but high levels of noise remained above m/z 1575. (Collisional 
activation waveforms could only be applied to activate ions within a mass window of 100 
u due to limitations of the instrument software.)  Collisional activation of m/z 1450 – 
1550 produced low abundances of peptide ions but at signal levels ~30
 lower in 
intensity than obtained by the IR activation process.  As a more direct comparison 
Figure 8.3  (a) Wide range isolation mass spectrum of m/z 1400 – 2000 (30 ms), (b) 
supplemental IR activation mass spectrum (30 ms, 50 W), and (c) collisional 
activation mass spectrum (30 ms, 100% normalized collision energy) of
angiotensin I (M).  Only ions of m/z 1450 – 1550 were activated in the 
collisional activation mass spectrum (range indicated with double-headed 
arrow) while all ions of m/z 1400 – 2000 were isolated.  All spectra are 
normalized to the same intensity. 
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between the effects of IR irradiation and collisional activation of specific noise regions, 
the narrow region from m/z 1900 to 2000 was isolated after infusion of a solution 
containing bradykinin (Figure 8.4a) and either subsequently irradiated or subjected to 
collisional activation.  IR irradiation yielded an intense signal of singly protonated 
bradykinin (m/z 1060.3) while collisional activation produced the same peptide ions at a 
150
 lower intensity (Figure 8.4b and 8.4c). 
The temperature of the inlet heated capillary was varied to provide more evidence 
that the source of chemical noise in the ESI mass spectra was solvated ions of unresolved 
m/z.  For a solution containing  reserpine, the m/z region 1900 – 2000 was isolated and 
subjected to 30 ms of IR irradiation to yield protonated reserpine (m/z 609.7), and the 
peak area of this ion was plotted vs. heated capillary temperature (Figure 8.5).  As a 
control, the peak area of protonated reserpine in the ESI mass spectra without isolation or 
Figure 8.4 (a) Isolation mass spectrum of m/z 1900 – 2000 (50 ms), (b) supplemental 
IR activation mass spectrum (50 ms, 25 W), and (c) collisional activation 
mass spectrum (30 ms, 100% normalized collision energy corresponding to 
348 mV amplitude at m/z 1950) of bradykinin (M).  All spectra are 
normalized to the same intensity. 
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IR activation was also plotted.  At low capillary temperatures, IR activation of m/z 1900 – 
2000 at 120 °C yielded the highest abundance of protonated reserpine, corresponding to 
significant IR desolvation of a large population of solvated ions.  As the capillary 
temperature was increased, the abundance of protonated reserpine produced upon IR 
activation decreased, in accordance with the existence of a smaller population of solvated 
ions due to more efficient desolvation of the ions exiting the ESI capillary.  In the 
absence of IR activation, the abundance of protonated reserpine in the ESI mass spectra 
increased with higher inlet capillary temperatures, indicative of the disruption of more of 
the solvent clusters and their conversion into desolvated reserpine.   
The abundance of various bradykinin peptide ions produced upon IR activation 
was also monitored as a function of the m/z window isolated and irradiated, ranging from 
m/z 1100 – 1200 to m/z 1900 – 2000.  IR activation of the m/z region just above that of 
Figure 8.5 Plot of [M+H]+ peak areas in the ESI mass spectra (black squares, ) and 
upon IR irradiation (30 ms, 50 W) of m/z 1900-2000 (gray circles, ) as a 
function of heated inlet capillary temperature when infusing a sample of
reserpine (1 M in MeOH).  Ions of m/z 1900 – 2000 were subjected to IR 
irradiation and the abundance of the [M+H]+ product ion was calculated. 
Data was acquired in triplicate; reserpine is represented by M. 
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protonated bradykinin (m/z 1060.3) yielded the highest abundances of protonated, doubly 
protonated, and sodium-cationized bradykinin (Figure 8.6).  As the isolation window 
increased from m/z 1100 – 1200 to m/z 1900 – 2000, the abundance of the peptide cations 
produced upon supplemental IR activation decreased, thus suggesting that the greatest 
portion of the chemical noise consists of bradykinin ions solvated by only a few solvent 
molecules with m/z values just above that of the protonated peptide, as opposed to large 
clusters of bradykinin ions surrounded by dozens of solvent molecules resulting in 
“noise” ions of much higher m/z. 
IR and collisional activation of an m/z region between that of the 1+ and 2+ 
charge states of fibrinopeptide A produced both the singly and doubly protonated peptide 
Figure 8.6 Plot of bradykinin (M) cations (protonated and sodium-cationized forms) 
observed upon IR irradiation of 100 m/z range windows.  Supplemental IR 
activation of each window (e.g., m/z 1100 – 1200) was performed using 50 
ms of irradiation at 25 W and the peak areas of [M+H]+ (filled black 
squares, ), [M+2H]2+ (filled red circles, ), [M+Na]+ (filled blue triangles, 
) and [M+H+Na]2+ (filled green diamonds, ) were measured.  The 
efficiency of producing bradykinin ions from chemical noise (i.e.,
conversion efficiency), defined as the sum of the peak areas of bradykinin 
ions divided by the total area of the noise in the isolation mass spectra, is
also plotted (open pink squares, ). 
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which suggests that charged solvent clusters also solvate the peptides (see Figure 8.7).  
Supplemental activation of this noise region also yielded stable hydrated forms of the 
peptide – up to six water molecule adducts were observed.  The observation of protonated 
fibrinopeptide A in Figure 8.7a is attributed to collisional activation of solvated ions 
during the isolation step (i.e., the application of the low amplitude isolation waveforms 
and the ramping of the rf amplitude to isolate the specified m/z range).  Both IR and 
collisional activation of the noise region of m/z 1200 – 1300 (Figure 8.7b and 8.7c, 
Figure 8.7 (a) Isolation (30 ms), (b) IR activation (30 ms, 50 W), and (c) collisional 
activation (100% normalized collision energy) mass spectra of m/z 1200 –
1300 for a sample of 10 M fibrinopeptide A in 50:50:1 H2O/MeOH/HOAc 
(v/v/v). 
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respectively) produced the singly and doubly protonated peptide as well as hydrated 
forms (up to six water molecule adducts) of the peptide.  The observation of the singly 
protonated peptide upon supplemental activation is attributed to the loss of H3O+ or other 
charged or protonated solvent clusters. 
The efficiency of converting noise into analyte ions, defined as the sum of the 
peak areas of the bradykinin ions produced by supplemental IR activation divided by the 
total area of the noise region in the isolation mass spectra, was also measured as a 
function of the m/z isolation and irradiation window (Figure 8.6).  Although the total 
abundance of bradykinin produced upon IR irradiation decreases with higher m/z 
windows, the conversion of chemical noise into bradykinin ions remains relatively 
constant at 19.8  2.1% averaged across the m/z isolation and irradiation windows, 
suggesting that at least ~20% of the chemical noise is composed of solvated analyte ions. 
At the high standard operating pressures of QITs, low power IR irradiation does 
not result in dissociation of covalent bonds of most analyte ions due to a near equivalent 
rate of ion activation through photon absorption and collisional cooling with the buffer 
gas.16  The non-resonant nature of IR activation provides an inherent advantage over 
collisional activation in that all ions in the trap are simultaneously irradiated by the laser 
beam and thus effectively desolvated.  It has been previously shown that broadband 
auxiliary waveforms can be used to heat a wider range of ions for successful noise 
reduction,8 a procedure that is not feasible on the current generation of commercial 
quadrupole ion traps. 
8.5 CONCLUSIONS
Chemical noise in ESI mass spectra was reduced by low power supplemental IR 
activation and produced protonated analyte ions.  IR irradiation increased the abundances 
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of protonated peptides and proteins by 30 – 70% upon isolation and irradiation of a wide 
m/z range.  Regions of chemical noise were drastically reduced upon IR irradiation and 
produced higher abundances of protonated analyte ions than collisional activation due to 
the non-resonant activation nature of photoabsorption.  It is speculated that solvated 
analyte ions and solvent-analyte clusters constitute a large portion of the chemical noise.  
Further application of supplemental IR activation in linear QITs prior to ion ejection or 
tandem MS could be used to reduce noise and increase analyte ion signal particularly for 
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Infrared multiphoton dissociation (IRMPD) on a linear ion trap mass spectrometer 
is applied for the sequencing of small interfering RNA (siRNA).  Both single-strand 
siRNAs and duplex siRNA were characterized by IRMPD, and the results were compared 
to that obtained by traditional ion trap based collision induced dissociation (CID).  The 
single-strand siRNA anions were observed to dissociate via cleavage of the 5’ P–O bonds 
yielding c- and y-type product ions as well as undergo neutral base loss.  Full sequence 
coverage of the siRNA anions was obtained by both IRMPD and CID.  While the CID 
mass spectra were dominated by base loss ions, accounting for ~25 – 40% of the product 
ion current, these ions were eliminated through secondary dissociation by increasing the 
irradiation time in the IRMPD mass spectra to produce higher abundances of informative 
sequence ions.  With longer irradiation times, however, internal ions corresponding to 
cleavage of two 5’ P–O bonds began to populate the product ion mass spectra as well as 
higher abundances of [a - Base] and w-type ions.  IRMPD of siRNA cations 
predominantly produced c- and y-type ions with minimal contributions of [a - Base] and 
w-type ions to the product ion current; the presence of only two complementary series of 
product ions in the IRMPD mass spectra simplified spectral interpretation.  In addition, 
IRMPD produced high abundances of protonated nucleobases – [G+H]+, [A+H]+, and 
[C+H]+ - which were not detected in the CID mass spectra due to the low-mass cut-off 
associated with conventional CID in ion traps.  CID and IRMPD using short irradiation 
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times of duplex siRNA resulted in strand separation, similar to the dissociation trends 
observed for duplex DNA.  With longer irradiation times, however, the individual single-




The identification and determination of the function of small non-coding (i.e., 
non-messenger) RNA including small interfering RNA (siRNA) and micro-RNA 
(miRNA) has become an important challenge due to the growing recognition of these 
RNAs in fundamental cellular processes including gene regulation, RNA processing, 
translocation of proteins, chromosome maintenance, and cancer and disease 
development.1, 2  For example, RNA interference (RNAi) is a biological pathway which 
down-regulates or silences gene expression and has shown great potential to be harnessed 
as a therapeutic tool via introduction of siRNA, typically short double stranded RNA 
consisting of approximately 25 nucleotides (per single strand), to cells.3, 4  Micro-RNAs, 
which consist of ~22 nucleotides, have also been shown to effect gene silencing by 
binding directly to the target mRNA.5  Several siRNA-based drugs are currently in 
clinical trials,6, 7 and recent studies have explored the impact of siRNA on coronary artery 
disease,8 Alzheimer’s disease,9 and HIV.10, 11 
 The traditional methods used to identify these non-coding RNAs are wet-lab 
techniques including over-expression and cloning, and sequencing.12  Deep sequencing 
analyses in conjunction with predictive computational approaches have also been utilized 
to identify miRNAs.13, 14  Tandem mass spectrometry is well-suited for the 
characterization of novel miRNAs, as well as synthesized siRNAs, including those that 
contain chemical modifications to increase their stability, such as deoxynucleotides, 3’-
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overhangs, or 2’-O-methyl modifications.15, 16  While tandem mass spectrometry has been 
widely used to sequence DNA,17-22 little effort has been devoted to the analysis of RNA 
until recently.23-27  Gas-phase dissociation of DNA anions is initiated by base loss and 
subsequent dissociation of the 3’ C O bond yielding complementary [a - Base] and w-
type ions.18  In contrast, collision-induced dissociation (CID) of RNA typically results in 
fragmentation of the 5’ P O bond producing complementary c- and y-type fragment 
ions.23-26  Schürch and co-workers observed that dissociation of RNA was independent of 
the nucleobase and that cleavage of the 5’ P O bond is related to the presence of the 2’-
hydroxyl group.24, 26  That is, upon ion activation, an intramolecular cyclic transition-state 
involving the 2’-hydroxyl proton and the 5’ oxygen of the phosphate is formed, and 
migration of the 2’-hydroxyl proton and subsequent cleavage yields the c- and y-type 
fragments.24, 26  McLuckey’s group observed that the dissociation pathways of RNA 
anions were charge-dependent in which more highly charged species predominantly 
underwent base loss, and the lower charge states gave higher sequence coverage.23  More 
recently, McLuckey et al. obtained full sequence coverage of deprotonated siRNA ions 
by CID with subsequent proton transfer reactions which effectively “deconvoluted” and 
simplified interpretation of the product ion mass spectra.27  The Håkansson group 
investigated the fragmentation pathways of oligoribonucleotides by both electron capture 
dissociation (ECD) and electron detachment dissociation (EDD).28  They observed that 
the ECD fragmentation patterns were dependent on the nucleobase.   Both c/y-type ions 
and d/w-type ions were produced by ECD; whereas EDD predominantly yielded d- and 
w-type ions, and full sequence coverage was obtained.   
Infrared multiphoton dissociation (IRMPD) has been previously been shown to be 
a viable alternative and complementary dissociation method to CID for the sequencing of 
DNA.19, 20, 29-31  One of the primary advantages of IRMPD in ion traps is that as a non-
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resonant method, the precursor ion and all ensuing product ions are activated by IR 
irradiation.  Uninformative product ions due to dead-end dissociation pathways (e.g., 
neutral base loss) can undergo secondary dissociation to yield diagnostic sequence ions.  
IRMPD also does not suffer significantly from the low-mass cut-off problem intrinsic to 
conventional CID in rf ion traps.  The energy deposition by conventional CID is 
dependent on the rf trapping voltage which prevents the storage of ions of m/z in the 
lower 28% of the mass range relative to the precursor ion.  Since IRMPD can be 
performed using far lower rf trapping levels, diagnostic low-mass product ions can be 
detected.  The energy deposition by photon absorption is also not dependent on the rf 
trapping voltage, but rather on the absorptivity of the ion at the wavelength of the laser.  
Compared to proteins and peptides which do not undergo efficient photodissociation at 
normal trap pressures of ~ 1 mTorr, oligonucleotides dissociate rapidly upon exposure to 
IR irradiation at 10.6 μm due to the high IR absorptivity of the phosphodiester backbone 
at this wavelength,32 an effect noted initially by Little et al.33  IRMPD also affords a high 
degree of tunability and control with regards to energy deposition, as the irradiation time 
and power can both be varied. 
In the present study, the use of IRMPD to sequence single-strand and duplex 
siRNA anions and cations as a function of charge state is examined.  Time-resolved 
IRMPD experiments reveal the genealogy of product ion formation.  Compared to CID, 
IRMPD produces a higher abundance of diagnostic sequence ions and favors the 
formation of shorter product ions in lower charge states.  Full sequence coverage was 
generally obtained by both dissociation techniques; however, the IRMPD product ion 
mass spectra were often simpler to interpret due to conversion of the neutral base loss 




9.3.1 Chemicals and Materials 
Imidazole, piperidine, and Amberlite IRN77 resin were purchased from Sigma-
Aldrich (St. Louis, MO).  Methanol, ammonium acetate, and isopropanol were obtained 
from Fisher Scientific (Fairlawn, NJ).  The siRNAs targeting the glyceraldehydes 3-
phosphate dehydrogenase (GAPDH) gene and the Lamin A/C gene were purchased from 
Integrated DNA Technologies (Coralville, IA). The sequences for anti-GAPDH were 
5’OH-GUGGAUAUUGUUGCCAUCAdTdT-3’OH (sense strand, GAPDH.S, 6633.9 
Da) and 5’OH-UGAUGGCAACAAUAUCCACdTdT-3’OH (antisense strand, 
GAPDH.AS, 6644.9 Da). The sequences for anti-Lamin A/C were 5’-biotin-
GGAACUGGACUUCCAGAAGAACAUCUA-3’OH (sense strand, Lamin A/C.S, 
9053.6 Da) and 5’-UAGAUGUUCUUCUGGAAGUCCAGUUCC (antisense strand, 
Lamin A/C.AS, 8544.1 Da).   
Single-strand siRNA samples were desalted by cation exchange using the 
Amberlite IRN77 resin as described by McLuckey et al.27  Duplex siRNA was annealed 
by combining the sense and antisense siRNA strands (30 M each) in 150 mM NH4OAc, 
pH 7.0.  The samples were heated at 90 °C for three minutes and then cooled to room 
temperature overnight.  Duplex siRNA solutions were diluted to 10 M in 25:75 (v/v) 
methanol/50 mM NH4OAc in nano-pure H2O.  Solutions of GAPDH single-strand 
siRNAs were prepared at 10 M in either 25:75 (v/v) methanol/25 mM NH4OAc for 
negative and positive electrospray mass spectrometry (ESI-MS) or 20:80 (v/v) 
isopropanol/H2O with 25 mM imidazole and 25 mM piperidine for negative ESI-MS.  
The Lamin A/C single strand siRNAs were prepared at 10 M in 25:75 (v/v) methanol/25 
mM NH4OAc for negative and positive ion ESI-MS. 
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9.3.2 Mass Spectrometry and Infrared Multiphoton Dissociation 
All experiments were conducted on a modified LTQ XL linear ion trap mass 
spectrometry (Thermo Fisher Scientific, San Jose, CA) with the standard electrospray 
ionization (ESI) source.  Samples were infused at 2.5 L/min and the ESI voltage was set 
to either -3.5 or +4.0 kV for negative and positive ion mode analysis, respectively.  The 
inlet heated capillary was maintained at 90 °C.  The mass spectrometer was modified to 
perform infrared multiphoton dissociation as previously described.34  Briefly, a ZnSe 
window was mounted to the back plate of the vacuum manifold to transmit 10.6 m 
radiation from a model 48-5 Synrad 50 W cw CO2 laser (Mukilteo, WA).  The laser was 
triggered through the LTQTune v.2.5.0 software during the activation step in the scan 
function.  The irradiation time was varied between 0.0 and 20.0 ms and the power was 
maintained at 10 W (25%).  The q-value for all IRMPD experiments was set between 
0.055 and 0.100.  Collision-induced dissociation was performed at the typical q-value of 
0.25, the activation time was set to 30 ms, and the normalized collision energy was 
adjusted to dissociate the precursor ion to less than 1% relative abundance. 
 
9.3.3 Data Analysis 
Time-resolved IRMPD experiments were performed by incrementally increasing 
the irradiation time and the abundances of the precursor and product ions were plotted 
against the irradiation time.  Ion abundances were determined by measuring the peak 
areas using Origin 7.0.  Product ions were identified using Mongo Oligo Mass Calculator 
(http://library.med.utah.edu/masspec/mongo.htm) in addition to an oligonucleotide 
product ion calculator program written in-house using National Instruments LabView 8.5.  
Only product ions which could be unambiguously identified were included in the product 
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ion type abundance calculations.  Product ions were labeled according to the 
nomenclature proposed by McLuckey et al.18 
 
9.4 RESULTS AND DISCUSSION
9.4.1 Infrared Multiphoton Dissociation vs. Collision-Induced Dissociation of 
Single-Strand siRNA 
In the negative ion mode, ESI of the GAPDH sequences in ammonium acetate 
buffer produced ions in the 4- to 6- charge states, while ESI of Lamin A/C samples in 
ammonium acetate yielded ions predominantly in the 5- and 6- charge states (data not 
shown).  Electrospray ionization of the GAPDH sequences in the imidazole/piperidine 
additive solution produced ions in charge states ranging from 6- to 10-.  In the positive 
mode, both the GAPDH and Lamin A/C sequences produced ions in only two charge 
states. The single-strand siRNAs were subjected to IRMPD, and the product ion mass 
spectra were compared to that obtained by conventional ion-trap CID.  Examples of the 
IRMPD and CID mass spectra are shown in Figures 9.1 and 9.2. Sannes-Lowery and 
Hofstadler have previously analyzed an oligoribonucleotide by IRMPD in an external 
hexapole by FT-ICR-MS,29 but IRMPD has not been extensively investigated as an 
alternative dissociation method for RNA.  The fragmentation patterns of siRNA anions 
by IRMPD is dependent on the irradiation time (i.e., photon flux), and thus by varying 
the time (or laser power), the product ion mass spectra can be effectively tuned by 
controlling the extent of secondary dissociation.  IRMPD of the 5- charge state of 
GAPDH.S using 6.0 ms irradiation predominantly yielded c- and y-type product ions due 
to cleavage of the 5’ P–O bond (Figure 9.1a).  Lower abundance [a - Base] and 
complementary w-type ions were also detected.  The abundances of product ions 
stemming from neutral base loss, which typically dominate CID product ion mass spectra 
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of RNA,23 were modest.   Almost a complete series of c-type (19/20) and y-type (18/20) 
ions was observed for this siRNA anion.  The three c and y product ions which were not 
observed were y1, its complementary c20 ion, and y20.  Cleavage between the two dT 
Figure 9.1 IRMPD product ion mass spectra of [GAPDH.S – 5H]5- of m/z 1326.0 using 
(a) 6.0 ms and (b) 8.0 ms of irradiation at 10 W at q-value of 0.10.  (c) CID 
product ion mass spectra of the same siRNA anion (14% normalized
collision energy, q = 0.25).  The precursor ion is indicated by an asterisk (*) 
and internal ions by #.  Not all peaks were labeled to reduce congestion. 
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nucleotides would yield the y1 and c20 ions, and these product ions are not likely to be 
observed due to the lack of the 2’-OH group to facilitate cleavage of the 5’ P–O bond.  
However, the w1 ion, which corresponds to cleavage of the 3’ C–O bond, was detected, 
and full sequence coverage of this siRNA anion was obtained.  The complementary [a20 - 
T] and the y20 product ions were most likely not detected due to secondary dissociation of 
these large product ions.  Upon increasing the irradiation time to 8.0 ms, the product ion 
mass spectra changes significantly (Figure 9.1b).  The more highly-charged and larger 
product ions observed in Figure 9.1a undergo secondary dissociation into smaller 
product ions.  Both the precursor ion and base loss product ions are almost completely 
dissociated, and the product ion mass spectrum is dominated by c- and y-type fragment 
ions.  A majority of the [a - Base] ions detected are due to the facile loss of neutral 
guanine (i.e., [an - G] product ions predominant) which has previously been reported to be 
a significant dissociation pathway for RNA anions in low charge states.23  The [a - Base] 
and w-type product ions are likely produced by secondary photodissociation of the 
neutral base loss product ions (e.g., [M - G]5-) and subsequent cleavage of the 3’ C–O 
bond of the ribose from which the base was lost.  Full sequence coverage of GAPDH.S 
was obtained using 8.0 ms of irradiation even though fewer sequence ions were detected 
(c1 – c12 and y2 – y15).  The lack of larger, more highly-charged product ions reduces the 
spectral complexity while still allowing the siRNA anion to be completely sequenced.  A 
majority of the product ions were singly or doubly charged.  Several low mass, singly 
charged product ions which could be not be identified as sequence (i.e., [a - Base], c-, y-, 
w-type) ions were also detected.  These product ions were determined to be internal ions 
due to cleavage of two 5’ P–O bonds.  These internal ions could not be unambiguously 
identified due to isobaric species (e.g., AUG = GAU).   The abundances of the internal 
ions are low, and the ions likely arise from secondary dissociation of larger c- and y-type 
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product ions.  The CID product ion mass spectrum of [GAPDH.S – 5H]5- was dominated 
by neutral base loss (Figure 9.1c).  Product ions were observed in all possible charge 
states and almost complete sequence coverage was obtained.  Due to the low-mass cut-off 
(LMCO) problem inherent to conventional CID, the low mass c1 (m/z 305) and w1 (m/z 
324) sequence ions could not be detected.  Fewer [a - Base] and w-type ions were 
observed upon CID, a result attributed to the fact that only the precursor ion is activated 
and primary product ions such as [M-G] are not further dissociated into sequence 
informative species.  Small internal ions were also detected by CID; however, these 
product ions were not as abundant as those in the IRMPD mass spectrum obtained using 
8.0 ms of irradiation. 
IRMPD mass spectra of the 6+ charge state of the sense strand of Lamin A/C 
using 4.0 and 6.0 ms of irradiation are shown in Figures 9.2a and 9.2b.  At short 
irradiation times, almost complete series of both c-ions (c1 – c25) and y-ions (y2 – y26) 
were observed.  In contrast to dissociation of siRNA anions, the product ions were 
predominantly composed of c/y-type fragments, and the mass spectrum was almost 
completely void of [a - Base] and w-type ions.  Also, siRNA cations of all charge states 
dissociated through protonated base loss, and the resulting protonated bases were 
observed in the low m/z range of the IRMPD mass spectrum.  The [Base + H]+ ions were 
the most abundant product ions in the mass spectrum with protonated guanine observed 
at higher abundance than [A + H]+ and [C + H]+; [U + H]+ and [T + H]+ were not 
detected in the IRMPD mass spectra of any of the siRNA cations.  The relative 
abundances of the protonated nucleobases are not directly proportional to the relative 
contribution of each nucleobase to the sequence composition. In fact, the position of the 
nucleobases and their relative gas-phase basicities influence the abundance of the 
protonated base product ions as well.  Since uracil and thymine have the lowest gas-phase 
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proton affinities of the five nucleobases35-37 the absence of these protonated bases in the 
IRMPD spectra is not surprising.  Low mass internal ions were also detected in the 
IRMPD mass spectrum.  Increasing the irradiation time to 6.0 ms led to significantly 
higher abundances of the three protonated nucleobases, [G + H]+, [A + H]+, and [C + H]+, 
as shown in Figure 9.2b.  Identical sequence coverage was obtained using 6.0 ms of 
Figure 9.2 IRMPD product ion mass spectra of [Lamin A/C.S + 6H]6+ of m/z 1509.8 
using (a) 4.0 ms and (b) 6.0 ms of irradiation at 10 W at q-value of 0.065. 
(c) CID product ion mass spectra of the same siRNA cation (17%
normalized collision energy, q = 0.25).  The precursor ion is indicated by an
asterisk (*) and internal ions by #.  Not all peaks were labeled to reduce 
congestion. 
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irradiation as 4.0 ms of irradiation, but base loss ions (e.g., [M - G]5+ and [M - A]5+) were 
significantly reduced in abundance, and a higher abundance of internal ions were 
produced.  With even longer irradiation times, sequence ions were converted almost 
exclusively into protonated bases (data not shown).  The CID mass spectrum of [Lamin 
A/C.S + 6H]6+ was dominated by protonated base loss, but due to the LMCO problem, 
the protonated base ions were not detected (Figure 9.2c).  While the spectrum is more 
cluttered than the IRMPD mass spectra, full sequence coverage was still obtained.  The 
c/y ions were prominent, but almost no [a - Base] and w-type ions were detected upon 
CID of siRNA cations.  Interestingly, a higher abundance of internal ions was observed 
upon CID of the siRNA cations than the anions. 
The percentages of c/y-type ions and [a - Base]/w-type ions observed by IRMPD 
and CID arising from IRMPD and CID are summarized for all of the siRNA ions in 
Figure 9.3.  In general, both IRMPD and CID yielded similar degrees of sequence 
coverage based on the number of unique product ions.  As the “charge level” (defined as 
the number of negative charges per phosphate for oligonucleotide anions38 or the number 
of positive charges per nucleobase for cations) of the anions increased above 33% (i.e., 7- 
through 10- charge states of GAPDH.S and GAPDH.AS), the percent of c/y-type ions 
observed by IRMPD and CID decreased as many product ions could not be 
unambiguously identified due to isobaric overlaps and the inability to isotopically resolve 
the peaks to determine the charge state.  For charge levels of the siRNA anions below 
33% (4- through 6- charge states), near complete series of c/y-ions were detected, and 
CID generally outperformed IRMPD as the longer c- and y-type ions were often not 
detected in the IRMPD mass spectra likely due to rapid secondary dissociation.  The 
percent of [a - Base]/w-ions was generally between 20 and 50% for the siRNA anions 
studied, and a higher number of these product ions were detected in the IRMPD mass 
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spectra.  This trend is attributed to secondary dissociation of base loss product ions by 
IRMPD as discussed earlier. 
Figure 9.3 (a) Percent of c- and y-type ions and (b) percent of [a - Base] and w-type 
ions of model single-strand siRNAs in various charge states observed by
IRMPD (light gray) and CID (dark gray).  The data was compiled from
IRMPD mass spectra in which the precursor ion was reduced to ~10%
relative abundance (required 5 – 7 ms of irradiation).  A value of 100% 
would indicate that all possible c/y-ions or [a - Base]/w-ions were detected. 
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In the positive ion mode, only two charge states of each the single-strand siRNAs 
were observed in the ESI mass spectra.  For the siRNA cations in all charge states 
examined, less than 10% of the possible [a - Base]/w-type ions were detected by both 
IRMPD and CID (Figure 9.3).  At charge levels above 20% (5+ charge state of GAPDH 
and 6+ charge state of Lamin A/C siRNAs), near complete series of c/y-ions were 
detected by both dissociation methods, but at charge levels below 20% (4+ charge state 
of GAPDH and 5+ charge state of Lamin A/C siRNAs) less than 40% of the possible c/y-
ions were observed.  IRMPD mass spectra of [Lamin A/C.AS + 5H]5+ and [GAPDH.AS 
+ 4H]4+ are shown in Figures 9.4a and 9.4b.  Fewer than 30 and 20 product ions were 
identified in the two product ion mass spectra, respectively, and only the 5’ and 3’ ends 
of the siRNAs were sequenced.  Between six and ten nucleotides from either terminal 
were sequenced for the GAPDH and Lamin A/C siRNAs.  For all of the siRNA cations in 
the lowest charge state (5+ for the Lamin A/C sequences and 4+ for the GAPDH 
sequences), no product ions stemming from cleavage of the phosphate backbone near the 
middle of the oligonucleotide were detected (typically the middle ten nucleotides).  A 
summary of the product ions observed by CID and IRMPD of these siRNA cations in low 
charge states is shown in Scheme 9.1.  Almost identical results were obtained by CID as 
well (data not shown).  The low sequence coverage of these siRNAs may be due in part 
to the high m/z value of the precursor ion.  Upon cleavage of the phosphate backbone, 
some of the expected product ions would have m/z values greater than 2000 due to their 
low charge states.  It is also possible that these siRNA cations have adopted an 
unexpected secondary structure which results in bond cleavage predominantly near the 5’ 
and 3’ terminals.  The lack of product ions arising from dissociation near the center of the 
siRNAs does not seem to be nucleobase dependent as this effect was observed for all four 
of the siRNAs which each have a different composition of nucleobases in this region. 
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Figure 9.4 IRMPD product ion mass spectra of (a) [Lamin A/C.AS + 5H]5+ of m/z
1710.0 using 5.0 ms of irradiation at 10 W (q-value = 0.058) and (b) 
[GAPDH.AS + 4H]4+ of m/z 1662.2 using 7.0 ms of irradiation at 10 W (q-
value = 0.060). The precursor ion is indicated by an asterisk (*) and internal
ions by #. 
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9.4.2 Product Ion Abundances and Time-resolved IRMPD of Single-Strand siRNA 
The contributions of each type of product ion to the total product ion current in 
IRMPD and CID mass spectra of GAPDH.AS in the 6-, 5-, 4-, 4+ and 5+ charge states 
were calculated and summarized in Figure 9.5.  (The more negatively charged 
GAPDH.AS precursor ions – 7-, 8-, 9- and 10- charge states – were not included in this 
analysis because many ions could not be unambiguously identified as the isotopic profiles 
of the more highly charged product ions could not be resolved.)  In general, 
approximately 40 – 50% of the product ion current was composed of c- and y-type ions; 
the lone exception was the 4- charge state of GAPDH.AS which was dominated by 
neutral base loss.  For the GAPDH.AS anions, [a - Base] and w-type ions comprised ~5 – 
Scheme 9.1 Observed bond cleavages of siRNA cations in the lowest observed charge 
states. 
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10% of the product ion current.  It should be noted that a majority of the [a - Base] and 
w-type ions of GAPDH siRNAs and Lamin A/C siRNAs contained fewer than 9 or 12 
nucleotides, respectively, suggesting that these fragments are produced by dissociation of 
base loss fragment ions.  Using short irradiation times (4.0 ms), the distribution of 
product ions in the IRMPD mass spectra were almost identical to that of the CID mass 
spectra.  Longer irradiation times yielded lower abundances of base loss ions and higher 
abundances of both internal ions and protonated base ions (for the GAPDH.AS cations).  
Figure 9.5 Relative abundances of different product ion types of GAPDH.AS in various
charge states observed by IRMPD at 4.0 and 6.0 ms of irradiation and by
CID.  The abundances are relative to the total product ion abundance in the 
product ion mass spectra. 
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Base loss ions were not observed for GAPDH.AS in the 4+ charge state as these product 
ions (e.g., [M-G]3+, m/z 2165.6), which are due to loss of protonated bases, have m/z 
values greater than that of the mass range of the linear ion trap.  Similar results were also 
observed for the Lamin A/C siRNA single strands – CID yielded more abundant base loss 
ions than IRMPD using irradiation times of greater than 6 ms (data not shown). 
The abundances of each of these product ion types was also monitored as a 
function of irradiation time as shown in Figure 9.6 for the 5-, 5+, 4- and 4+ charge states 
of GAPDH.S.  Base loss ions are initially observed at irradiation times of ~2 ms while c- 
and y-type ions begin to appear at irradiation times of ~3 ms for the GAPDH.S anions 
(Figure 9.6a and 9.6c).  However, [a - Base] and w-type ions appear after using longer 
irradiation times, again providing evidence that a significant abundance of these products 
ions may be secondary fragment ions of base loss species or larger c/y-type ions.  As the 
irradiation time increased, a maximum relative abundance of base loss ions was observed 
at ~5 ms at which point the abundance of base loss ions decreased at a similar rate to that 
of the precursor ion.  After 8 ms of IR irradiation, the precursor ion was completely 
dissociated and base loss ions accounted for less than 3% of the total ion current in the 
IRMPD mass spectra.  Since the precursor ion and the base loss ions contain the same 
number of chromogenic phosphate groups and, for the GAPDH.S anions, the same 
charge, it is not unexpected that both of these species would photodissociate at a similar 
rate.  The c- and y-type ions were observed to have similar relative abundances 
independent of the irradiation time as one would expect for complementary fragment 
ions.  For the GAPDH.S siRNA anions, c- and y-type ions accounted for more than 30 – 
40% of the total ion current at irradiation times of ~7 ms at which point their abundances 
decreased due to secondary dissociation.  The complementary [a - Base] and w-type ions 
comprised between 10 and 15% of the total ion current at their maximum abundance for 
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the siRNA anions.  In contrast, c/y-type ions accounted for upwards of 50% of the total 
ion current in the IRMPD mass spectra of [GAPDH.S + 5H]5+ and only 25% for 
Figure 9.6 Relative abundances of product ions and the precursor ion as a function of
irradiation time for the (a) 5-, (b) 5+, (c) 4-, and (d) 4+ charge states of 
GAPDH.S.  Abundances are relative to the total ion current in each IRMPD
product ion mass spectrum. 
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[GAPDH.S + 4H]4+ (Figure 9.6b and 9.6d).  Base loss ions and c/y-type ions for the 
GAPDH.S cations were initially observed at ~3 ms of irradiation whereas the onset for 
[Base + H]+ ions was at ~4 ms.  The abundance of protonated bases increased almost 
linearly with irradiation time for the GAPDH.S siRNA cations.  Internal ions were also 
observed to increase in abundance with time, but at long irradiation times their abundance 
tapered off for the 5+ charge state of GAPDH.S as these ions were likely further 
dissociated into protonated base product ions.   
The average charge state and the average length (in number of nucleotides) of the 
product ions of GAPDH.S were also plotted as a function of irradiation time for the 
IRMPD mass spectra, in addition to the values obtained from the CID mass spectra in 
Figure 9.7.  The complete charge state distribution plots and relative abundances of 
product ions of varying nucleotide length are shown in Figures 9.8 and 9.9 for the 
GAPDH.S anions and cations, respectively.  Both the average charge state and the 
average product ion length decreased exponentially as the irradiation time increased.  As 
the abundance of more highly-charged product ions decreased, the abundance of product 
ions in lower charge states correspondingly increased due to secondary dissociation of the 
more highly-charged species (Figure 9.7a).  At irradiation times less than 4 ms, a 
majority of product ions of [GAPDH.S – 5H]5- were in the 5-, 4- and 3- charge states, but 
at 7 ms, doubly charged product ions dominated the IRMPD mass spectra.  Singly 
charged product ions were predominantly observed at irradiation times of greater than 10 
ms, with negligible contributions from ions in the 5-, 4-, and 3- charge states were 
negligible.  In fact, greater than 90% of the identified product ions were singly or doubly 
charged after 10 ms irradiation.  At 20 ms of irradiation time, 89% of the identified 
product ions were singly charged.  The same trends were also observed for the Lamin 
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A/C siRNAs – long irradiation times yielded product ions in lower charge states and with 
fewer nucleotides (data not shown). 
While these trends suggest that more highly charged product ions undergo more 
rapid secondary dissociation potentially due to a greater charge mobility, other factors are 
likely in play.  In particular, one must note that product ions observed in higher charge 
states also are generally greater in size (i.e., number of nucleotides) and have a greater 
number of phosphate chromophores.  Upon examination of the relative abundances of 
products ions of varying length vs. irradiation time, a similar trend is observed (Figure 
9.7b).  Product ions containing all 21 nucleotides (i.e., base loss ions) were initially 
observed as the most abundant fragment ion at irradiation times less than 5 ms.  As the 
Figure 9.7 (a) Average charge state (absolute value) and (b) average length (in # of
nucleotides) of product ions of GAPDH.S in the 5- (squares), 5+ (upside-
down triangles), 4- (circles) and 4+ (triangles) charge states as a function of
irradiation time.  Values from the CID mass spectra are also plotted as the
right most points in each panel. 
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irradiation increased, the abundance of longer product ions decreased and product ions 
containing fewer nucleotides increased.  As the irradiation time increased from 7 to 9 ms, 
the average length of the product ions of the 5- charge state of GAPDH.S was reduced 
from ~9 to ~7 nucleotides but at 20 ms of irradiation, less than 8% of the total ion current 
was composed of product ions of greater than 6 nucleotides.  For the GAPDH.S cations, 
the abundance of product ions with fewer than 6 nucleotides actually decreased at 
irradiation times greater than 10 – 12 ms as these small product ions were dissociated into 
protonated base ions.  These trends suggest that both the charge state and the number of 
chromophores (i.e., phosphate groups) influence the rate of IR photodissociation of 
oligoribonucleotides. 
The IRMPD results using a short and a longer irradiation time complement each 
other in that each provide different levels of sequence confirmation.  Short irradiation 
times predominantly yield large product ions in high charge states and a minimal 
abundance of [a - Base] and w-type ions which simplifies spectral interpretation as one 
only has to search for a single ion type.  By using longer irradiation times, one can more 
easily unambiguously identify the product ions as a majority of the species will be singly 
or doubly charged.  Also, the presence of more [a – Base] and w-type ions provides 
confirmation of the nucleobase and the sequence.  For potential de novo sequencing 
algorithms, it may be better to provide a product ion mass spectrum which only contains 
a single 5’-series and a single 3’-series of product ions (e.g., the c- and y-ions), but for 
database searching, more product ions (e.g., [a - Base], c-, w-, y-type ions) may yield 
more confident results.  IRMPD of siRNAs can yield product ion mass spectra containing 
both types of information. 
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Figure 9.8 Charge state distribution of product ions observed in IRMPD mass spectra 
of (a) 5- and (b) 4- charge states of GAPDH.S as a function of irradiation
time.  Relative abundances of product ions containing 1-4, 5-8, 9-12, 13-16, 
17-20, and 21 nucleotides as a function of irradiation time in the IRMPD 
mass spectra of the (c) 5- and (d) 4- charge states of GAPDH.S. 
Abundances are relative to the total ion current in the IRMPD mass spectra.
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Figure 9.9 Charge state distribution of product ions observed in IRMPD mass spectra
of (a) 5+ and (b) 4+ charge states of GAPDH.S as a function of irradiation
time.  Relative abundances of product ions containing 1-4, 5-8, 9-12, 13-16, 
17-20, and 21 nucleotides as a function of irradiation time in the IRMPD
mass spectra of the (c) 5+ and (d) 4+ charge states of GAPDH.S.
Abundances are relative to the total ion current in the IRMPD mass spectra.
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9.4.3 IRMPD vs. CID of Duplex siRNA 
For effective down-regulation of target genes, duplex siRNA generally needs to 
be introduced to the organisms.  The annealed duplex GAPDH and duplex Lamin A/C 
siRNAs were characterized by both CID and IRMPD.  Strand separation was observed 
upon CID of duplex GAPDH in the 9- charge state as shown in Figure 9.10a.  Similar 
results were observed for the other charge states of duplex GAPDH and for duplex Lamin 
A/C (data not shown).  Asymmetric charge partitioning of the duplex siRNAs is evident 
in Figure 9.10a in which the two single-strands are observed in the 6- charge state 
preferentially as opposed to the more symmetric 5- and 4- charge states.  (It is presumed 
that the 3- charge state of the single-strands is also produced, however, these ions are not 
observed as they have m/z values beyond that of the mass analyzer.)  The CID results are 
in line with previous reports on the gas-phase dissociation trends of DNA duplexes.39-41  
Diagnostic sequence ions were observed by CID when the collisional energy was 
increased as  previously reported,27 but the sequence coverage was limited to less than 5 
nucleotides (data not shown).  IRMPD using 2.0 ms of irradiation yielded a product ion 
mass spectrum (Figure 9.10b) almost identical to the CID mass spectrum in which the 
only dissociation channel observed was strand separation.  With longer irradiation times, 
however, these single strands dissociated into diagnostic sequence ions, predominantly c- 
and y-type product ions, as shown in Figure 9.10c.  Due to homologous sequences 
between the two single strands, the origin of many of the product ions could not be 
unambiguously determined, and the overall sequence coverage of the individual single 
strands was low.  All product ions observed were in the 1- or 2- charge state and none 
contained greater than eight nucleotides.  While IRMPD of siRNA duplexes can yield 
informative product ions, the sequence information is limited to generally between 5 and 
8 nucleotides from either terminal.   
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9.5 CONCLUSIONS
Infrared multiphoton dissociation of model single-strand siRNAs yields complete 
sequence coverage and has been shown to be a complementary dissociation method to 
traditional ion-trap based collision-induced dissociation.  IRMPD affords rapid and 
Figure 9.10 (a) CID product ion mass spectra of [duplex GAPDH – 9H]9- of m/z 1475 
(17% normalized collision energy).  IRMPD product ion mass spectra of the 
same duplex siRNA anion using (b) 2.0 ms and (c) 8.0 ms of irradiation at
10 W (q-value = 0.1).  The precursor ion is indicated by an asterisk (*) and
internal ions by #.  Sense and antisense single strands are indicated by S and
AS, respectively. 
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efficient dissociation of siRNAs in less than 10 ms.  The siRNA ions preferentially 
dissociated through cleavage of the 5’ P–O bonds by both IRMPD and CID to produce 
c/y-type sequence ions.  The other dominant dissociation pathway was loss of neutral 
nucleobases from the siRNA anions or loss of protonated nucleobases from precursor 
cations.  While CID produced high abundances of base loss ions, the irradiation time 
could be tuned to reduce the abundance of these uninformative product ions through 
secondary dissociation to yield higher abundances of c- and y-type fragment ions.  The 
large degree of secondary dissociation also produced higher abundances of [a - Base] and 
w-type ions, as well as internal ions due to cleavage of two 5’ P–O bonds.  At long 
irradiation times, larger and more highly charged product ions were also dissociated into 
shorter products in lower charge states.  In fact, at irradiation times of greater than 10 ms, 
greater than 90% of the identified product ions were singly or doubly charged.  While this 
effect reduced the total number of unique fragment ions in the IRMPD mass spectra, full 
sequence was still obtained and the product ion mass spectra was simpler to interpret.  
IRMPD of the siRNA cations produced high abundances of protonated bases with the 
exceptions of uracil and thymine.  The protonated bases were only detected in the 
IRMPD mass spectra due to the alleviation of the low-mass cut-off.  Both CID and 
IRMPD of the siRNA cations in charge levels above 20% yielded full sequence coverage 
and only c- and y-type fragment ions were observed; [a - Base] and w-ions were detected 
at insignificant levels.  Near complete sequence coverage was obtained for most of the 
siRNA anions and cations by both IRMPD and CID.  The primary differences between 
the IRMPD and CID mass spectra were in the total number of product ions observed.  
With longer irradiation times, larger product ions were eliminated from the IRMPD mass 
spectra (due to conversion to smaller, diagnostic ions), however full sequence coverage 
was generally maintained in all cases.  Short irradiation times typically yielded near 
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complete series of c- and y-type ions, similar to results obtained by CID.  These results 
suggest IRMPD analysis of siRNA in the positive ion mode may be a more fruitful means 
of sequencing oligoribonucleotides as the cations primarily dissociated through a single 
pathway to yield c- and y-type ions.  While duplex siRNA predominantly underwent 
strand separation by CID, either single strands or sequence ions were produced by 
IRMPD by varying the irradiation time. 
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Mass spectrometry has continued to play a greater role in the field of proteomics, 
particularly for the structural characterization of biological complexes.  Chemical cross-
linking of proteins along with mass spectrometric analysis has shown to be an effective 
tool to obtain low resolution distance constraint information and for three-dimensional 
structural determination of proteins as well as to map interfaces of protein-protein 
interactions.  As this field continues to expand, there is a growing need to develop 
analytical tools to more readily and confidently identify chemical cross-links.  In this 
dissertation, selective dissociation methods coupled with chromogenic cross-linkers were 
developed, and systematic studies focusing on the gas-phase dissociation trends of cross-
linked peptides and RNA were examined. 
Intermolecularly cross-linked peptides were observed to have similar dissociation 
trends to linear peptides, as discussed in Chapter 3.  Both prolyl and aspartyl residues 
influenced the dissociation of cross-linked peptides identically to that observed for 
unmodified peptides.  For cross-linked peptides containing prolyl residues, cleavage N-
terminal to the proline was dominant, and in particular for cross-linked peptide ions 
without a mobile proton, a high degree of internal ion formation was observed with Pro 
as the N-terminal residue.  Cleavage C-terminal to aspartyl residues was dominant also 
for cross-linked peptide ions with all protons sequestered.  Collision-induced dissociation 
of cross-linked peptides possessing mobile protons predominantly yielded single 
cleavage product ions due to dissociation of a single amide bond of one of the two 
constituent peptides.  A high abundance of double cleavage product ions were detected 
for cross-linked peptides without mobile protons.  In addition, cross-linker specific 
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product ions were detected for all species.  Incorporation of these dissociation trends into 
database search algorithms should improve sequencing of cross-linked peptides and 
facilitate more accurate protein identification for in vivo cross-linking experiments in 
which the proteins cross-linked are unknown a priori. 
An IR chromogenic cross-linker (IRCX) possessing a phosphate was utilized to 
provide rapid differentiation of cross-linked peptides in enzymatic digests and to simplify 
the product ion spectra of cross-linked peptides by selective IRMPD, as reported in 
Chapter 4.  Only peptides containing the chromogenic cross-linker were observed to 
undergo efficient and complete dissociation by IR irradiation.  All primary product ions 
which possessed the cross-linker underwent secondary photodissociation resulting in 
IRMPD mass spectra which predominantly contained y-type product ions originating 
from each peptide C-terminal to the cross-linked lysines.  These series of y-ions could 
potentially be used to de novo sequence the cross-linked peptides for identification of the 
site of cross-link and to identify the proteins.  Research in the Brodbelt group is currently 
aimed at applying widely used database search algorithms to more confidently identify 
and sequence cross-linked peptides. 
As discussed in Chapter 5, selective photodissociation methods were further 
applied to conjugated peptides, in which a bis-arylhydrazone (BAH) UV-chromophore 
was formed only upon cross-linked, allowing the use of UVPD for rapid differentiation of 
cross-linked and un-cross-linked products.  UVPD also provided greater sequence ion 
coverage than CID alone for the BAH-conjugated peptides.  The UVPD efficiencies were 
charge-dependent – protonation of the hydrazone bond was necessary for successful 
UVPD which mirrored the solution phase behavior of the chromophore.  BAH-
conjugated peptides were further analyzed by ETD and preferential dissociation of the 
hydrazone bond was observed (Chapter 6).  Preferential cleavage of the hydrazone bond 
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yielded the two constituent peptides – one with a 131 Da mass tag (even-electron) and the 
other with a 119 Da mass tag (odd-electron).  These modified peptides were subsequently 
characterized by CID to sequence the peptides and locate the original site of cross-
linking.  Greater sequence coverage of the peptides was obtained by the ETD-CID 
method than CID of the intact cross-linked peptides.  This preferential dissociation of 
BAH-cross-linked has great potential for not only the characterization of protein-protein 
complexes but as a complement or substitute to MS-based applications utilizing gas-
phase labile bonds.  As an ergodic dissociation method in which the internal energy is re-
distributed amongst all vibrational modes of the ion, CID may not predominantly result in 
cleavage of the desired bond due to competing low-energy dissociation pathways.  
However, ETD should generally result in preferential cleavage of the hydrazone bond 
regardless of the presence of labile functional groups on the peptide.  Further 
investigation and research into the hydrazone bond functionality as it relates to ETD 
including molecular modeling studies is ongoing. 
IRMPD of peptide cations was explored on a dual pressure linear ion trap (LIT) 
mass spectrometer (Chapter 7).  Peptide cations were observed to undergo efficient and 
rapid photodissociation exclusively in the low pressure cell due to the lower rate of 
collisional deactivation.  No dissociation was detected when peptide ions were irradiated 
in the high pressure cell or in similar experiments on a single cell LIT.  Greater sequence 
coverage of the peptides was obtained by IRMPD performed in the low pressure cell than 
CID.  In fact, IRMPD generally produced singly-charged product ions due to secondary 
dissociation of the more-highly charged primary product ions, which resulted in product 
ion mass spectra that were more easily interpreted.  As the necessary instrument 
modifications to interface lasers to quadrupole ion trap mass spectrometers become less 
arduous and the shortcomings of IRMPD are circumvented, IRMPD will likely be 
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presented as an option on commercial instruments similar to that already available for 
FT-ICR mass spectrometers.    
In Chapter 8, supplemental IR irradiation was applied to reduce the chemical 
noise in ESI mass spectra and to increase the abundance of protonated analyte ions.  The 
chemical noise was determined to predominantly consist of highly solvated analyte ions 
of unresolved m/z, and IR irradiation of the noise regions effectively “desolvated” these 
ions.  IR irradiation was observed to more effectively reduce chemical noise than 
collisional activation.  Due to the high bath gas pressure in the linear ion trap, 
supplemental IR irradiation selectively dissociates only species with low dissociation 
energies such as non-covalent complexes of solvated ions and does not result in covalent 
bond dissociation.  To improve sensitivity, one could envision irradiating ions of a wide 
range of m/z values in the high pressure cell of the dual pressure LIT to increase analyte 
ion abundance and then transfer this greater ion population to the low pressure cell for 
IRMPD and peptide sequencing. 
Complete sequence coverage of siRNA anions and cations was obtained by 
IRMPD (Chapter 9).  RNA is well-suited for sequence analysis by IRMPD because of its 
IR chromogenic phosphodiester backbone which allows for it to be rapidly dissociated by 
IR irradiation.  IRMPD of siRNA anions predominantly yielded c- and y-ions and [a-
Base]/w-ions to a lesser degree.  In contrast, IRMPD mass spectra of siRNA cations were 
dominated by c- and y-type ions with [a-Base]/w-ions contributing insignificantly to the 
product ion current.  IRMPD of duplex siRNA yielded sequence ions originated from 
both single strands whereas CID resulted in strand separation providing no sequence 
coverage.  The IRMPD mass spectra could be “tuned” to predominantly consist of singly 
and doubly charged product ions or of larger, more highly charged species by adjusting 
the IR irradiation time.   
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The work presented in this dissertation helps pave the way for the analysis of 
larger macromolecular complexes whose functions or structure have yet to be 
determined.  Ribonucleoproteins are a prime example of biologically relevant complexes 
which the techniques described herein could be applied.  RNA-protein complexes could 
be covalently chemically or photo-cross-linked for analysis by selective 
photodissociation mass spectrometry.  As unmodified peptides are not observed to 
undergo efficient IRMPD, only peptides bound to the RNA, which is inherently IR 
chromogenic due to its phosphodiester backbone, would photodissociate allowing ready 
differentiation between RNA-peptide cross-links from free RNA or peptide ions.  
Furthermore, ETD could be applied to these cross-linked species which would selectively 
cleave the peptide backbone and allow the sites of cross-links to be pinpointed.  Ongoing 
work in the Brodbelt group is focusing on using IRCX with selective IRMPD for the 
characterization of eukaryotic translation initiation factor-4E (eIF4E) with its protein 
binding partners as well as its mRNA target.  The structure eIF4E protein and its 
complexes are of interest as protein synthesis in eukaryotic cells begins with the binding 
of eIF4E with mRNA. 
As the complexity of the biological macromolecules increases, there is a growing 
need for higher resolution and higher mass accuracy mass spectrometers.  This research 
has led to the design, development, and current construction of a quadrupole – rectilinear 
ion trap – time-of-flight (Q-RIT-TOF) mass spectrometer in the Brodbelt group.  The Q-
RIT-TOF will be able to analyze ions of a larger mass range (> m/z 50,000) while 
providing higher mass resolution than that available on quadrupole ion trap mass 
spectrometers.  This instrument will have dual sources – one for electrospray ionization 
of the macromolecular complex and the second for reagent anions – and have an IR laser 
or UV laser interfaced to allow for multiple types of ion activation and dissociation to be 
 261
performed simultaneously or sequentially during a single experiment.  Intact 
macromolecular complexes will be subjected to IR or UV irradiation and then the 
primary product ions which will exist in multiple charge states, will undergo proton 
transfer reactions with a reagent anion to reduce the product ions to lower charge states 
for TOF-MS analysis.  It is the goal that a combination of selective dissociation methods 
along with higher resolution MS analysis will allow for more rapid and definitive 
structural characterization of biological macromolecular complexes. 
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